Advertisement

Arzneiformen

  • Th. Wimmer
  • M. Van Ooteghem
  • W. Schneider
  • J. Setter
  • C. Müller-Goymann
  • M. Folger
  • T. Rades
  • R. G. Werner
  • H. Langlouis-Gau
  • J. Friesejones
  • R. Rössler
  • Lösungsmittel Wasser
  • C.-D. Herzfeldt
  • C.-M. Lommer
  • K. Knop
  • B. C. Lippold
  • E. Nürnberg
  • B. Nürnberg
  • H. Egermann
  • I. Benes
  • H. Ungeheuer
  • K. Klokkers-Bethke
  • G. Schepky
  • M. Dittgen
  • E. Spingler
  • M. Bornschein
  • J. Ziegenmeyer
  • J. Lingnau

Zusammenfassung

Aerosole sind eine vergleichsweise moderne Darreichungsform. Monographien für Zubereitungen in Druckbehältnissen sind erst in jüngerer Zeit in ausführlicher Form in die Arzneibücher aufgenommen worden. Der Vorteil von Aerosolen ist die feine Verteilung der Arzneistoffe, die bei der Inhalation eine pulmonale Resorption ermöglicht. Der Wirkungseintritt entspricht u. U. dem einer i. v. Injektion und erlaubt eine Umgehung des First-pass-Effektes.

Literatur

  1. 1.
    Molina MJ, Rowland FS (1974) Nature 249:810–812Google Scholar
  2. 2.
    Thoma K (1984) Aerosole und Sprays — gegenwärtiger Stand und Entwicklungstendenzen. In: Concept Heidel-berg (Hrsg.), Pharma Technologie, Heidelberg, S. 94–102Google Scholar
  3. 3.
    Voigt R (1987) Lehrbuch der pharmazeutischen Techno-logie, 6. Auflage, Verlag Chemie, WeinheimGoogle Scholar
  4. 4.
    Stoffel G (1990) Seifen, Oele, Fette, Wachse 116:150–151Google Scholar
  5. 5.
    Kaufmann L (1984) Aluminium-Monobloc-Aerosoldo-sen; Herstellung und Normierung. In: Concept Heidel-berg (Hrsg.), PharmaGoogle Scholar
  6. 6.
    Technologie, Heidelberg, S. 109–112Google Scholar
  7. 7.
    Warnke G (1988) aerosol report 27:297–304Google Scholar
  8. 8.
    Simpson A (1989) Seifen, Fette, Oele, Wachse 115:107–111Google Scholar
  9. 9.
    Miles GM (1987) Seifen, Oele, Fette, Wachse 113:433–436Google Scholar
  10. 10.
    Firmeninformation Fa. Coster GmbH, D-6000 Frank-furt/Main Industrie-Gemeinschaft Aerosole e.V. (IGA) (1989) aero-sol report 28:607–610Google Scholar
  11. 11.
    Sickmüller B (1989) Pharm Ind 51:616–632Google Scholar
  12. 12.
    Propan-Menke, Shell-Treibmittel für Aerosole, HamburgGoogle Scholar
  13. 13.
    Lehmann H (1987) aerosol report 26:40–45Google Scholar
  14. 14.
    Grigo J (1975) Pharm Ind 37:18–21Google Scholar
  15. 15.
    Thoma K (1979) Aerosole, Werbe-und Vertriebsges. deut-scher Apotheker, Frankfurt/MainGoogle Scholar
  16. 16.
    Fischer FX, Hess H, Sucker H, Byron PR (1989) Pharm Technol Int 1:16–18Google Scholar
  17. 17.
    Tauscher W, (1987) Seifen, Oele, Fette, Wachse 113: 419–422Google Scholar
  18. 18.
    Frigen®-Informationsdienst der Hoechst AG (1987) Sei-fen, Oele, Fette, Wachse 113:423–424Google Scholar
  19. 19.
    Litchfleld MH, Longstaff E (1984) Food Chem Toxicol 22:465–475Google Scholar
  20. 20.
    Debets FMH (1990) aerosol report 29:16–22Google Scholar
  21. 21.
    Tauscher W (1990) Seifen, Oele, Fette, Wachse 116:137–140Google Scholar
  22. 22.
    Anonym (1986) Seifen, Oele, Fette, Wachse 112:104–106Google Scholar
  23. 23.
    Stoffel G (1990) aerosol report 29:73–80Google Scholar
  24. 24.
    Thoma K, Merk B, (1986) Neue Arzneiformen in der Apothekenrezeptur: Kapseln, Pumpsprays, Cremes, Hy-drogele; Schriftenreihe der Bayer. Landesapothekerkam-mer, Heft 34, München, S. 53–62Google Scholar
  25. 25.
    Szirmai S, Baktay G, Ginesi O, Cserfalvi T, Farkas A, Körnony M (1987) aerosol report 26:353–361Google Scholar
  26. 26.
    Tauscher W (1990) aerosol report 29:89–102Google Scholar
  27. 27.
    Schönfeld KW (1970) aerosol report 9:340–348Google Scholar
  28. 28.
    Gewerbeaufsichtsamt Sigmaringen (1987) aerosol report 26:280–284Google Scholar
  29. 29.
    Eichner K (1984) Die pharmazeutisch-galenische Doku-mentation bei der Zulassung von Aerosolen. In: Concept Heidelberg (Hrsg.), Pharma Technologie, Heidelberg, S. 105–108Google Scholar
  30. 30.
    Anonym (1990) Seifen, Oele, Fette, Wachse 116:225–226Google Scholar
  31. 31.
    Schmidt R (1988) Seifen, Oele, Fette, Wachse 114:662–665Google Scholar
  32. 32.
    Schütz W (1989) Seifen, Oele, Fette, Wachse 115:411–414Google Scholar
  33. 1.
    Thews G, Mutschier E, Vaupel P (1980) Gesichtssinn. In: Anatomie, Physiologie, Pathophysiologic des Men-schen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 588–613Google Scholar
  34. 2.
    Pedler C (1962) Exp Eye Res 1:286–289PubMedGoogle Scholar
  35. 3.
    Davson H (1980) The vegetative physiology and bioche-mistry of the eye. In: Physiology of the eye, 4th ed., Chur-chill Livingstone, Edinburgh, p 89–115Google Scholar
  36. 4.
    Pfister RR, Burstein N (1976) Invest Ophthalmol Vis Sci 15:246–259Google Scholar
  37. 5.
    Millodot M (1984) Ophthalm Physiol Opt 4:305–318Google Scholar
  38. 6.
    Botelho SY (1964) Sci Am 211:78–85PubMedGoogle Scholar
  39. 7.
    Doane MG (1981) Ophthalmology (Rochester) 88:844–851Google Scholar
  40. 8.
    Mishima S, Gasset A, Klyce SO, Baum JL (1966) Invest Ophthalmol Sci 15:264–266Google Scholar
  41. 9.
    Jordan AJ, Baum JL (1980) Ophthalmology (Rochester) 87:920–930Google Scholar
  42. 10.
    Crandall DC, Leopold IH (1979) Ophthalmology (Ro-chester) 86:115–125Google Scholar
  43. 11.
    Polak BCP (1987) Doc Ophthalmol 67:115–117PubMedGoogle Scholar
  44. 12.
    Norn M (1985) Trans Ophthalmol SocUK 104:410–414PubMedGoogle Scholar
  45. 13.
    Krupin T, Cross DA, Becker B (1977) Arch Ophthalmol 95:107–108PubMedGoogle Scholar
  46. 14.
    Egger-Büssing CH, Zirm M (1980) Klin Monatsbl Au-genheilk 176:85–87Google Scholar
  47. 15.
    Zirm M (1982) Der Tränenfilm im Normalen und Patho-logischen. In: Marquardt R (Hrsg.) Chronische Con-junctivitis trockenes Auge, Springer, Wien New York, S. 88–104Google Scholar
  48. 16.
    Ibrahim H, Buri P, Gurny R (1988) Pharm Acta Helv 63:146–154PubMedGoogle Scholar
  49. 17.
    Calabria G, Rolando M (1984) Struttura e funzione del film lacrimale. In: Calabria G, Rolando M (eds.) Fisiopa-tologia del film lacrimale, Simposio del 64° Congresso del Società Oftalmol Ital Genova, p 9–15Google Scholar
  50. 18.
    Drew GC (1951) Quart J Exp Psychol 3:73–88Google Scholar
  51. 19.
    Carney LG (1984) Int Contact Lens Clin 11:249–252Google Scholar
  52. 20.
    Welsch FB, Hoyt WF (1969) Clinical Neurophthalmo-logy, Williams & Wilkins, Baltimore, p 318–328Google Scholar
  53. 21.
    Doane MG (1980) Am J Ophthalmol 89:507–516PubMedGoogle Scholar
  54. 22.
    Hung G, Hsu F, Stark L (1977) Am J Optom Physiol Opt 54:678–690PubMedGoogle Scholar
  55. 23.
    Maurice DM (1987) Kinetics of topically applied oph-thalmic drugs. In: Saettone MF, Bucci M, Speiser P (eds.) Ophthalmic Drug Delivery. Fidea Research Series, Vol. 11, Srpinger, Berlin Heidelberg New York Tokyo, p 19–26Google Scholar
  56. 24.
    Schoenwald RD, Huang HS (1983) J Pharm Sci 72:1266–1272PubMedGoogle Scholar
  57. 25.
    Wilson FM (1979) Surv Ophthalmol 24:57–88PubMedGoogle Scholar
  58. 26.
    Scoville B, Krieglstein GK, Then E, Yokoyama S, Yokoyama T (1985) J Clin Pharmacol 25:210–218PubMedGoogle Scholar
  59. 27.
    Draize JH, Woodard G, Calvery HO (1944) J Pharmacol Exp Ther 82:377–390Google Scholar
  60. 28.
    Kelly C (1989) United States Pharmacopeial Forum, Jan/Feb:4815–4824Google Scholar
  61. 29.
    Lippa EA, Von Denffer HA, Hofmann HM, Brunner- Ferber FL (1988) Arch Ophthalmol 106:1694–1696Google Scholar
  62. 30.
    Benedetto DA (1982) Invest Ophthalmol Vis Sci 21 (AR- VOSuppl.):221Google Scholar
  63. 31.
    Chrai SS, Makoid MC, Eriksen SP, Robinson JR (1974) J Pharm Sci 63:333–338PubMedGoogle Scholar
  64. 32.
    File RR, Patton TF (1980) Arch Ophthalmol 98:112–115PubMedGoogle Scholar
  65. 33.
    Terry JE, Hill RM (1978) Arch Ophthalmol 96:120–122PubMedGoogle Scholar
  66. 34.
    Benjamin WJ, Hill RM (1983) Invest Ophthalmol Vis Sci 24:1624–1626PubMedGoogle Scholar
  67. 35.
    Gilbard PJ, Farris RL (1978) Arch Ophthalmol 96: 677–681PubMedGoogle Scholar
  68. 36.
    Holly FJ, Lamberts DW (1981) Invest Ophthalmol Vis Sei 20:236–245Google Scholar
  69. 37.
    Mishima S (1965) Exp Eye Res 11:30–33Google Scholar
  70. 38.
    Barendsen H, Oosterhuis JA, Van Haeringen NJ (1979) Ophthalmic Res 11:83–89Google Scholar
  71. 39.
    Carney LG, Hill RM (1976) Arch Ophthalmol 94:821–824PubMedGoogle Scholar
  72. 40.
    Fisher FH, Weiderholt M B (1982) Graefes Arch Clin Exp Ophthalmol 96:677–681Google Scholar
  73. 41.
    Hill RM, Carney LG (1978) J Am Optom Assoc 49:269–270PubMedGoogle Scholar
  74. 42.
    Dahl H, Dahl C (1985) Acta Ophthalmol (Copenhagen) 63:692–694Google Scholar
  75. 43.
    Thygesen JEM, Jensen OL (1987) Acta Ophthalmol (Co-penhagen) 65:134–136Google Scholar
  76. 44.
    Norn MS (1988) Acta Ophthalmol 66:485–489Google Scholar
  77. 45.
    Abelson MB, Sadun AA, Udell IJ, Weston JH (1980) Am J Ophthalmol 90:866–869PubMedGoogle Scholar
  78. 46.
    Jaros PA, Coles WH (1983) CLAO Journal 9:333–336PubMedGoogle Scholar
  79. 47.
    Holly FJ, Lemp MA (1971) Exp Eye Res 11:239–250PubMedGoogle Scholar
  80. 48.
    Tiffany JM, Winter N, Bliss G (1989) Curr Eye Res 8:507–515PubMedGoogle Scholar
  81. 49.
    Efron N, Young G, Brennan NA (1989) Curr Eye Res 8:507–515Google Scholar
  82. 50.
    Wilson WS, Duncan AJ, Jay JL (1975) Br J Ophthalmol 59:667–669PubMedGoogle Scholar
  83. 51.
    Hamano H, Mitsunaga S (1973) Jpn J Ophthalmol 17:290–299Google Scholar
  84. 52.
    Schuller WO, Yang WH, Hill RM (1972) J Am Optom Ass 43:1358–1361Google Scholar
  85. 53.
    Eastman NC, Rose JK (1968) Hydroxyethylcellulose. In: Davidson RL, Settig M (eds.) Water soluble resins, Rein-hold Book Corp., New York, p 63–90Google Scholar
  86. 54.
    Dudinski O, Finnin BC, Reed BL (1983) Current Ther Res 33:322–337Google Scholar
  87. 55.
    Wallhäusser KH (1988) Luftkeimzahlen-Standards- Richtlinien, Beispiele. In: Wallhäusser KH (Hrsg.) Praxis der Sterilisation-Desinfektion-Konservierung, 4. Aufl.,Thieme, Stuttgart, S. 138–141Google Scholar
  88. 56.
    Botzenhart K (1980) Erfassung und Beurteilung von Luftkeimen aus hygienischer Sicht, Concept Symposi-um, Heidelberg, S. 74Google Scholar
  89. 57.
    Watsky MA, Jablonski MM, Edelhauer HE (1988) Curr Eye Res 7:483–486PubMedGoogle Scholar
  90. 58.
    Rao NA, Riggio DW, Delmage JM, Calandra AJ, Evans S, Lewis W (1985) Curr Eye Res 4:851–856PubMedGoogle Scholar
  91. 59.
    Stern GA, Lubniewski A, Allen C (1985) Arch Ophthal-mol 103:1221–1225Google Scholar
  92. 60.
    Selsted ME, Martinze RJ (1982) Exp Eye Res 34:305–318PubMedGoogle Scholar
  93. 61.
    Allen HF, Mangiaracine AB (1964) Arch Ophthalmol 72:452–462Google Scholar
  94. 62.
    McJulloch JC (1943) Arch Ophthalmol 29:924–935Google Scholar
  95. 63.
    Harte VJ, Hanrahan MT, Timoney RF (1978) Int J Pharmacol 1:165–171Google Scholar
  96. 64.
    Lass JH, Haaf J, Foster CS, Belcher C (1981) Am J Oph-thalmol 92:384–390Google Scholar
  97. 65.
    Mayo MS, Schlitzer RL, Ward MA, Wilson LA, Ahearn DG (1987) J Clin Microbiol 25:1398–1400PubMedGoogle Scholar
  98. 66.
    Stehr-Green JK, Bailey TM, Brandt FH, Carr JH, Bond WW, Visvesvara GS (1987) J Am Med Assoc 258:57–60Google Scholar
  99. 67.
    Easty DL (1978) Practitioner 220:581–590PubMedGoogle Scholar
  100. 68.
    Coombs RRA, Gell PGH (1975) Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell PHG, Coombs RRA, Lachmann PJ (eds.) Clinical aspects of immunology, Blackwell, Lon-don Melbourne, p 761–781Google Scholar
  101. 69.
    Allansmith MR, Ross RN (1988) Clin Allergy 18:1–13PubMedGoogle Scholar
  102. 70.
    Fraunfelder FT, Meyer SM (1989) Drug induced ocular side effects. Drug Interactions, 3rd. Ed., Lea & Febiger, Philadelphia London, p 1–489Google Scholar
  103. 71.
    Hätinen A, Teräsvirta M, Fräki JE (1985) Acta Ophthal-mol (Copenhagen) 63:424–426Google Scholar
  104. 72.
    Kruyswijk MRL, Van Driel LMJ, Polak BCP, Go-Senne-ma N (1979) Doc Ophthalmol 48:251–253Google Scholar
  105. 73.
    Polak BCP (1988) Bijwerkingen van geneesmiddelen in de oogheelkunde. In: Vorderingen in de geneeskunde II. Stafleu Alphen a/d Rijn, Brüssel, S. 71–85Google Scholar
  106. 74.
    Burstein NL (1985) Trans Ophthalmol Soc UK 104:402–409PubMedGoogle Scholar
  107. 75.
    Bourrinet P, Rodde D (1975) Labo-Pharma Probl Tech 240:121–124Google Scholar
  108. 76.
    Gasset AR (1977) Am J Ophthalmol 84:169–171PubMedGoogle Scholar
  109. 77.
    Boer Y (1981) Pharm Weekbl Sei Ed 3:826–827Google Scholar
  110. 78.
    Van Haeringen NJ (1987) Pharm Weekbl 122:1101–1102Google Scholar
  111. 79.
    Ludwig A, Van Ooteghem M (1989) J Pharm Belg 44:391–397PubMedGoogle Scholar
  112. 80.
    Bisantis C, Squeri CA, Colsi P, Provenzano P, Trombetta C (1982) Bull Mem Soc Fr Ophthalmol 94:75–78Google Scholar
  113. 81.
    Riegelman S, Vaughan DG (1958) J Am Pharm Ass Pract Ed 8:474–477Google Scholar
  114. 82.
    Trolle-Lassen C (1958) Pharm Weekbl 93:148–155PubMedGoogle Scholar
  115. 83.
    Maurice DM (1971) Exp Eye Res 11:30–33PubMedGoogle Scholar
  116. 84.
    Ludwig A, Van Ooteghem M (1987) J Pharm Belg 42:259–266PubMedGoogle Scholar
  117. 85.
    Mishima S, Herbeys BO (1967) Exp Eye Res 6:10–32PubMedGoogle Scholar
  118. 86.
    Dolder R (1990) Die Angleichung des pH-Wertes. In: Dolder R, Skinner F (Hrsg.) Ophthalmika, 4. Aufl., Wis-senschaftliche Verlagsgesellschaft, Stuttgart, S. 385–393Google Scholar
  119. 87.
    Motolko M, Breslin CW (1981) Am J Ophthalmol 91:781–784PubMedGoogle Scholar
  120. 88.
    Hill RM, Carney LG (1980) Invest Ophthalmol Vis Sei 19:207–210Google Scholar
  121. 89.
    Carney LG, Mauger TF, Hill RM (1990) Acta Ophthal-mol (Copenhagen) 68:75–79Google Scholar
  122. 90.
    Norn M (1985) Acta Ophthalmol (Copenhagen) 63, suppl. 173:32–34Google Scholar
  123. 91.
    Bron AJ (1985) Trans Ophthalmol Soc UK 104:801–826PubMedGoogle Scholar
  124. 92.
    Ludwig A, Van Ooteghem M (1989) Int J Pharm 54:95–102Google Scholar
  125. 93.
    Lang E, Mark D, Miller FA, Wik O (1984) Arch Ophthal-mol 102:1079–1082Google Scholar
  126. 94.
    Bothner H, Waaler T, Wik O (1990) Drug Dev Ind Pharm 16:755–768Google Scholar
  127. 95.
    Blaug SM, Canada AT (1965) Am J Hosp Pharm 22:662–666PubMedGoogle Scholar
  128. 96.
    Adler CA, Maurice DM, Paterson ME (1971) Exp Eye Res 11:34–42PubMedGoogle Scholar
  129. 97.
    Chrai SS, Robinson JR (1974) J Pharm Sei 63:1218–1223Google Scholar
  130. 98.
    Patton TF, Robinson JR (1975) J Pharm Sci 64:1312–1316PubMedGoogle Scholar
  131. 99.
    Steiger-Trippi K (1958) Schweiz Apoth Ztg 96:961–972Google Scholar
  132. 100.
    Benedetto DA, Shah DO, Kaufman HE (1975) Invest Ophthalmol 14:887–902PubMedGoogle Scholar
  133. 101.
    Duke-Elder S, Mac Faul P (1972) Retained Foreign Bo-dies. In: Duke-Elder S (ed.) System of Ophthalmology, Vol. XIV Injuries; Part 1 Mechanical Injuries, Kimpton, London, p 451–576Google Scholar
  134. 102.
    Müller F, Seidel H (1963) Pharmazie 18:803–807Google Scholar
  135. 103.
    Doden W (1959) Klin Mbl Augenheilk 135:305–347Google Scholar
  136. 104.
    Speiser P (1962) APV Informationsdienst 8:87–103Google Scholar
  137. 105.
    Skinner FS (1990) Die Teilchenfeinheit in Augensalben. In: Dolder D, Skinner FS (Hrsg.) Ophthalmika, 4. Aufl., Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 469–483Google Scholar
  138. 106.
    Jaensch PA (1958) Augenschädigungen in Industrie und Gewerbe, Wissenschaftliche Verlagsgesellschaft, Stutt-gart. 153–174Google Scholar
  139. 107.
    Speiser P (1967) II Farmaco (Ed. Prat.) 23:181–209Google Scholar
  140. 108.
    Borka L (1977) Norg Apot Tidsskr 85:440–442Google Scholar
  141. 109.
    Parrish CM, Chandler JW (1988) Corneal Trauma. In: Kaufman HE, Barron BA, McDonald MB, Waltman SR, The Cornea, Churchill Livingstone, New York, p 566–646Google Scholar
  142. 110.
    Gombos GM (1973) Handbook of ophthalmic emergen-cies, Medical Examination Publishing, Flushing, NY, p 99Google Scholar
  143. 111.
    Voigt R, Bornschein M (1973) Augentropfen. In: Lehr-buch der pharmazeutischen Technologie, VEB Verlag Volk und Gesundheit, Berlin, S. 459–467Google Scholar
  144. 112.
    Hamano H, Hori M, Kawabe H, Umeno M (1980) Folio Ophthalmol Jpn 31:529–532Google Scholar
  145. 113.
    Honegger H, Werry H (1990) Nebenwirkungen und Schädigungen durch Augentropfen und Augensalben. In: Dolder D, Skinner FS (Hrsg.) Ophthalmika, 4. Aufl., Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 14–24Google Scholar
  146. 114.
    Dorvault F (1978) L,Officine, Vigot, Paris, S. 346Google Scholar
  147. 115.
    Menghini C (1952) Pharm Acta Helv 27:91–206,212–228Google Scholar
  148. 116.
    Robinson JR, Goshman LM (1982) Topical Drug-Deli-very Systems (Eye, Ear, Nose). In: Banker G, Chalmers R (eds.) Pharmaceutics and Pharmacy Practice, Lippincott, Philadelphia, p 312–352Google Scholar
  149. 117.
    Bogs U (1960) Pharmazie 15:603–609Google Scholar
  150. 118.
    Trose D (1962) Pharmazie 17:81–85Google Scholar
  151. 119.
    Baeschlin K, Etter JC (1968) Schweiz Apoth Ztg 106:935–939Google Scholar
  152. 120.
    Nürnberg E (1986) Augentropfen, Guttae ophthalmicae. In: Hartke K, Mutschier E, DAB 9-Kommentar, Bd. 2, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 896Google Scholar
  153. 121.
    Akers M, Schoenwald R (1977) Drug Dev Ind Pharm 3:185–217Google Scholar
  154. 122.
    Hecht G, Roehrs R, Shively D (1979) Design and evalua-tion of ophthalmic products. In: Banker G, Rhodes C (eds.) Modern pharmaceutics, Dekker, New York, p 479–564Google Scholar
  155. 123.
    Vergazova S, Kandratyeeva T, Denisova T, Arzamastsev A (1985) Farmatsiya (Moscow) 34:32–35Google Scholar
  156. 124.
    Raether G, Wollmann H (1979) Pharmazie 34:667–668PubMedGoogle Scholar
  157. 125.
    Raether G, Wollmann H (1982) Pharmazie 37:382–383PubMedGoogle Scholar
  158. 126.
    Bojtor K, Gergely-Zobin A, Budvary-Barany Z, Gergely A (1985) Gyogyszereszet 24:449–452Google Scholar
  159. 127.
    Saettone MF, Giannaccini B, Delmonte G, Campigli V, Tota G, La Marca F (1988) Int J Pharm 43:67–76Google Scholar
  160. 128.
    Pharmacia AB, Uppsala (1985). Eye drop composition. Patent PCT WO 85/01875 von 9/5/85; ref. Pharm Ind (1966)46:676Google Scholar
  161. 129.
    Van Doorne H, Lerk CF (1988) Pharm Weekbl (Sei Ed) 10:100Google Scholar
  162. 130.
    Chiou GCY, Chuiang CY (1989) J Pharm Sei 78:815–818Google Scholar
  163. 131.
    Miestereck H (1981) Konservierung von Augentropfen. Referate des Symposions „Konservierung pharmazeuti-scher und kosmetischer Produkte“, Concept, Heidel-berg,4:21–26Google Scholar
  164. 132.
    Coad CT, Osato MS, Wilhelmus KR (1984) Am J Oph-thalmol 98:548–551Google Scholar
  165. 133.
    Äslund B, Olson OT, Sandell E (1978) Acta Pharm Suec 15:389–394PubMedGoogle Scholar
  166. 134.
    Templeton WC, Eiferman RA, Snyder JW, Melo JC, Raff MJ (1982) Am J Ophthalmol 93:723–726PubMedGoogle Scholar
  167. 135.
    Waylward G, Wilson RS (1987) Br Med J 294:1587Google Scholar
  168. 136.
    Hovding G, Sjursen H (1982) Acta Ophthalmol 60:213–222Google Scholar
  169. 137.
    Schein OD, Wasson PJ, Boruchoff SA, Kenyon KR (1988) Am J Ophthalmol 105:361–365PubMedGoogle Scholar
  170. 138.
    Wallhäusser KH (1974) Pharm Ind 36:716–722Google Scholar
  171. 139.
    Crawford SY (1989) Am J Hosp Pharm 46:1984Google Scholar
  172. 140.
    Wallhäusser KH (1978) Dtsch Apoth Ztg 118:1510–1515Google Scholar
  173. 141.
    Hamacher H (1976) Pharm Unserer Zeit 5:77–93PubMedGoogle Scholar
  174. 142.
    Abdou MAF (1973) Pharm Ind 35:857–867Google Scholar
  175. 143.
    Bean HS (1972) J SocCosmet Chem 23:703–720Google Scholar
  176. 144.
    Kohn SR, Gershenfeld L, Barr M (1963) J Pharm Sei 52:967–974Google Scholar
  177. 145.
    Zembrzuska E (1978) Farm Pol 34:233–235Google Scholar
  178. 146.
    Lingnau J (1977) Acta Pharm Technol 23:39–52Google Scholar
  179. 147.
    Anonym Codex der Augenarzneistoffe und Hilfsstoffe (1990). In: Dolder R, Skinner FS, Ophthalmika, 4. Aufl., Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 130–347Google Scholar
  180. 148.
    Wallhäusser KH (1985) Pharm Ind 47:191–202Google Scholar
  181. 149.
    Schlumpf R, Skinner FS (1990) Sterilität und Konservie-rung wäßriger Augentropfen. In: Dolder R, Skinner FS, Ophthalmika, 4. Aufl., Wissenschaftliche Verlagsgesell-schaft, Stuttgart, S. 415–441Google Scholar
  182. 150.
    Anonym (1987) Schweiz Apoth Ztg 125:526Google Scholar
  183. 151.
    Richards RME, Cavill RH (1976) J Pharm Sei 65:76–80Google Scholar
  184. 152.
    Tromp TFJ, Dankert J, De Rooy SH, Huizinga T (1976) Pharm Weekbl 111:561–569Google Scholar
  185. 153.
    Chrai S, Gupta S, Brychta K (1977) Bull Parenter Drug Assoc 4:195–200Google Scholar
  186. 154.
    Pohloudek-Fabini R, Martin E (1981) Pharmazie 36:683–685PubMedGoogle Scholar
  187. 155.
    Lüdtke E, Darsow H, Pohloudek-Fabini R (1977) Phar-mazie 32:99–100Google Scholar
  188. 156.
    Anthony Y, Meakin BJ, Davis DJG (1981) J Pharm Phar-macol 33:Suppl. 73PGoogle Scholar
  189. 157.
    Morton DJ (1985) Int J Pharm 23:357–358Google Scholar
  190. 158.
    Winder AF, Astbury NJ, Sheraidah GAK, Ruben M (1980) Lancet 2:237–239PubMedGoogle Scholar
  191. 159.
    Pohloudek-Fabini R, Martin E, Ramm R (1982) Pharma-zie 37:261–263Google Scholar
  192. 160.
    Garron LK, Wood IS, Spencer WH, Hayes TL (1976) Trans Am Ophthalmol Soc 74:295–320PubMedGoogle Scholar
  193. 161.
    Oelschläger H, Canenbley R (1983) Pharm Ztg 128:1166–1168Google Scholar
  194. 162.
    Wallhäusser KH (1988) Chlorhexidin. In: Wallhäusser KH (Hrsg.) Praxis der Sterilisation-Desinfektion-Kon-servierung, 4. Aufl., Thieme, Stuttgart, S. 562–564Google Scholar
  195. 163.
    Boer Y (1981) Pharm Weekbl Sei Ed 3:122–123Google Scholar
  196. 164.
    Wozniak-Parnowska W, Krowczynski L (1981) Pharm Int 2:91–94Google Scholar
  197. 165.
    Frauch P (1968) Schweiz Apoth Ztg 106:43–48,74–78Google Scholar
  198. 166.
    Dolder R (1978) Arzneiformen zur Anwendung an Auge, Ohr und Nase. In: Sucker H, Fuchs P, Speiser P (Hrsg.) Pharmazeutische Technologie, Thieme, Stuttgart New York, S. 693–729Google Scholar
  199. 167.
    Van Ooteghem M (1990) Viskosität. In: Dolder R, Skinner FS (Hrsg.) Ophthalmika, 4. Aufl., Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 393–407Google Scholar
  200. 168.
    Ludwig A, Van Ooteghem M (1989) The evaluation of cellulosic polymers in ophthalmic formulations. Proc 5th Int Conf Pharm Technology (APGI), Paris, Vol. 1, p 313–321Google Scholar
  201. 169.
    Kläwicke G (1969) Hydroxyaethylcellulosum. Kommen-tar zum Deutschen Arzneibuch 7. Ausgabe, Akademie Verlag, BerlinGoogle Scholar
  202. 170.
    Kassem MA, Attia MA, Habib FS, Mohamed AA (1987) Drug Dev Ind Pharm 13:1447–1469Google Scholar
  203. 171.
    Saettone M F, Giannaccini B, Ravecca S, La Marca F, Tota G (1984) Int J Pharm 20:187–202Google Scholar
  204. 172.
    Saettone MF, Alderigi C, Giannaccini B, Galli-Angeli D (1989) Drug Dev Ind Pharm 15:2621–2637Google Scholar
  205. 173.
    Nerlo H, Wilunska Z (1975) Farm Pol 31:565–569Google Scholar
  206. 174.
    Anderman G (1979) Dissertation, Universität StrasbourgGoogle Scholar
  207. 175.
    Krishna N, Brow F (1964) Am J Ophthalmol 57:99–106PubMedGoogle Scholar
  208. 176.
    Patton TE, Robinson JR (1975) J Pharm Sei 64:1312–1316Google Scholar
  209. 177.
    Saettone MF, Giannaccini B, Teneggi A, Savigni P, Teilini N (1982) J Pharm Pharmacol 34:464–466PubMedGoogle Scholar
  210. 178.
    Green K, Dows SJ (1975) Arch Ophthalmol 93:1165–1168PubMedGoogle Scholar
  211. 179.
    Callas B (1978) Dissertation, Universität MontpellierGoogle Scholar
  212. 180.
    Ludwig A, Van Ooteghem M (1988) Drug Dev Ind Pharm 14:2267–2284Google Scholar
  213. 181.
    Deshpande SG, Shirolkar S (1989) J Pharm Pharmacol 41:197–200PubMedGoogle Scholar
  214. 182.
    Ludwig A, Unlü N, Van Ooteghem M (1990) Int J Pharm 61:15–25Google Scholar
  215. 183.
    Van Bijsterfeld OP (1988) Z Prakt Augenheilk 9:151–154Google Scholar
  216. 184.
    Lemp MA, Szymanski S (1975) Arch Ophthalmol 93:134–136PubMedGoogle Scholar
  217. 185.
    Gossel TA (1985) US Pharm 10:20,22–24Google Scholar
  218. 186.
    Nelson JD, Farris RL (1988) Arch Ophthalmol 106:484–487PubMedGoogle Scholar
  219. 187.
    Saettone MF, Chetoni P, Torracca MT, Burgulassi S, Giannaccini B (1989) Int J Pharm 51:203–212Google Scholar
  220. 188.
    Hazlett LD, Barrett R (1987) Ophthalmie Res 19.277–284Google Scholar
  221. 189.
    Camber O, Edman P (1989) Current Eye Res 8:563–567Google Scholar
  222. 190.
    Gurny R, Ibrahim H, Aebi A, Buri P, Wilson CG, Washington N, Edman P, Camber O (1987) J Contr Rel 6:367–373Google Scholar
  223. 191.
    Limberg MB, McCaa C, Kissling GE, Kaufman HE (1987) Am J Ophthalmol 103:194–197PubMedGoogle Scholar
  224. 192.
    McDermott ML, Edelhauser HF (1989) Arch Ophthal-mol 107:261–263Google Scholar
  225. 193.
    Azuma I, Sakaguchi K, Yukioka Y, Miura M (1965) Acta Soc Ophthalmol Jap 68:1018–1023Google Scholar
  226. 194.
    Isacoff H, Ziegler TF (1978) Drug Cosmet Ind 126, 10:46–49Google Scholar
  227. 195.
    Maichuk YV, Tishina IF (1971) Vest Oftal 84,6:60–63Google Scholar
  228. 196.
    Kondratyeva TS, Pirozhnikova LN (1975) Farmatsiya (Moscow) 24:29–33Google Scholar
  229. 197.
    Grigoryeva ON, Kondratyeva TS, Maichuk YV, Kromov GL (1982) Farmatsiya (Moscow) 31:20–23Google Scholar
  230. 198.
    Weast RC (1978) Handbook of Chemistry and Physics, 58th ed., C.R.C. Press, Cleveland, D-220Google Scholar
  231. 199.
    Spegg H (1976) Dtsch Apoth Ztg 16:1939–1944Google Scholar
  232. 200.
    Skinner FS (1990) Suspensions-Augentropfen. In: Dol-der R, Skinner FS (Hrsg.) Ophthalmika, 4. Aufl., Wissen-schaftliche Verlagsgesellschaft, Stuttgart, S. 441–447Google Scholar
  233. 201.
    Grmusa J, Stupar M, Vuleta G, Parunovic A (1985) Arch Farm 35:175–177Google Scholar
  234. 202.
    Timouth T, Briscoe J (1984) Med J Aust 140:119Google Scholar
  235. 203.
    Salminen L (1959) Acta Ophthalmol 57:633–636Google Scholar
  236. 204.
    Dolder R (1990) Ölige Augenarzneien. In: Dolder R, Skinner FS (Hrsg.) Ophthalmika, 4. Aufl., Wissenschaft-liche Verlagsgesellschaft, Stuttgart, S. 451–452Google Scholar
  237. 205.
    Lippold BC, Steinke G (1990) Biopharmazeutische Aspekte der Augenarzneizubereitungen. In: Dolder R, Skinner FS (Hrsg.) Ophthalmika, 4. Aufl., Wissenschaft-liche Verlagsgesellschaft, Stuttgart, S. 354–368Google Scholar
  238. 206.
    Horsch W (1969) Augentropfen. In: Jung F, Kny L, Pethke W, Pohloudek-Fabini R, Richter J (Hrsg.) Kommen-tar zum Deutschen Arzneibuch 7. Ausgabe, Akademie- Verlag, BerlinGoogle Scholar
  239. 207.
    Werner R, Fischer D (1987) Schweiz Apoth Ztg 125:339–340Google Scholar
  240. 208.
    Beyrich T (1976) Pharmazie 31:577PubMedGoogle Scholar
  241. 209.
    Loeffler M, Hornblass A (1990) Arch Ophthalmol 108:640Google Scholar
  242. 210.
    Dolder R (1990) Einzeldosenbehältnisse. In: Dolder R, Skinner FS (Hrsg.) Ophthalmika, 4. Aufl., Wissenschaft-liche Verlagsgesellschaft, Stuttgart, S. 591–598Google Scholar
  243. 211.
    Anonym (1981) Pharm Ztg 126:164Google Scholar
  244. 212.
    Anonym (1973) Dtsch Apoth Ztg 113:200Google Scholar
  245. 213.
    Cambrosio F (1990) Industrielle Fertigung von Augen-arzneimitteln. In: Dolder R, Skinner FS (Hrsg.) Ophthal-mika, 4. Aufl., Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 565–575Google Scholar
  246. 214.
    Skaletzki B, Wollmann H (1973) Pharmazie 28:1–6PubMedGoogle Scholar
  247. 215.
    Aspinall JA, Duffy TD, Saunders MB, Taylor CC (1980) J Clin Hosp Pharm 5:21–29Google Scholar
  248. 216.
    Florentine M (1959) Am J Hosp Pharm 16:513–518Google Scholar
  249. 217.
    Veikko Pirilä H (1990) US Patent No. 4.936.498Google Scholar
  250. 218.
    Boer Y, Nijland CJ (1981) Pharm Weekbl 116:371–374Google Scholar
  251. 219.
    Graf E (1978) Pharm Unserer Zeit 7:99–104PubMedGoogle Scholar
  252. 220.
    Fröhlich J (1977) Dtsch Apoth Ztg, Beilage Kranken-hausapotheke 27:26–29Google Scholar
  253. 221.
    Brouwers JRBJ (1977) Pharm Weekbl 112:157–159Google Scholar
  254. 222.
    Groos M (1984) Dtsch ApothZtg 124:1614–1615Google Scholar
  255. 223.
    Kass MA, Hodapp E, Gordon M, Kolker AE, Goldbeig I (1982) Ann Ophthalmol 14:889–893PubMedGoogle Scholar
  256. 224.
    List H (1980) Arzneiformenlehre, 2. Aufl., Wissenschaft-liche Verlagsgesellschaft, Stuttgart, S. 409–423Google Scholar
  257. 225.
    Norn MS (1964) Acta Ophthalmol (Copenhagen) 42:727–734Google Scholar
  258. 226.
    Hardberger R, Hanna C, Boyd DM (1975) Arch Ophthal-mol 93:42–45Google Scholar
  259. 227.
    Cable MK, Hendrickson RO, Hanna C (1978) Arch Ophthalmol 96:84–86PubMedGoogle Scholar
  260. 228.
    Jacknowitz AI (1986) US Pharm 11:29Google Scholar
  261. 229.
    Robin JS, Ellis PP (1978) Surv Ophthalmol 22:335–340PubMedGoogle Scholar
  262. 230.
    Shell JW (1984) Surv Ophthalmol 29.117–128PubMedGoogle Scholar
  263. 231.
    Kragh G, Berneis KH, Münzel K (1966) Sei Pharm 34:42–66Google Scholar
  264. 232.
    Voigt R, Bornschein M (1973) Lehrbuch der pharmazeu-tischen Technologie, VEB Verlag Volk und Gesundheit, berlin, S. 328–333Google Scholar
  265. 233.
    Brenner J (1969) Pharm Acta Helv 44:193–207Google Scholar
  266. 234.
    Kagan EZ (1971) Antibiotiki 16:987–990PubMedGoogle Scholar
  267. 235.
    Richter G (1957) Arzneim Forsch 7:419–435Google Scholar
  268. 236.
    Sieg JW, Robinson JR (1979) J Pharm Sei 68:724–728Google Scholar
  269. 237.
    Lieb W (1987) Klin Mbl Augenheilk 190:125–126PubMedGoogle Scholar
  270. 238.
    Amdidouche D, Dutertre H, Chaumeil JC (1989) Pharm Acta Helv 64:273–275Google Scholar
  271. 239.
    Stenbeck A, Östholm I (1954) Acta Ophthalmol (Copen-hagen) 32:405–423Google Scholar
  272. 240.
    Eisner Z, Grzegorzewicz W (1970) Farm Pol 26:899–903Google Scholar
  273. 241.
    Newton DW, Becker CH, Torosian G (1973) J Pharm Sei 62:1538–1542Google Scholar
  274. 242.
    Friede R (1952) Klin Mbl Augenheilk 120:163–172Google Scholar
  275. 243.
    Lazareva EN (1971) Chim Farm Z (Moskva) 5:30–34Google Scholar
  276. 244.
    Vander Wyk RW, Granston AE (1958) J Am Pharm As-soc Sei Ed 47:193–196Google Scholar
  277. 245.
    Bowman FW, Holdowsky S (1959) J Am Pharm Assoc Sei Ed 48:95–96Google Scholar
  278. 246.
    Bowman FW (1969) J Pharm Sei 58:277–278Google Scholar
  279. 247.
    Bowman FW, Knoll EW, White M, Mislivec P (1972) J Pharm Sei 61:532–535Google Scholar
  280. 248.
    Ayliffe GAJ, Barry DR, Lowburry EJL, Roper-Hall MJ, Walker WM (1966) Lancet 1:1113–1117PubMedGoogle Scholar
  281. 249.
    Engler GR (1981) Pharm Int 2:141–144Google Scholar
  282. 250.
    Mitchell AG, Kazmi SJA (1977) CosmToil 92:33–43Google Scholar
  283. 251.
    Ivanova LA, Kondrateva TS (1970) Farmacija (Moskva) 19:23–26Google Scholar
  284. 252.
    Spieser P (1968) Pharm Acta Helv 43:193–227Google Scholar
  285. 253.
    Dankert J, Tromp TFJ, Doets A, Huizinga T (1975) Pharm Weekbl 110:189–193Google Scholar
  286. 254.
    List PH, Momberger H (1974) Dtsch Apoth Ztg 114:1062Google Scholar
  287. 255.
    Gallinger S (1974) Dtsch Apoth Ztg 114:1678Google Scholar
  288. 256.
    Horsch W, Bogs U (1969) Augensalben. In: Jung F, Kny L, Poethke W, Pohloudek-Fabini R, Richter J (Hrsg.) Kommentar zum Deutschen Arzneibuch 7. Ausgabe, Akademie-Verlag, BerlinGoogle Scholar
  289. 257.
    Frauch P (1970) Pharm Acta Helv 45:75–88PubMedGoogle Scholar
  290. 258.
    Stozek T, Krowczynski L, Ozimek M (1971) Farm Pol 27:477–483Google Scholar
  291. 259.
    Przyborowski R (1967) Wiss Z Humboldt-Univ Berlin Math Nat R 16:239–242Google Scholar
  292. 260.
    Pferdekämper G (1966) Pharm Ind 28:379–384Google Scholar
  293. 261.
    Horsch W, Seifferth R, Ullrich M (1972) Pharmazie 27:800–801PubMedGoogle Scholar
  294. 262.
    Horsch W, Seifferth R, Ullrich M (1973) Zentralbl Pharm Pharmakother Laboratoriumsdiagn 112:227–233Google Scholar
  295. 263.
    Hangay G (1970) Acta Pharm Hung 40:75–80PubMedGoogle Scholar
  296. 264.
    Schwenker G, Vogt H (1962) Pharm Ind 24:163–167Google Scholar
  297. 265.
    Hüttenrauch R, Süss W, Schmeiss U (1974) Pharmazie 29:31–35PubMedGoogle Scholar
  298. 266.
    Anonym (1978) Manuf Chem Aerosol New 49:64Google Scholar
  299. 267.
    Trose D (1962) Pharm Prax 17:215–217Google Scholar
  300. 268.
    Quellmalz K, Schmidt R, Kastens W (1971) Pharm Prax 26:113.115Google Scholar
  301. 269.
    Kata M, Mayer A (1973) Gyôgyszerészet 4:136–137Google Scholar
  302. 270.
    Mozsgai K (1972) Gyôgyszerészet 16:339–342Google Scholar
  303. 271.
    Lerk CF, Zuurman K (1972) Pharm Weekbl 107:173–178PubMedGoogle Scholar
  304. 272.
    Boymond P (1960) Schweiz Apoth Ztg 98:561–563Google Scholar
  305. 273.
    Weis-Fogh O, Wiese CF (1964) Arch Pharm Chemi 71:835–844Google Scholar
  306. 274.
    Chrai SS, Stupak EI (1976) Bull Parent Drug Assoc 30:100–103Google Scholar
  307. 275.
    Bormann G (1974) Pharm Prax 29:9–10Google Scholar
  308. 276.
    Lagner HJ, Ketelhohn K (1974) Pharm Ind 36:596–600Google Scholar
  309. 277.
    Smith GG, Fonner DE, Griffin JC (1975) Bull Parent DrugAssoc 29:18–25Google Scholar
  310. 278.
    Abshire R, Cash P (1986) J Parent Sei Technol 40:97–99Google Scholar
  311. 279.
    Jacobsen F (1969) J Mond Pharm 40:14–22Google Scholar
  312. 280.
    Ruetz A (1974) Drugs made Ger 17:90–96Google Scholar
  313. 281.
    Atawowczyk A, Kryzyzanowska T (1974) Farm Pol 30:1029–1033Google Scholar
  314. 282.
    Paris G.A.W.J.O.E. (1953) Pharm Weekbl 86:646–647Google Scholar
  315. 283.
    Van Ooteghem M (1964) Pharm Tijdschr Belg 41:104–114Google Scholar
  316. 284.
    Sandeil E, Ernerot L (1966) Acta Pharm Suec 3:59–60Google Scholar
  317. 285.
    Weiss H (1974) Pharmazie 29:427Google Scholar
  318. 286.
    Britton SC (1952) Tin Res Inst 15:23–25Google Scholar
  319. 287.
    Sacharow S (1968) Pharm Weekbl 103:1261–1265PubMedGoogle Scholar
  320. 288.
    Van Ooteghem M, Cambrosio F (1990) Augensalbentu-ben. In: Dolder R, Skinner FS (Hrsg.) Ophthalmika, 4. Aufl., Wissenschaftliche Verlagsgesellschaft, Stutt-gart. 586–591Google Scholar
  321. 289.
    Anonym (1955) Das chemische Verhalten von Alumini-um, Aluminium-Verlag, Düsseldorf, S. 64–211Google Scholar
  322. 290.
    Cooper J (1966) J Mond Pharm 9:259–281Google Scholar
  323. 291.
    Marks A (1967) APV-Informationsdienst 13:164Google Scholar
  324. 292.
    Aerts A, Alexis J, Barbé P, Boudon P, Delattre L, Leloup J, Stein E, Van den Eeckhout E (1972) J Pharm Belg 27:480–492PubMedGoogle Scholar
  325. 293.
    Stehle-Sand U (1989) Pharm Praxis (Beilage Acta Pham Technol) 11:1–5Google Scholar
  326. 294.
    Münzel K (1953) Schweiz Apoth Ztg 91:273–283Google Scholar
  327. 295.
    Kochel F (1966) Krankenhaus-Apotheke (Beilage Dtsch ApothZtg) 16:9–14Google Scholar
  328. 296.
    Polli GP, Fong DTK, Shoop CE (1972) J Pharm Sei 51:1078–1080Google Scholar
  329. 297.
    Pochapinskii YI (1962) Med Prom Ud SSR 16:34–39Google Scholar
  330. 298.
    Golda H (1984) Die Sauberhaltung bei der Herstellung von Tuben. In: Algner S, Heibig J, Spingier E (Hrsg.) Pri-mär-Packmittel, Paperback APV 9, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 32–38Google Scholar
  331. 299.
    British Standard 4230: (1967 and 1986). Specification for metal collapsible tubes for eye ointmentsGoogle Scholar
  332. 300.
    U.N.I 3061 (1950). Tubetti metallici deformabili con pun-ta oftalmica. Dimensioni, caratteritichiGoogle Scholar
  333. 301.
    DIN 5061 Teil 1 (1985) Tuben aus Aluminium; DIN 5061 Teil 2 (1989) Tuben aus KunststoffGoogle Scholar
  334. 302.
    Cavatorta L, Romaniello E, Allievi R (1968) Boll Chim Farm 107:721–725PubMedGoogle Scholar
  335. 303.
    Brunzell A, Nilsson G (1973) Acta Pharm Suec 10:247–253PubMedGoogle Scholar
  336. 304.
    Dolder R (1963) Pharm Acta Helv 38:418–422PubMedGoogle Scholar
  337. 305.
    Dolder R (1973) Schweiz Apoth Ztg 111:487–489Google Scholar
  338. 306.
    Cable MK, Hendrickson RO, Hanna C (1978) Arch Ophthalmol 96:84–96PubMedGoogle Scholar
  339. 307.
    Wyatt BK (1984) Am J Hosp Pharm 41:654–655PubMedGoogle Scholar
  340. 308.
    Kunstcher H (1973) Pharm Ind 35:422–434Google Scholar
  341. 309.
    Horsch W, Kny L, Röthig J, Dressel H (1973) Zentralbl Pharm Pharmakother Laboratoriumsdiagn 112:909–910Google Scholar
  342. 310.
    Fulmek R (1967) Wien Med Wochenschr 117:838–840PubMedGoogle Scholar
  343. 311.
    Fulmek R (1967) Arch Phys Ther (Leipzig) 19:151–155Google Scholar
  344. 312.
    Ogielska E, Baran L, Barczyk I, Madeyski A (1979) Klin Oczan 81:271–273Google Scholar
  345. 313.
    Wittlinger P (1961) US Patent No. 2.987.439Google Scholar
  346. 314.
    Hall VC (1965) US Patent No. 3.170.462Google Scholar
  347. 315.
    Carroll A (1967) US Patent No. 3.314.426Google Scholar
  348. 316.
    Hollet CC (1969) US Patent No. 3.506.001Google Scholar
  349. 317.
    Coleman DJ, Trokel SL (1977) US Patent No. 4.052.985Google Scholar
  350. 318.
    Mansour A, Aswad MI, Traboulsi EI (1984) Am J Oph-thalmol 97:245Google Scholar
  351. 319.
    Longwell A, Birss S, Keller N, Moore D (1976) J Pharm Sci 65:1654–1657PubMedGoogle Scholar
  352. 320.
    Halberg GP, Kelly SE, Morrone M (1975) Ann Ophthal-mol 7:1199–1209Google Scholar
  353. 321.
    Sharp J, Hanna C (1977) J Arkansas Med Soc 73:462–463PubMedGoogle Scholar
  354. 322.
    Sharp J, Wallace T, Hanna C (1975) J Pediat Ophthalmol 12:119–122Google Scholar
  355. 323.
    Popescu MP (1975) Oftalmologia (Bucuresti) 19:73–77Google Scholar
  356. 324.
    Buschmann W, Linnert D (1980) Klin Mbl Augenheilk 177:345–353PubMedGoogle Scholar
  357. 325.
    Fraunfelder FT, Zacarian SA, Limmer BL, Wingfield D (1980) Ophthalmology (Rochester) 87:461–465Google Scholar
  358. 326.
    Frauenfelder FT, Pertursson GJ (1979) Ophthalmie Surg 10:42–46Google Scholar
  359. 327.
    Heilmann K, Sinz U (1974) Klin Monatsbl Augenheilkd 165:519–524PubMedGoogle Scholar
  360. 328.
    Heilmann K (1984) Okulares therapeutisches System. In: Heilmann K (Hrsg.) Therapeutische Systeme, Enke, Stuttgart, S. 58–59Google Scholar
  361. 329.
    Buri P (1985) Voie oculaire. In: Buri P, Puisieux F, Boel-ker E, Benoit JP (eds.) Formes pharmaceutiques nouvel-les, Technique et documentation Lavoisier, Paris p 411–439Google Scholar
  362. 330.
    Beyrich T, Krugmann G (1981) Zentralbl Pharm Pharma-kother Laboratoriumsdiagn 120:1017–1020Google Scholar
  363. 331.
    Dolder R (1990) Weitere Augenpräparate. In: Dolder R, Skinner FS (Hrsg.) Ophthalmika, 4. Aufl., Wissenschaft-liche Verlagsgesellschaft, Stuttgart, S. 493–502Google Scholar
  364. 332.
    Calabria G, Rathschuler F (1987) Contact lenses as thera-peutic systems. In: Saettone MS, Bucci G, Speiser P (eds.) Ophthalmic drug delivery: biopharmaceutical, technological and clinical aspects. Fidia research series Vol. 11, Springer, Berlin, p 67–81Google Scholar
  365. 333.
    McDermott ML, Chandler JW (1989) Surv Ophthalmol 33:381–394PubMedGoogle Scholar
  366. 334.
    Hillman JS (1974) Br J Ophthalmol 58:674–679PubMedGoogle Scholar
  367. 335.
    Hillman JS, Marsters JB, Broad A (1975) Trans Ophthal-mol Soc UK 95:79–84Google Scholar
  368. 336.
    Kaufman HE, Uoltila MH, Gasset AR, Wood TO, Ellison ED (1971) Trans Am Acad Ophthalmol Otolaryngol 75:361–373PubMedGoogle Scholar
  369. 337.
    Podos SM, Becker B, Asseff C, Harstein J (1972) Am J Ophthalmol 73:336–341PubMedGoogle Scholar
  370. 338.
    Ruben M, Watkins R (1975) Brit J Ophthalmol 59:455–458Google Scholar
  371. 339.
    Smolen VF, Vemuri R, Miya TS, Williams EJ (1975) Drug Dev Comm 1:479–494Google Scholar
  372. 340.
    Krohn DL, Breitfeiler JM (1975) Invest Ophthalmol 14:152–155PubMedGoogle Scholar
  373. 341.
    Marmion VJ, Yurdakul S (1977) Trans Ophthalmol Soc UK 97:162–163PubMedGoogle Scholar
  374. 342.
    Zatloukal Z, Dolezal P, Skubalova Z (1986) Cesk Farm 35:318–321PubMedGoogle Scholar
  375. 343.
    Goto S (1988) Folia Ophthalmol Jpn 39:574–579Google Scholar
  376. 344.
    Hull DS, Edelhauser HF, Hyndiuk RA (1974) Arch Ophthalmol 92:413–416PubMedGoogle Scholar
  377. 345.
    Friedman Z, Allen RC, Raph SM (1985) Arch Ophthal-mol 103:963–966Google Scholar
  378. 346.
    Shchipanova AI, Maichuk YF, Babich GA, Kivaev AA, Zelenskaya AA (1982) Vestn Oftamol 99:74–76Google Scholar
  379. 347.
    Coto S, Fujiwara H, Egi K, Katayama T, Suzuki T (1989) Acta Soc Ophthalmol Jpn 93:254–257Google Scholar
  380. 348.
    Lemp MA (1978) Ann Ophthalmol 10:1319–1321PubMedGoogle Scholar
  381. 349.
    Jain MR, Lai S (1983) Ind J Ophthalmol 31:645–648Google Scholar
  382. 350.
    McCarey BE, Schmidt FM, Wilkinson KD, Baum JP (1984) Curr Eye Res 3:977–989PubMedGoogle Scholar
  383. 351.
    Busin M, Spitnas M (1988) Ophthalmology (Rochester) 95:796–798Google Scholar
  384. 352.
    Jain MR (1988) Br J Ophthalmol 72:150–154PubMedGoogle Scholar
  385. 353.
    Praus R, Brettschneider L, Kreja L, Kalvadora D (1972) Ophthalmologica 165:62–70PubMedGoogle Scholar
  386. 354.
    Brettschneider L, Preus R, Kreja L, Havranek M B (1975) Ophthalmol Res 7:296–299Google Scholar
  387. 355.
    Matoba AY, McCulley JP (1985) Ophthalmology (Ro-chester) 92:97–99Google Scholar
  388. 356.
    Lyons RW (1979) New Engl J Med 300.372–373PubMedGoogle Scholar
  389. 357.
    Dumortier G, Zuber M, Chaumeil JC (1989) S T P Phar-ma 5:561–566Google Scholar
  390. 358.
    Garfinkle B, Cochran J, Snyder J, Trasher G, Thompson B, Orlowski S, Harwoord RJ, Cohen EW (1985) J Paren-ter Sei Technol 39:246–250Google Scholar
  391. 359.
    Rubin AL, Stenzel KH, Miyata T, White MD, Dunn M (1973) J Clin Pharmacol New Drugs 13:309–312Google Scholar
  392. 360.
    Kitazawa Y (1975) Acta Soc Ophthalmol Jap 79:1715–1747Google Scholar
  393. 361.
    Vansantha R, Sehgal PK, Panduranga Rao K (1988) Int J Pharm 47:95–102Google Scholar
  394. 362.
    Bloomfield SE, Miyata T, Dunn MW, Bueser N, Stenzel KH, Rubin AL (1978) Arch Ophthalmol 96:885–887PubMedGoogle Scholar
  395. 363.
    Phinney RB, Schwartz SD, Lee DA, Mondino BJ (1988) Arch Ophthalmol 106:1599–1604PubMedGoogle Scholar
  396. 364.
    Rootman DS, Avaria M, Bassu PK (1990) Abstracts of papers presented at 9th Int Congress of Eye Research, Helsinki (1990) 219:773Google Scholar
  397. 365.
    Hwang DG, Stern WH, Hwang PH, MacGowan-Smith LA (1990) Arch Ophthalmol 107:1375–1380Google Scholar
  398. 366.
    Ivanova LA, Abramova TA, Popova ZS, Felisova EV (1988) Farmatsiya (Moscow) 37:24–27Google Scholar
  399. 367.
    Kaufman HE (1990) Abstracts of papers presented at 9th Int Congress of Eye Research, Helsinki (1990) 219: 772Google Scholar
  400. 368.
    Reidy JJ, Gebhardt BM, Kaufman HE (1990) Cornea 9:196–199PubMedGoogle Scholar
  401. 369.
    Gebhardt BM, Chen YF, Reidy JJ, Kaufman HE (1990) Abstracts of papers presented at 9th Int Congress of Eye Research, Helsinki (1990) 220:776Google Scholar
  402. 370.
    Sawusch MR, Brien TP, Dick JD, Gottsch JD (1988) Am J Ophthalmol 106:279–281PubMedGoogle Scholar
  403. 371.
    D’Oncien MJ, Amrani K, Santoul C, Coquelet C, Bonne C (1990) Abstracts of papers presented at the 4th Eur Congress Bipharmaceutics and Pharmacokinetics, Ge-neave (1990) 8:209Google Scholar
  404. 372.
    GosslerJR, Ashton P, Van Meter WS, Smith TJ (1990) In-vest Ophthalmol Vis Sei 31 (ARVO Suppl):485Google Scholar
  405. 373.
    Colin J, Malet F, Richard MC, Chastel C (1991) Contac-tologial 3D:23–25Google Scholar
  406. 374.
    Schwartz SD, Harrison SA, Engstrom RE, Bawden RE, Lee DA, Mondino BJ (1990) Invest Ophthalmol Vis Sei 31 (ARVO Suppl):485Google Scholar
  407. 375.
    Finkelstein I, Trope GE, Menon IA, Spero L, Rootman DS, Heathcote G (1990) Invest Ophthalmol Vis Sei 31 (ARVO Suppl):591Google Scholar
  408. 376.
    Bloomfield SE, Dunn MW, Miyata T, Stenzel KH, Rändle SS, Rubin AL (1977) Arch Ophthalmol 95:247–250PubMedGoogle Scholar
  409. 377.
    Shaker GJ, Ueda S, LoCascio JA, Aquavella JV (1989) In-vest Ophthalmol Vis Sei 30:1565–1568Google Scholar
  410. 378.
    Frantz JM, Dupuy BM, Kaufman HE, Beuerman RW (1989) Am J Ophthalmol 108:524–528PubMedGoogle Scholar
  411. 379.
    Murata Y, Yoshioka H, Kitaoka M, Iyama K, Okamura R, Usuku G (1990) Ophthalmic Res 22:144–151PubMedGoogle Scholar
  412. 380.
    Marquardt R, Pillunat LE (1990) Abstracts of papers pre-sented at the 9th Int Congress of Eye Research, Helsinki (1990) 219:774Google Scholar
  413. 381.
    James V, Aquavella MD (1990) Abstracts of papers pre-sented at the 9th Int Congress of Eye Research, Helsinki (1990) 219:775Google Scholar
  414. 382.
    Yakolev AA, Lenkevich MM (1966) Vestn Oftal 79:40–42Google Scholar
  415. 383.
    Saettone MF, Giannaccini B, Chetoni P, Galli G, Chiellini E (1984) J Pharm Pharmacol 36:229–234PubMedGoogle Scholar
  416. 384.
    Kelly JA, Molyneux PD, Smith SA, Smith SE (1989) J Pharm Pharmacol 73:360–372Google Scholar
  417. 385.
    Harwood RJ, Schwartz JB (1982) Drug Dev Ind Pharm 8:663–682Google Scholar
  418. 386.
    Urtti A, Salminen L, Miinalainen O (1985) Int J Pharm 23:147–161Google Scholar
  419. 387.
    Saettone MF, Chetoni P, Torracca MT, Giannaccini B, Naber I, Conte U, Sangalli ME, Gazzaniga A (1990) Acta Pharm Technol 36:15–19Google Scholar
  420. 388.
    Urtti A, Juslin M, Miinalaine O (1985) Int J Pharm 25:165–178Google Scholar
  421. 389.
    Urtti A, Periviita L, Salminen L, Juslin M (1985) Drug Dev Ind Pharm 11:257–268Google Scholar
  422. 390.
    Dumortier G, Zuber M, Chast F, Sandouk P (1989) Pro-ceedings of 5th Int Conf Pharm Technol, Paris 1989, Vol. l,p61–69Google Scholar
  423. 391.
    Dumortier G, Zuber M, Chast F, Sandouk P, Chaumeil JC (1990) Int J Pharm 59:1–7Google Scholar
  424. 392.
    Gelatt KN, Gum GG, Williams LM, Peiffer RL (1979) Am J Vet Res 40:702–704PubMedGoogle Scholar
  425. 393.
    Hovding G, Aasved H (1981) Acta Ophthalmol (Copen-hagen) 59:842–846Google Scholar
  426. 394.
    Werblin TP, Rheinstrom SD, Kaufman HE (1981) Oph-thalmology (Rochester) 88:78–81Google Scholar
  427. 395.
    Wright P, Vogel R (1983) Br J Ophthalmol 67:393–397PubMedGoogle Scholar
  428. 396.
    Harwood RJ (1984) Eur Pat Appl EP 108,661Google Scholar
  429. 397.
    Cordonnier M, Pereleux A, Herode A, Zanen A (1985) Bull Soc Belg Ophthalmol 212:65–69Google Scholar
  430. 398.
    Hill JC (1989) Br J Ophthalmol 73:151–154PubMedGoogle Scholar
  431. 399.
    Molemans M, Maugdal PC, Misotten L (1982) Bull Soc Belg Ophthalmol 201:93–97Google Scholar
  432. 400.
    Loucas SP, Haddad HM (1975) Metabolic Ophthalmolo-gy, Pergamon, London, Vol. 1:27–34Google Scholar
  433. 401.
    Katz IM (1982) US Patent No. 4.343.787Google Scholar
  434. 402.
    Gonzales GM, Jimeno JCP (1984) Arch Soc Esp Oftal-mol 47:435–440Google Scholar
  435. 403.
    Lamberts DW, Langston DP, Chu W (1978) Ophthalmo-logy (Rochester) 85:794–800Google Scholar
  436. 404.
    Katz JI, Kaufman HE, Breslin C, Katz IM (1978) Oph-thalmology (Rochester) 85:787–793Google Scholar
  437. 405.
    Gautheron PD, Lotti VJ, Le Douarec JC (1979) Arch Ophthalmol 97:1944–1947PubMedGoogle Scholar
  438. 406.
    Salminen L, Urtti A, Kujari H, Juslin M (1983) Graefes Arch Ophthalmol 221:96–99Google Scholar
  439. 407.
    Maichuk YF, Pozdnyakov VI, Khromov GL, Koneva EB, Starunova LN (1974) Vestn Oftal 90:73–76Google Scholar
  440. 408.
    Khromov GL, Davydov AB, Maichuk YF, Tishina IF (1974) Ger Patent 2.251.076Google Scholar
  441. 409.
    Maichuk YF (1977) Arch Ophthalmol (Paris) 37:545–550Google Scholar
  442. 410.
    Nuritidinov VA (1980) Vestn Oftal 97:59–60Google Scholar
  443. 411.
    Harwood R (1988) US Patent No. 4.730.013Google Scholar
  444. 412.
    Khromov GL, Starunova LN, Maichuk YF, Davydov AB, Kondrateva TS (1974) Khim Farm Zh 8:24–29Google Scholar
  445. 413.
    Maichuk YV (1975) Lancet 1:173PubMedGoogle Scholar
  446. 414.
    Maichuk YV (1975) Invest Ophthalmol 14:87–90PubMedGoogle Scholar
  447. 415.
    Khromov GL, Davydov AB, Maichuk YF, Tishina IF (1976) US Patent No. 3.978.201Google Scholar
  448. 416.
    Khromov GL, Erofeeva LN, Maichuk YF, Davydov AB (1975) Khim Farm Zh 9:31–34Google Scholar
  449. 417.
    Maichuk YF, Khromov GL (1977) Vest Oftal 94:61–62Google Scholar
  450. 418.
    Dohlman CH, Pavan-Langston D, Rose J (1972) Ann Ophthalmol 4:832–833Google Scholar
  451. 419.
    Allansmith MR, Lee JR, McClellan BH, Dohlman CH (1975) Trans Am Acad Ophthalmol 79:OP128–OP136Google Scholar
  452. 420.
    Keller N, Longwell AM, Birss SA (1976) Arch Ophthal-mol 94:664–652Google Scholar
  453. 421.
    Pavan-Langston D, Langston RHS, Geary PA (1975) Arch Ophthalmol 93:1349–1351PubMedGoogle Scholar
  454. 422.
    Capozza RC (1974) Ger Patent 2.505.305Google Scholar
  455. 423.
    Higuchi T, Hussain A, Shell JW (1976) Can Patent 989.732Google Scholar
  456. 424.
    Kassem MA, Attia MA, Safwat SM (1986) J Pharm Belg 41:106–110PubMedGoogle Scholar
  457. 425.
    Attia MA, Kassem MA, Safwat SM (1988) Int J Pharm 47:21–30Google Scholar
  458. 426.
    Habib FS, Attia MA (1986) Acta Pharm Technol 32:133–136Google Scholar
  459. 427.
    Grass GM, Cobby J, Makoid MC (1984) J Pharm Sci 73:618–621PubMedGoogle Scholar
  460. 428.
    Maichuk YF (1967) Antibiotiki 5:435Google Scholar
  461. 429.
    Urtti A (1985) Int Pharm 26:45–55Google Scholar
  462. 430.
    Finne U, Kyyrönen K, Urtti A (1989) J Controlled Re-lease 10:189–194Google Scholar
  463. 431.
    Finne U, Väisänen V, Urtti A (1990) Int J Pharm 65:19–27Google Scholar
  464. 432.
    Miyazaki S, Ishii K, Takada M (1982) Chem Pharm Bull 30:3405–3407PubMedGoogle Scholar
  465. 433.
    Salimen L (1987) Pilocarpine inserts: experimental and clinical experiences. In: Saettone MS, Bucci G, Speiser P (eds.) Ophthalmic drug delivery: biopharmaceutical, technical and clinical aspects. Fidia research series Vol. 11, Springer,Berlin,pl 61–170Google Scholar
  466. 434.
    Gurny R (1981) Pharm Acta Helv 56:130–132PubMedGoogle Scholar
  467. 435.
    Gurny R (1985) Systèames thérapeutiques à base de latex. In: Buri P, Puisieux F, Doelker E, Benoit JP (eds.) For-mes pharmaceutiques nouvelles, Technique et Docu-mentation, Lavoisier Paris, p 657–671Google Scholar
  468. 436.
    Gurny R, Ibrahim H, Boye T, Buri P (1987) Latices and thermosensitive gels as sustained delivery systems to the eye. In: Saettone MS, Bucci G, Speiser P (eds.) Ophthal-mic drug delivery: biopharmaceutical, technical and cli-nical aspects. Fidia research series Vol. 11, Springer, Ber-lin p 27–36Google Scholar
  469. 437.
    Ibrahim H, Gurny R, Bindschaedler C, Buri P (1989) Pro-ceedings of the 5th Int Conf Pharm Technol (Paris 1989), Vol. l, p 70–76Google Scholar
  470. 438.
    Haddad HM, Loucas SP (1975) US Patent No. 3.870.791Google Scholar
  471. 439.
    Dolder R (1990) Weitere Augenpräparate. In: Dolder R, Skinner FS (Hrsg.) Ophthalmika, 4. Aufl., Wissenschaft-liche Verlagsgesellschaft, Stuttgart, S. 493–504Google Scholar
  472. 440.
    Rozier A, Mazuel C, Grove J, Plazonnet B (1989) Int J Pharm 57:163–168Google Scholar
  473. 441.
    Miller CM, Donovan MD (1982) Int J Pharm 12:147–152Google Scholar
  474. 442.
    Ticho U, Blumenthal M, Zonis S, Gal A, Blank I, Mazor Z (1979) Ann Ophthalmol 11:555–561PubMedGoogle Scholar
  475. 443.
    Ticho U, Blumenthal M, Zonis S, Gal A, Blank I, Mazor Z (1979) BrJ Ophthalmol 63:45–47Google Scholar
  476. 444.
    Mazor A, Ticho U, Rehany U, Rose L (1979) Br J Oph-thalmol 63:48–51Google Scholar
  477. 445.
    Blumenthal J, Ticho U, Zonis S, Gal A, Blank I, Mazor Z (1979) Glaucoma 1:145–148Google Scholar
  478. 446.
    Leibowitz HM, Chang RK, Mandell AI (1984) Ophthal-mology (Rochester) 91:1199–1204Google Scholar
  479. 447.
    Leucata SE (1989) Int J Pharm 54:71–78Google Scholar
  480. 448.
    Wood RW, Li VHK, Kreuter J, Robinson JR (1985) Int J Pharm 23:175–183Google Scholar
  481. 449.
    Kreuter J (1987) Nanoparticles and liposomes in oph-thalmic drug delivery. In: Saettone MS, Bucci G, Speiser P (eds.) Ophthalmie drug delivery: biopharmaceutical, technical and clinical aspects. Fidia research series Vol. 11,Springer, Berlin, p 101–106Google Scholar
  482. 450.
    Harmia T, Speiser P, Kreuter J (1987) Pharm Acta Helv 62:322–331PubMedGoogle Scholar
  483. 451.
    Harmia T, Kreuter J, Speiser P, Boye T, Gurny R, Kubis A (1986) Int J Pharm 33:187–193Google Scholar
  484. 452.
    Diepold R, Kreuter J, Guggenbuhl P, Robinson JR (1989) IntJ Pharm 54:149–153Google Scholar
  485. 453.
    Diepold R, Kreuter J, Himber J, Gurny R, Lee VHL, Robinson JR (1989) Graefes Arch Ophthalmol 277:188–193Google Scholar
  486. 454.
    Alonso MJ, Losa C, Seijo B, Torres D, Vila Jato JL (1989) Proceedings of the 5th Int Conf Pharm Technol (Paris 1989), Vol. l,p77–83Google Scholar
  487. 455.
    Marchal-Heussler L, Maincent P, Hoffman M, Spittler J, Couvreur P (1990) Int J Pharm 58:115–122Google Scholar
  488. 456.
    Jacob-Labarre JT, Kaufman HE (1990) Invest Ophthal-mol Vis Sei 31 (ARVO Suppl):485Google Scholar
  489. 457.
    Meisner D, Pringle J, Mezei M (1989) Int J Pharm 55:105–113Google Scholar
  490. 458.
    Schaeffer HE, Brietfeller JM, Krohn DL (1983) Invest Ophthalmol Vis Sei 25:530–533Google Scholar
  491. 459.
    Megaw JM, Takei Y, Lerman S (1981) Exp Eye Res 32:395–405PubMedGoogle Scholar
  492. 460.
    Singh K, Mezei M (1984) Int J Pharm 19:263–269Google Scholar
  493. 461.
    Stanford RE, Yang DC, Redell MA, Lee VHL (1983) Int J Pharm 13:263–272Google Scholar
  494. 462.
    Stanford RE, Yang DC, Redell MA, Lee VHL (1983) Curr Eye Res 2:377–386Google Scholar
  495. 463.
    Simmons ST, Sherwood MB, Nochols DA, Penne RB, Sery T, Spaeth GL (1988) BrJ Ophthalmol 72:688–691Google Scholar
  496. 464.
    Barza M, Baum J, Szoka F (1984) Invest Ophthalmol Vis Sei 25:486–490Google Scholar
  497. 465.
    Fitzgerald P, Hadgraft J, Wilson CG (1987) J Pharm Pharmacol 39:487–490PubMedGoogle Scholar
  498. 466.
    Smolin G, Okumoto M, Feiler S, Gondon D (1981) Am J Ophthalmol 100:481–483Google Scholar
  499. 467.
    Schaeffer HE, Krohn DL (1982) Invest Ophthalmol Vis Sci 22.220–227PubMedGoogle Scholar
  500. 468.
    Lee VHL, Takemoto KA, Iimoto DS (1984) Curr Eye Res 3:585–591PubMedGoogle Scholar
  501. 469.
    Singh K, Mezei M (1983) Int J Pharm 16:339–344Google Scholar
  502. 470.
    Lee VHL, Urrea PT, Smith RE, Schanzlin DJ (1985) Surv Ophthalmol 29.335–348PubMedGoogle Scholar
  503. 471.
    Shell JW (1985) Drug Dev Res 6:245–261Google Scholar
  504. 472.
    Schoenwald RD, Folk JC, Kumar V, Piper JG (1987) J Ocular Pharmacol 3:333–340Google Scholar
  505. 473.
    Duzman E, Chen CC, Anderson J, Blumenthal M, Twizer H (1982) Arch Ophthalmol 100:1916–1919PubMedGoogle Scholar
  506. 474.
    Sugrue MF, Gautheron P, Grove J, Mallorga P, Viader MP (1987) Invest Ophthalmol Vis Sci 28 (ARVO Suppl):267Google Scholar
  507. 475.
    Bundgaard H, Falch E, Larsen C, Mikkelson TJ (1986) J Pharm Sci 75:36–43PubMedGoogle Scholar
  508. 476.
    Bundgaard H, Falch E, Larsen C, Mosher G, Mikkelson TJ (1986) J Pharm Sci 75:775–783PubMedGoogle Scholar
  509. 477.
    Mosher GL, Bundgaard H, Falch E, Larsen C, Mikkelson TJ (1987) IntJ Pharm 39:113–120Google Scholar
  510. 478.
    Bundgaard H (1989) Proceedings of the 5th Int Conf Pharm Technol (Paris 1989), Vol. 1, p 52–60Google Scholar
  511. 479.
    Narurkar MM, Mitra AK (1986) Pharm Res 3 (Suppl):48sGoogle Scholar
  512. 480.
    Leibowitz HM, Kupferman A, Stewart RH, Kimbrough RL (1978) Am J Ophthalmol 86:418–423PubMedGoogle Scholar
  513. 481.
    Lee VHL, Li VKL (1989) Adv Drug Delivery Res 3:1–38Google Scholar
  514. 482.
    Nelson JD (1982) Surv Ophthalmol 27:67–69PubMedGoogle Scholar
  515. 483.
    Korsatko W, Egger G (1988) Pharmazie 43:776–779PubMedGoogle Scholar
  516. 484.
    Alani DS (1978) Acta Ophthalmol 56:473–474Google Scholar
  517. 485.
    Alani DS (1978) Acta Pharm Suec 15:237–240PubMedGoogle Scholar
  518. 486.
    Dimenäs E, Blychert LO, Lambert H (1981) Acta Oph-thalmol 59:453Google Scholar
  519. 487.
    Nielson NV (1981) Acta Ophthalmol 59:495–502Google Scholar
  520. 488.
    Gwon A, Borrmann LR, Duzman E, Robins DS, Shen D (1986) Ophthalmology (Rochester) 93 (Suppl):82–85Google Scholar
  521. 489.
    Novack GD, Ober M, Batoosingh AL, Eto CY, Mordaunt JM (1988) Invest Ophthalmol Vis Sci 29 (ARVO Suppl):83Google Scholar
  522. 490.
    Tan-Liu DDS, Sandri R (1989) J Ocular Pharmacol 5:133–140Google Scholar
  523. 491.
    Bagley JL (1984) Am Drug 189:94,96,98Google Scholar
  524. 492.
    MacKeen DL (1986) Am Pharm NS 26:27–31Google Scholar
  525. 493.
    Anonym (1987) Drug Topics 131:73Google Scholar
  526. 494.
    Assmann A (1979) Dtsch Apoth Ztg 119:400Google Scholar
  527. 495.
    Dolder R (1988) Schweiz Apoth Ztg 126:603Google Scholar
  528. 496.
    Faure M, Heitz R (1988) Contactologia 10:190–193Google Scholar
  529. 497.
    Kreiner CF (1989) Acta Pharm Technol 35:58–66Google Scholar
  530. 498.
    Brethfeld V (1989) Contactologia 11:105–107Google Scholar
  531. 499.
    Brethfeld V (1989) Contactologia 11:155–158Google Scholar
  532. 500.
    Bürki E (1989) Contactologia 11:1–4Google Scholar
  533. 501.
    Wing DS, Gellathy KW (1987) Can Pharm J 120:161–166Google Scholar
  534. 502.
    Swarbrick HA (1988) Int Contact Lens Clin 15:13–19Google Scholar
  535. 503.
    Baldone JA, Kauman HE (1983) Ann Ophthalmol 15:595–596PubMedGoogle Scholar
  536. 504.
    Driebe WT (1989) Surv Ophthalmol 34:44–46PubMedGoogle Scholar
  537. 505.
    Pace P, Guyot-Sionet M, Vidal R, Giorgi G, Jonard M (1989) Contactologial l:59–62Google Scholar
  538. 506.
    Kersley HJ (1989) Contactologia 11:108–111Google Scholar
  539. 507.
    Brewitt H, Mandel S (1990) Contactologia 12:1–6Google Scholar
  540. 508.
    Philips AJ, Stone J (1989) Appropriate drugs and solu-tions for use with contact lenses. In: Philips AJ, Stone J (eds.) Contact lenses, A textbook for practitioner and stu-dent, 3rd Edition, Butterworth, London, p 979–988Google Scholar
  541. 509.
    Davies DJG (1978) J Appi Bacteriol 44:XIX-XXVIIGoogle Scholar
  542. 510.
    Van Ooteghem M (1982) Labo Pharm Probi Techn 30:802–811Google Scholar
  543. 511.
    Medicines Act 1968: Control of contact lens fluids. De-partment of Health and Social Security; Medicines Divi-sion, London, Mai 53:1–40Google Scholar
  544. 512.
    Faure M (1982) Labo Pharm Probi Techn 30:92–97Google Scholar
  545. 1.
    Berggard J (1965) Identification and isolation of urinary proteins. In: Peeters H (Ed.) Protides of the biological fluids. Proc. 12th Col Bruges, 1964, p 285–291Google Scholar
  546. 2.
    Berglöf JH, Eriksson SE (1989) Plasma fractionation by chromatography of albumin and IgG. In: Stoltz JF (Ed.) Biotechnology of plasma proteins. Colloque INSERM, Vol. 175, p 201–206Google Scholar
  547. 3.
    Björling H (1972) Vox Sang 23:18–26PubMedGoogle Scholar
  548. 4.
    Burstein M (1970) J Lipid Res 11:583–595PubMedGoogle Scholar
  549. 5.
    Chanutin A, Curnish RR (1960) Arch Biochem Biophys 89:218–220PubMedGoogle Scholar
  550. 6.
    Cohn EJ, Strong LE, Hughes WL jr, Mulford DJ, Ashworth JN, Melin M, Taylor HL (1946) J Am Chem S 68:459–475Google Scholar
  551. 7.
    Einarsson M (1988) Scand J Infect Dis 17:141–146Google Scholar
  552. 8.
    Eriksson S, Berglöf JH, Suomela H (1982) Recovery of human albumin from Cohn fraction IV paste. In: Curling JM (Ed.) Separation of Plasma Proteins. Pharmacia, p 89–102Google Scholar
  553. 9.
    Foster PR, Dunnill P, Lilly MD, (1973) Biochim Biophys Acta 317:505–516PubMedGoogle Scholar
  554. 10.
    Friedli H, Kistler P (1972) Chimica 26:25–27Google Scholar
  555. 11.
    Friedli H, Mauerhofer M, Faes A, Kistler P (1976) Vox Sang 31:289–295PubMedGoogle Scholar
  556. 12.
    Gellis S (1948) J Clin Invest 27.239–244Google Scholar
  557. 13.
    Gofman JW, Lindgren IT, Elliot H (1949) J Biol Chem 179:973–979PubMedGoogle Scholar
  558. 14.
    Haupt H, Heide K (1966) Klin Wochenschr 47:270–272Google Scholar
  559. 15.
    Heide K, Haupt H, Schwick HG (1977) Plasma Protein Fractionation. In: Putnam FW (Ed.) The Plasma Proteins, Vol. III. Academic Press, New York San Francisco Lon-don, pp 545–597Google Scholar
  560. 16.
    Heimberger N, Haupt H (1988) Plasmafraktionierung. In: Mueller-Eckhardt (Hrsg.) Transfusionsmedizin, Springer, New York Berlin Heidelberg, S. 246–277Google Scholar
  561. 17.
    Hink JH, Hildalgo J, Seeberg VP, Johnson FF (1957) Vox Sang 2:174–186PubMedGoogle Scholar
  562. 18.
    Horejsi J, Smetana R (1956) Acta Med Scan 155:65–70Google Scholar
  563. 19.
    Ingham KC (1978) Arch Biochem Biophys 186:106–113PubMedGoogle Scholar
  564. 20.
    Juckes IRM (1971) Biochim Biophys Acta 229:535–546PubMedGoogle Scholar
  565. 21.
    Kistler P, Nitschmann H (1962) Vox Sang 7:414–424PubMedGoogle Scholar
  566. 22.
    Liautaud J, Pia J, Debrus A, Gattel P, Plan R, Peyron L (1973) 13th Intern Congr of IABS, Budapest 1973, Part A: Purification of Proteins, Develop biol Standard, Vol. 27, p107–114Google Scholar
  567. 23.
    Newman J, Johnson AJ, Karpatkin MH, Puszkins S (1971) BrJ Haematol 21:l-20Google Scholar
  568. 24.
    Nitschmann H, Rickli E, Kistler P (1959) Helv Chim Acta 17:2198–2211Google Scholar
  569. 25.
    Oncley JL, Melin M, Richert DA, Cameron JW, Gross PM jr (1949) J Amer Chem S 71:541–550Google Scholar
  570. 26.
    Poison A, Potgieter GM, Largier JF, Mears GEF, Joubert FG (1964) Biochim Biophys Acta 82:463–475Google Scholar
  571. 27.
    Poison A, Ruiz-Bravo C (1972) Vox Sang 23:107–118Google Scholar
  572. 28.
    Porath J, Flodin P (1959) Nature 183:1657–1659PubMedGoogle Scholar
  573. 29.
    Schneider W, Lefevre H, Fiedler H, McCarty LJ (1975) Blut 30:121–134PubMedGoogle Scholar
  574. 30.
    Schneider W, Wolter D, McCarty U (1976) Blut 33:275–278PubMedGoogle Scholar
  575. 31.
    Schultze HE, Heide K, Haupt H (1962) Clin Chim Acta 7:854–868Google Scholar
  576. 32.
    Schultze HE, Heremans JF (1966) Molecular Biology of Human Proteins, Vol. I. Elsevier Publishing Company, Amsterdam London New YorkGoogle Scholar
  577. 33.
    Smith JK, Watt JG, Watson CN, Mastenbroek GGA (1972) Vox Sang 22:120–130PubMedGoogle Scholar
  578. 34.
    Steinbuch M (1972) Vox Sang 23:92–106PubMedGoogle Scholar
  579. 35.
    Surgenor DM (1952) Rev Int Med Dermatol 9:145Google Scholar
  580. 36.
    Wickerhauser M, Sgouris JT (1972) Vox Sang 22:137–160PubMedGoogle Scholar
  581. 37.
    Wickerhauser M, Hao YL (1972) Vox Sang 23:119–125PubMedGoogle Scholar
  582. 38.
    Wickerhauser M Hao YL, Mercer JE (1978) Abstracts of the Joint Congress of the International Societies of Hae-matology and Blood Transfusion, Paris, p 483Google Scholar
  583. 39.
    Wickerhauser M, Williams C, Mercer JE (1979) Vox Sang 36:281–293PubMedGoogle Scholar
  584. 40.
    Wieland T, Goldmann H, Kern W, Schultze HE, Matheka HD (1953) Makromol Chem 10:136–146Google Scholar
  585. 41.
    Piszkiewicz D, Kingdon H, Apfelzweig R (1985) Lancet 1188–1189Google Scholar
  586. 42.
    Wells M, Wittek A, Epstein J (1986) Transfusion 26:210–213PubMedGoogle Scholar
  587. 1.
    Hager H (1878) Hagers Handbuch der Pharmaceutischen Praxis, 1. Aufl., Springer, BerlinGoogle Scholar
  588. 2.
    Geissler E, Moeller J (1908) Real-Enzyklopädie der ge-samten Pharmazie, 2. Aufl. Moeller J, Thoms H (Hrsg.) Urban & Schwarzenberg, Berlin WienGoogle Scholar
  589. 3.
    Rocha Filho PA, Vaution C, Seiller M (1989) STP Pharma 5:652–660Google Scholar
  590. 4.
    Tadros TF (1989) Pestic Sei 26:51–77Google Scholar
  591. 5.
    Handjani-Vila RM, Ribier A, Rondot A, Vanlerberghe G (1979) Int J Cosmet Sei 1:303–314Google Scholar
  592. 6.
    Müller-Goymann C, Führer C (1982) Acta Pharm Technol 28:243–251Google Scholar
  593. 7.
    Chevalier Y, Zemb T (1990) Rep Prog Phys 53:279–371Google Scholar
  594. 8.
    Hoar TP, Schulmann JH (1943) Nature 152:102–103Google Scholar
  595. 9.
    Eicke HF (1982) Pharm Acta Helv 57:322–329Google Scholar
  596. 10.
    Scriven LE (1976) Nature 263:123–125 und Proc Int Symp Micellization, Solubilization, Microemulsions 2:877–93Google Scholar
  597. 11.
    Kahlweit M, Strey R, Firman P, Haase D, Jen J, Schomäcker R (1988) Langmuir 4:499–511Google Scholar
  598. 12.
    Keipert S, Siebenbrodt I, Lüders F, Bornschein M (1989) Pharmazie 44:433–444PubMedGoogle Scholar
  599. 13.
    Johnson KA, Shah DO (1985) J Coli Interf Sei 107:269–271Google Scholar
  600. 14.
    Osborne DW, Middleton CA, Rogers RL (1988) J Disp Sei Tech 9:415–423Google Scholar
  601. 15.
    Delord P, Lärche FC (1984) J Coli Interf Sei 98:277–278Google Scholar
  602. 16.
    Kölln CJ (1986) Dissertation, Universität KielGoogle Scholar
  603. 17.
    Luszcak E (1990) Österr Apothek Ztg 44:741–742Google Scholar
  604. 18.
    Fiedler HP (1989) Lexikon der Hilfsstoffe für Pharmazie, Kosmetik und angrenzende Gebiete, 3. Aufl., Band I und II, Editio Cantor, AulendorfGoogle Scholar
  605. 19.
    Gebler H (1982) Tabellen für die Pharmazeutische Praxis, 2. Aufl., 1. Erg. 1987, Govi, FrankfurtGoogle Scholar
  606. 20.
    Koglin B (1984) Kontinuierliche Herstellung von Salben, Cremes und Emulsionen. In: Asche H, Essig D, Schmidt PC (Hrsg.) Technologie von Salben, Suspensionen und Emulsionen, Wissenschaftliche Verlagsgesellschaft, Stutt-gart, S. 134–159Google Scholar
  607. 21.
    Rogasch R, List PH, Bremecker KD (1990) Acta Pharm Technol 36:17SGoogle Scholar
  608. 22.
    Junginger HE (1989) Persönliche MitteilungGoogle Scholar
  609. 23.
    Müller RH (1983), Beilage der Dtsch Apothek Ztg Phar-mazeutische Verfahrenstechnik heute 1:87–89,91–94Google Scholar
  610. 24.
    Brandau R, Bold KW (1976) Pharm Ind 38:379–380Google Scholar
  611. 25.
    Reng AK (1984) Stabilitätsprüfungen von dispersen Zu-bereitungen. In: Asche H, Essig D, Schmidt PC (Hrsg.) Technologie von Salben, Suspensionen und Emulsionen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 189–206Google Scholar
  612. 26.
    Thoma K, Gröning R, Zimmer T (1978) Pharm Ztg 123:1762–1773Google Scholar
  613. 27.
    Thiele OW (1979) Lipide, Isoprenoide mit Steroiden, Thieme, Stuttgart, S. 118–121Google Scholar
  614. 1.
    Dolittle RF (1986) Die Moleküle des Lebens, Spektrum der Wissenschaft, S. 42–52Google Scholar
  615. 2.
    Bretscher MS (1986) Die Moleküle des Lebens, Spektrum der Wissenschaft, S. 54–63Google Scholar
  616. 3.
    Snyder SH (1986) Die Moleküle des Lebens, Spektrum der Wissenschaft, S. 90–99Google Scholar
  617. 4.
    Berridge MJ (1986) Die Moleküle des Lebens, Spektrum der Wissenschaft, S. 100–110Google Scholar
  618. 5.
    Tonegawa S (1987) Die Moleküle des Lebens, Spektrum der Wissenschaft, S. 80–89Google Scholar
  619. 6.
    Dickerson RE (1986) Erbsubstanz DNA, Spektrum der Wissenschaft, S. 21Google Scholar
  620. 7.
    Chambon P (1986) Erbsubstanz DNA, Spektrum der Wis-senschaft, S. 84Google Scholar
  621. 8.
    Crick FHC (1986) Erbsubstanz DNA, Spektrum der Wis-senschaft, S. 75Google Scholar
  622. 9.
    Watson JD, Tooze J, Kurtz DT (1986) Rekombinierte DNA, Spektrum der Wissenschaft, S. 56Google Scholar
  623. 10.
    Watson JD, Tooze J, Kurtz DT (1986) Rekombinierte DNA, Spektrum der Wissenschaft, S. 57Google Scholar
  624. 11.
    Watson JD, Tooze J, Kurtz DT (1986) Rekombinierte DNA, Spektrum der Wissenschaft, S. 63Google Scholar
  625. 12.
    Watson JD, Tooze J, Kurtz DT (1986) Rekombinierte DNA, Spektrum der Wissenschaft, S. 72Google Scholar
  626. 13.
    Werner RG, Merk W, Walz F (1988) Arzneim Forsch/Drug Res 38 (I):320–325Google Scholar
  627. 14.
    Gebb C, Clark JJ, Hirtenstein MD (1982) Develop Biol Stand 50:95Google Scholar
  628. 15.
    Renveny S, Corett R, Mizrahi A (1984) World Biotech Rep (Europe) 1:343Google Scholar
  629. 16.
    Renveny S, Silberstein L, Shahar A, Freeman E, Mizrahi A (1982) In Vitro 18:92Google Scholar
  630. 17.
    Renveny S, Mizrahi A, Kotler M, Freeman A (1983) Am N Y Acad Sei 431 Biochem Eng 111:413Google Scholar
  631. 18.
    Keese CR, Giaever I (1983) Science 219:1448PubMedGoogle Scholar
  632. 19.
    Wissemann KW, Jakobson BS (1985) In Vitro 21:391Google Scholar
  633. 20.
    Gebb C, Clark JM, Hirtenstein MD, Lindgren GE, Lund-gren BJ, Lindskog U, Vretblas PA (1984) Enkaryotic Cell Cultures In: Action RT, Lynn JD (Hrsg.) Plenum Press, New York London, S. 151–167Google Scholar
  634. 21.
    Müller (1985) Forum Mikrobiol 8:296Google Scholar
  635. 22.
    Lim F, Sun AM (1980) Science 210:908PubMedGoogle Scholar
  636. 23.
    Jarvis Jr Ap, Grdina TA (1983) Biotechniques 1:22Google Scholar
  637. 24.
    Posillico EG (1986) Bio/Technology 4:114Google Scholar
  638. 25.
    PIC-Dokument PH 1/81Google Scholar
  639. 26.
    Werner RG, Berthold W (1988) Arzneim Forsch/Drug Res 38 (1)3:422–428Google Scholar
  640. 27.
    Foster PR, Dunhill P, Lilly MD (1973) Biochim Biophys Acta 317:505–516Google Scholar
  641. 28.
    Hönig W, Kula MR (1976) Anal Biochem 72:502–512PubMedGoogle Scholar
  642. 29.
    Bergmeyer HU, Naeher G, Thum W, Weimann G (1970) DP 20019027Google Scholar
  643. 30.
    Scopes RK (1983) Protein Purification - Principles and Practice, Springer, Heidelberg New York TokyoGoogle Scholar
  644. 31.
    Chase HA (1983) Chem Eng Sei 39:1099Google Scholar
  645. 32.
    Reagan ME, Robb H, Bornstein J, Niday EG (1985) Thromb Res 40:1PubMedGoogle Scholar
  646. 33.
    Sulkowski E (1985) Trends Biotechnol 3:1Google Scholar
  647. 34.
    Rijken DC, Collen DJ, (1981) Biochem 256:7035Google Scholar
  648. 35.
    Winkler ME, Blaber M, Bennett GC, Holmes W, Vehar GA (1985) bio/Technology 3:990Google Scholar
  649. 36.
    Someno T, Saino T, Katoh K, Miyazaki H, Ishii S (1985) J Biochem 97:1493PubMedGoogle Scholar
  650. 37.
    Staehelin T, Hobbs DS, Kung H, Pesta S (1981) Meth Enzymol 78:505PubMedGoogle Scholar
  651. 38.
    Einarsson M, Brandt J, Kaplan L (1985) Biochem Biophys Acta 830:1PubMedGoogle Scholar
  652. 39.
    Werner RG, Langlouis-Gau H, Walz F, Allgaier H, Hoff-mann H (1988) Arzneim-Forsch/Drug Res 38 (I) 6: 855–862Google Scholar
  653. 40.
    Office of Biologies Research and Review Center for Drugs and Biologies (1985) Points to consider in the Production and Testing of New Drugs and Biologicals Produced by Recombinant DNA-TechnologyGoogle Scholar
  654. 41.
    Committee for proprietary medicinal products (1987) Notes to Applicants for Marketing Authorization. On Requirements for the production and quality control of medicinal prodcucts derived by recombinant DNA-tech-nologyGoogle Scholar
  655. 42.
    World Health Organization (1987) Technical Report Series 747, GenfGoogle Scholar
  656. 43.
    American Society for Testing and Materials (ASTM) (1988) Draft Standard Guide for Determination of Purity, Impurities, and Containments in Biological Drug Products, Philadelphia, PAGoogle Scholar
  657. 44.
    Garnick RL (1989) J of Pharmaceutical and Biomedical Analysis 7 (2):255–266Google Scholar
  658. 45.
    Kafatos FC, Jones CW, Efstratiadis A (1979) Nucleic Acids Res 7:1541:1552Google Scholar
  659. 46.
    Carlson RH, Garnick RL, Jones AJS, Meunier AM (1988) Anal Biochem 168:428–435PubMedGoogle Scholar
  660. 47.
    Küenzi M et al (1985) Safe Biotechnology (1) - General Considerations; Appl Microbiol Biotechnol 21: l-6Google Scholar
  661. 48.
    OECD–Report (1986) Recombinant DNA Safety Con–siderations, ISBN 92–64–12857–3, ParisGoogle Scholar
  662. 49.
    Frommer W et al (1981) Safe Biotechnology (2), Appl Microbiol Biotechnol 30–541–552Google Scholar
  663. 1.
    DAB 9, S. 846–847Google Scholar
  664. 2.
    Nürnberg E (1987) Granulate. In: Kommentar zum DAB 9, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 1804–1807Google Scholar
  665. 3.
    Bauer KH, Frömming KH, Führer C (1989) Pharmazeu-tische Technologie, 2. Aufl., Thieme, Stuttgart, S. 365Google Scholar
  666. 4.
    DAB 9, S. 847Google Scholar
  667. 5.
    HelvVII, GranulataGoogle Scholar
  668. 6.
    PhEur, S. 499Google Scholar
  669. 7.
    DAB 9, S. 848Google Scholar
  670. 8.
    BP 88, Vol. II. p 695Google Scholar
  671. 9.
    DAB 9, S. 943Google Scholar
  672. 10.
    Ridge way K (1987) Hard Capsules-Development and Technology, Pharmaceutical Press, London, p 200Google Scholar
  673. 11.
    Ho T, Hersey JA (1979) Powder Technol 23:191–195Google Scholar
  674. 12.
    Kristensen HG, Schaefer T (1987) Drug Dev Ind Pharm 13 (4 +5): 803–872Google Scholar
  675. 13.
    Newitt DM, Conway-Jones JM (1958) Trans Inst Chem Eng 36:430Google Scholar
  676. 14.
    Bier HP, Leuenberger H (1979) Acta Pharm Technol Suppl 7:41–44Google Scholar
  677. 15.
    Leuenberger H (1982) Pharm Acta Helv 57/5:72–82PubMedGoogle Scholar
  678. 16.
    Fahrig W, Hofer U (1983) Die Kapsel, Paperback APV Band 7, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 87–95Google Scholar
  679. 17.
    Grimm W, Schepky G (1980) Stabilitätsprüfung in der Pharmazie, Editio Cantor, Aulendorf, S. 206Google Scholar
  680. 18.
    Nyqvist H, Brodin A (1982) Acta Pharm Suec 19/2:81–90PubMedGoogle Scholar
  681. 19.
    Dawoodbhai S, Rhodes CT (1989) Drug Dev Ind Pharm 15/10:1577–1600Google Scholar
  682. 20.
    Alderborn G (1988) Acta Pharm Suec 25:229–238Google Scholar
  683. 21.
    Cole ET, Elworthy PH, Sucker HJ (1975) J Pharm Phar-macol Suppl 27:1PGoogle Scholar
  684. 22.
    Bauer KH, Frömming KH, Führer C (1989) Pharmazeu-tische Technologie, 2. Aufl., Thieme, Stuttgart, S. 363–373Google Scholar
  685. 23.
    Fiedler HP (1989) Lexikon der Hilfsstoffe, Bd. 1 und 2, Editio Cantor, AulendorfGoogle Scholar
  686. 24.
    The Pharmaceutical Society of Great Britain (1986) Handbook of Pharmaceutical Excipients, 1 Lambeth High Street, London SEI 7JN, EnglandGoogle Scholar
  687. 25.
    Ciba-Geigy, Hoffmann-La Roche, Sandoz (1974) Kata-log pharmazeutischer Hilfsstoffe, Deutscher Apotheker Verlag, StuttgartGoogle Scholar
  688. 26.
    Tappert Gl, Lingberg NO (1986) Acta Pharm Suec 23:47–56Google Scholar
  689. 27.
    El-Gindy NA, Samaha MW, El-Maradyn HA (1988) Drug Dev Ind Pharm 14/7:977–1005Google Scholar
  690. 28.
    Wan LSC, Prasad KPP (1989) Pharm Ind 51/1:105–109Google Scholar
  691. 29.
    Voigt R, Richter M (1988) Pharmazie 43/3:191–194PubMedGoogle Scholar
  692. 30.
    Stammberger W (1975) Acta Pharm Technol 21/3: 177–184Google Scholar
  693. 31.
    Brögmann B (1986) Dissertation, Phillips-Universität, MarburgGoogle Scholar
  694. 32.
    Schmidt PC, Christin I (1990) Pharmazie 45/2:89–101PubMedGoogle Scholar
  695. 33.
    Thum U (1970) Dissertation, ETH ZürichGoogle Scholar
  696. 34.
    Schepky G (1978) Acta Pharm Technol 24/3:185–212Google Scholar
  697. 35.
    Kristensen HG, Schaefer T (1987) Drug Dev Ind Pharm 13(4 + 5):829–843Google Scholar
  698. 36.
    Schaefer T (1988) Acta Pharm Suec 25:205–228Google Scholar
  699. 37.
    Davies WL, Gloor WT (1971) J Pharm Sei 60/12: 1869–1874Google Scholar
  700. 38.
    Schaefer T, Worts O (1978) Arch Pharm Chem Sei 6: 22–25Google Scholar
  701. 39.
    Bartknecht W (1976) Maschinenmarkt 82:826–829Google Scholar
  702. 40.
    Külling W (1977) Pharm Ind 39:631–636 sowie 831–834Google Scholar
  703. 41.
    Siwek R (1987) Pharm Ind 49/11:1165–1175Google Scholar
  704. 42.
    Schepky G (1978) Acta Pharm Technol 24/3:208–209Google Scholar
  705. 43.
    Jäger KF, Bauer KH (1982) Pharm Ind 44/2:193–197Google Scholar
  706. 44.
    Jones DM (1985) Pharm Technol 4:50–62Google Scholar
  707. 45.
    Hüttlin H, US-Patent 4.320.584 vom 23.03.1982Google Scholar
  708. 46.
    Luy B, Hirschfeld P, Leuenberger H (1989) Pharm Ind 51/1:89–94Google Scholar
  709. 47.
    Junginger H (1984) Acta Pharm Technol 30/1:68–77Google Scholar
  710. 48.
    Kala H, Traue I (1983) Acta Pharm Technol 29/1:29–34Google Scholar
  711. 49.
    Hertzfeld CD, Priewer H (1982) Acta Pharm Technol 28/3:191–197Google Scholar
  712. 50.
    Nürnberg E (1980) Acta Pharm Technol 26/1:39–67Google Scholar
  713. 51.
    Schaefer T, Bäk HH, Jaegerskou A, Kristensen A, Svensson JR, Holm P, Kristensen HG (1986) Pharm Ind 48/9:1083–1084Google Scholar
  714. 52.
    Bartsch H (1979) Pharm Ind 41/7:696–698Google Scholar
  715. 53.
    Ullah I, Corrao RG, Wiley Gl, Lipper RA (1987) Pharm Technol 9:48–54Google Scholar
  716. 54.
    Bakele W (1983) Chem Tech 12/5:73Google Scholar
  717. 55.
    Seibt Pharma Technik (1991) 9. Ausg., Seibt, MünchenGoogle Scholar
  718. 56.
    Sherrington PJ, Oliver R (1981) Granulation, Heyden, London Philadelphia RheineGoogle Scholar
  719. 57.
    Pietsch W (1973) APV Informat 19(2/3):147–182Google Scholar
  720. 58.
    Herrmann W (1973) Das Verdichten von Pulvern zwi-schen zwei Walzen, Verlag Chemie, WeinheimGoogle Scholar
  721. 59.
    Dehont FR, Hervieu PM (1989) Drug Devel Ind Pharm 15(14–16):2245–2263Google Scholar
  722. 60.
    Scott MW, Lieberman HA, Rankell AS, Chow FS, Johnston GW (1963) J Pharm Sei 52/3:284–291Google Scholar
  723. 61.
    Köblitz T, Eberhardt L (1985) Pharm Technol 3:62–81Google Scholar
  724. 62.
    Schepky G (1972) Dtsch Apoth Ztg 112/3:87–93Google Scholar
  725. 63.
    Köblitz T, Körblein G, Eberhardt L, Peter S (1985) Pharm Ind 47/1:104–112Google Scholar
  726. 64.
    Doyle C, Cliff MI (1987) Manufact Chem 2:23–25,32Google Scholar
  727. 65.
    De Smet P, (1989) Manufact Chem 3:37–39Google Scholar
  728. 66.
    De Smet P, (1989) Manufact Chem 4:49–53Google Scholar
  729. 67.
    Anonyme Mitteilung (1981) Verfahrenstechnik 15/2:123–129Google Scholar
  730. 68.
    Kristensen HG, Schaefer T (1987) Drug Dev Ind Pharm 13(4 + 5):849–863Google Scholar
  731. 69.
    Werani J (1988) Acta Pharm Suec 25:247–266Google Scholar
  732. 70.
    Ritala M, Holm P, Schaefer T, Kristensen HG (1988) Drug Dev Ind Pharm 14/8:1041–1060Google Scholar
  733. 71.
    Parker MD, Rowe RC (1989) J Pharm Pharmacol Suppl 12:31PGoogle Scholar
  734. 72.
    Kristensen HG, Schaefer T (1987) Drug Dev Ind Pharm 13(4 + 5):820–872Google Scholar
  735. 73.
    Beränek J, Rose K, Winterstein G (1975) Grundlagen der Wirbelschichttechnik, Krausskopf, LeipzigGoogle Scholar
  736. 74.
    Stahl PH (1980) Feuchtigkeit und Trocknen in der phar-mazeutischen Technologie, Steinkopff, Darmstadt, S. 129–133Google Scholar
  737. 75.
    Hauschild G (1977) Acta Pharm Technol Suppl 4:53–59Google Scholar
  738. 76.
    Burns M (1980) Ind Res Dev 3:126–130Google Scholar
  739. 77.
    Sucker H (1982) Pharm Ind 44/3:312–316Google Scholar
  740. 78.
    Gordon RE, Rosanske TW, Fonner DE (1990) Granula-tion Technology. In: Lieberman HA, Lachman L, Schwartz JB (Eds.) Pharmaceutical Dosage Forms: Ta-blets, Vol. 2., Dekker, New York Basel, pp. 245–316Google Scholar
  741. 79.
    Dahlinder LE, Johansson M, Sjörgren J (1982) Drug Dev Ind Pharm 8/3:455–461Google Scholar
  742. 80.
    Laughlin SM, Carstensen JT (1981) J Pharm Sei 70/6:711–713Google Scholar
  743. 81.
    Carstensen JT, Ching Chang P (1977) J Pharm Sei 66/9:1235–1238Google Scholar
  744. 82.
    DIN 53912(1969) Bestimmungen der Schütt-und Rüttel-dichte von Pulvern und GranulatenGoogle Scholar
  745. 83.
    DIN ISO 784 (1983) Bestimmung des Stampfvolumens und der Stampfdichte. Teil 11: Prüfung von Pigmenten und anderen pulverförmigen und granulierten Erzeug-nissen. Bestimmung des Stampfvolumens und der StampfdichteGoogle Scholar
  746. 84.
    Gordon RE, Rosanske TW, Fonner DE (1990) Granula-tion Technology. In: Lieberman HA, Lachman L, Schwartz JB (Eds.) Pharmaceutical Dosage Forms: Ta-blets, Vol. 2., Dekker, New York Basel, pp. 201–202Google Scholar
  747. 85.
    DIN 66145 (1976) Darstellung von Korn-(Teilchen-) grö-ßenverteilungen, RRSB-NetzGoogle Scholar
  748. 86.
    Motzi II, Anderson NR (1984) Drug Dev Ind Pharm 10/2:225–239Google Scholar
  749. 87.
    DAC 86, S. 11Google Scholar
  750. 88.
    Zografi G (1988) Drug Dev Ind Pharm 14/14:1905–1926Google Scholar
  751. 89.
    Schepky G (1975) Acta Pharm Technol 21/4:267–268Google Scholar
  752. 90.
    Schepky G (1989) Drug Dev Ind Pharm 15/10:1715–1741Google Scholar
  753. 91.
    DAB 9, S. 142–143Google Scholar
  754. 92.
    USP XXI, S. 1280–1281Google Scholar
  755. 93.
    PhEur, V.3.5.6Google Scholar
  756. 94.
    USP XXI, S. 1619–1621Google Scholar
  757. 95.
    Connors KA (1988) Drug Dev Ind Pharm 14/14:1891–1903Google Scholar
  758. 96.
    Vemuri S (1983) Pharm Technol 9:119–123Google Scholar
  759. 97.
    Stahl PH (1980) Feuchtigkeit und Trocknen in der phar-mazeutischen Technolgoie, Steinkopff, Darmstadt, S. 60–105Google Scholar
  760. 98.
    DAB 9, S. 847,105–106Google Scholar
  761. 99.
    DAB 9, S. 847,104–105Google Scholar
  762. 100.
  763. 101.
    Rubinstein MH, Musikabhumma P (1978) Pharm Acta Helv 53/5:125–129Google Scholar
  764. 102.
    Gordon RE, Rosanske TW, Fonner DE (1990) Granula-tion Technology. In: Lieberman HA, Lachman L, Schwartz IB (Eds.) Pharmaceutical Dosage Forms: Ta-blets, Vol. 2, Dekker, New York Basel, pp. 216–222Google Scholar
  765. 103.
    Feldkamp H, Fuchs P, Sucker H (1983) Pharmazeutische Qualitätskontrolle, Thieme, Stuttgart New York, S. 685–715Google Scholar
  766. 104.
    Bauer KH, Frömming KH, Führer C (1989) Pharmazeu-tische Technologie, 2. Aufl., Thieme, Stuttgart, S. 365Google Scholar
  767. 105.
    Kroll K, Kast W (1989) Trocknen und Trockner in der Produktion, 3. Bd., Springer, Berlin HeidelbergGoogle Scholar
  768. 106.
    Van Scoik KG, Zoglio M, Carstensen JT (1990) Drying. In: Lieberman HA, Lachman L, Schwartz JB (Eds.) Pharmaceutical Dosage Forms: Tablets Vol. 2, Dekker, New York BaselGoogle Scholar
  769. 1.
    Merck-Index (1968) Merck&Co. Rahway (USA),S. 1281–1289Google Scholar
  770. 2.
    Gstirner F (1960) Grundstoffe und Verfahren der Arznei-bereitung, Enke, Stuttgart, S. 169–236Google Scholar
  771. 3.
    Stivic I, Jalsenjak I (1968) Acta Pharm Jugosl, 18:91–98Google Scholar
  772. 4.
    Krummholz B, Vatzek H (1937) Wien Monatsh Chem, 70:437Google Scholar
  773. 5.
    DIN 58 377, Blatt 1Google Scholar
  774. 6.
    DIN 58 366, Blatt 1Google Scholar
  775. 7.
    DIN 58 363, Blatt 5Google Scholar
  776. 8.
    Zimmermann L (1983) Pharm Ind, 45:1175–1181Google Scholar
  777. 9.
    HIMA Report No. 78–4.12 vom Februar 1980Google Scholar
  778. 10.
    Wallhäußer KH (1981) Pharm Ind, 43:104,146Google Scholar
  779. 11.
    Schroeder HG, Deluca PP (1980) Pharm Techn 11:80Google Scholar
  780. 12.
  781. 13.
    Wallhäußer KH (1984) Praxis der Sterilisation, Desinfek-tion-Konservierung, Keimidentiflzierung-Betriebshygie-ne, Thieme, Stuttgart New York, S. 181Google Scholar
  782. 14.
    Stumbo CR (1973) Thermobacteriology in Food Proces-sing, 2nd ed., Academic Press, New York LondonGoogle Scholar
  783. 15.
    Deutscher Arzneimittel-Codex (DAC) (1986) Bundesver-einigung Deutscher Apothekerverbände (ABDA), Deut-scher Apotheker-Verlag, StuttgartGoogle Scholar
  784. 16.
    Rose WC (1949) Fed Proc 4:546–552Google Scholar
  785. 17.
    Prankerd RJ, Stella VJ (1990) J Parenter Sei Technol 44:139–149Google Scholar
  786. 18.
    Machy P, Leserman L (1987) Liposomes in Cell Biology and Pharmacology, J. Libbey & Co. Ltd., LondonGoogle Scholar
  787. 19.
    Gregoriadis G (1988) Liposomes as Drug Carrier, Recent Trends and Progress, J. Wiley & Sohns, New YorkGoogle Scholar
  788. 20.
    Mentrup E, Butz P, Strieker H, Ludwig H (1988) Pharm Ind 50:363–366Google Scholar
  789. 21.
    Kibat P, Strieker H (1988) Arzneim Forsch/Drug Res, 38 (II), 10,1472–1478Google Scholar
  790. 22.
    USPXXII (1990) 1597Google Scholar
  791. 23.
    USPXXII (1990) 1596Google Scholar
  792. 1.
    Friedland J (1987) Arzneiformenlehre, Thieme, Stuttgart New YorkGoogle Scholar
  793. 2.
    Alles über die Hartgelatinekapsel (1987) Capsugel AG, CH-BaselGoogle Scholar
  794. 3.
    Fahrig W, Hofer U (Hrsg.) (1983) Die Kapsel. Grundla-gen, Technologie und Biopharmazie einer modernen Apzneiform, 1. Aufl., Wissenschaftliche Verlagsgesell-schaft, StuttgartGoogle Scholar
  795. 4.
    Kapsel-Kompendium, R.P. Scherer GmbH, EberbachGoogle Scholar
  796. 5.
    Deasy PB (1984) Microencapsulation and Related Drug Processes, 1. Ed., Marcel Dekker Inc., New York BaselGoogle Scholar
  797. 6.
    Herzfeldt CD (1986) Acta Pharm Teahnol, Beil APV Pharm i d Praxis 2:3–6Google Scholar
  798. 7.
    Herzfeldt CD, Cappel M, Diepold R, Weigel P (1987) Acta Pharm Technol, Beil APV Pharm i d Praxis 3:1–3Google Scholar
  799. 8.
    Braun R (Hrsg.) (1988) Standardzulassungen für Fertig-arzneimittel. Text und Kommentar, Deutscher Apotheker Verlag Stuttgart, Govi, FrankfurtGoogle Scholar
  800. 9.
    ABDA (Hrg.) (1986) Deutscher Arzneimittel Codex Bd. 3, Neues Rezeptur Formularium, Govi, Frankfurt a. M., Deutscher Apotheker Verlag StuttgartGoogle Scholar
  801. 10.
    Herzfeldt CD (1987/88/89) Defektur. Leitfaden für die apothekengerechte Arzneimittelproduktion, Govi, Frank-furtGoogle Scholar
  802. 11.
    Thoma K, Merk B (1986) Neuere Arzneiformen in der Apothekenrezeptur, Schriftenreihe der Bayrischen Lan-desapothekerkammer Heft 34, MünchenGoogle Scholar
  803. 12.
    Herzfeldt CD, Scherer D (1987) Acta Pharm Technol, Beil APV Pharm i d Praxis 4:1–3Google Scholar
  804. 13.
    Herzfeldt CD (1988) Acta Pharm Technol, Beil APV Pharm i d Praxis 7:3–5Google Scholar
  805. 14.
    Herzfeldt CD, Westerhove A (1988) Acta Pharm Technol, Beil APV Pharm i d Praxis 8:4–6Google Scholar
  806. 15.
    Strittmatter T, Siewert M (1982) Pharm Ztg 127:495–496Google Scholar
  807. 16.
    Müller BW (1984). In: Offizinpharmazie, Bd. 8, Thieme, Stuttgart New York, S. 60–69Google Scholar
  808. 17.
    Herzfeldt CD (1988) pta i d apotheke 17:369–373Google Scholar
  809. 18.
    Herzfeldt CD (1988) pta i d apotheke 17:416–423Google Scholar
  810. 19.
    Herzfeldt CD (1988) pta i d apotheke 17:491–493Google Scholar
  811. 20.
    Schmidt PC, Stockebrand B (1986) Pharm Ztg 131:1095–1102Google Scholar
  812. 21.
    List PH (1970). In: Hagers Handbuch der Pharmazeuti-schen Praxis, 4. Aufl., Bd. 7 Teil A, Springer, Berlin Hei-delberg New York, S. 482–502Google Scholar
  813. 22.
    Formularium der Nederlandse Apothekers (F.N.A.) Ko-ninklijke Nederlandse Maatschappij ter Bevordering der Pharmacie, NL-s’GravenhageGoogle Scholar
  814. 23.
    Bremecker KD (1988) Pharm Ind 50:487–490Google Scholar
  815. 24.
    Channer KS, Virjee J (1982) Br Med J 285:1702Google Scholar
  816. 25.
    Mitteilung des Herstellers Boehringer IngelheimGoogle Scholar
  817. 26.
    Kreuter J (1988) J Microcapsulation 5:115–127Google Scholar
  818. 1.
    Stricker H (1987) Physikalische Pharmazie, 3. Aufl., Wis-senschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  819. 2.
    Hartke K, Mutschier E, Kommentar zum Deutschen Aiz-neibuch 9. Ausg., Bd. 1–3, Wissenschaftliche Verlagsge-sellschaft, StuttgartGoogle Scholar
  820. 3.
    List H (1985) Arzneiformenlehre, 4. Aufl., Wissenschaftli-che Verlagsgesellschaft, StuttgartGoogle Scholar
  821. 4.
    Bauer KH, Führer C, Frömming KH (1986) Pharmazeuti-sche Technologie, Thieme, StuttgartGoogle Scholar
  822. 5.
    Fricker A (1984) Lebensmittel - mit allen Sinnen prüfen, Springer, HeidelbergGoogle Scholar
  823. 6.
    Voigt R (1975) Lehrbuch der Pharmazeutischen Techno-logie, VEB-Verlag Volk und Gesundheit, BerlinGoogle Scholar
  824. 7.
    Gerthsen C, Kneser HO (1971) Physik, 11. Aufl., Springer, Berlin Heidelberg New YorkGoogle Scholar
  825. 8.
    Sucker H, Fuchs P, Speiser P (1978) Pharmazeutische Technologie, Thieme, StuttgartGoogle Scholar
  826. 9.
    Nürnberg E, Lommer CM (1984) Dtsch Apoth Ztg 124:2170–2175Google Scholar
  827. 10.
    Triebe J, Lommer CM, Pietsch B (1985) Krankenhaus-pharmazie 6:274Google Scholar
  828. 11.
    Deutsche Trinkwasserverordnung (BGBl. 11976 S. 2612)Google Scholar
  829. 12.
    Arzneimittel-Warnhinweisverordnung (AMWarnV) vom 21. Dezember 1984 (BGBl. 1 1985 S. 22), geändert durch Verordnung vom 24. Oktober 1987 (BGBl. I S. 2333)Google Scholar
  830. 13.
    Gesetz zur Neuordnung des Arzneimittelrechtes vom 24. August 1976 (BGBl. I S. 2445), geändert durch das Erste Gesetz zur Änderung des Arzneimittelgesetzes vom 24. Feburar 1983 (BGBl. IS. 169) durch das zweite Gesetz zur Änderung des Arzneimittelgesetzes vom 16. August 1986 (BGBl. S. 1296 vom 21. August 1986) und durch das Dritte Gesetz vom 20. Juli 1988 (BGBl. I S. 1050)Google Scholar
  831. 14.
    Verordnung über gefährliche Stoffe (Gefahrstoffverord-nung-GefStoffV) vom 26. August 1986 (BGBl. I S. 1470) i.d.F. der Ersten Änderungsverordnung vom 16. Dezem-ber 1987 (BGBl. I S. 2721 vom 22. Dezember 1987)Google Scholar
  832. 15.
    Retzlaff G, Rust G, Waibel J (1978) Statistische Versuchs-planung, 2. Aufl., VCH, WeinheimGoogle Scholar
  833. 16.
    Bartholome E, Bickert E, Hellmann H (Hrsg.) Ulimanns Encyclopaedie der technischen Chemie, Bd.l bis 25, 4. Aufl., VCH, WeinheimGoogle Scholar
  834. 17.
    Barrow GM (1979) Physikalische Chemie, 3. Aufl., Vie-weg, BraunschweigGoogle Scholar
  835. 18.
    Pearson ES, Hartley HO (1970) Biometrical Tables for staticians Cambridge University PressGoogle Scholar
  836. 19.
    Kendall NN (1970). In: Biometrical Tables for staticians, Cambridge University PressGoogle Scholar
  837. 20.
    Babington NN, Smith NN (1970). In: Biometrical Tables for staticians, Cambridge University PressGoogle Scholar
  838. 21.
    Friedmann NN (1970). In: Biometrical Tables for stati-cians, Cambridge University PressGoogle Scholar
  839. 22.
    Schmidt P (1979) Arbeitsunterlage für den APV-Kurs „Lö-sungen“ MainzGoogle Scholar
  840. 1.
    Flaig E (1987) Herstellung von Pellets durch Sprüh-und Wirbelschichtverfahren. Aus: APV-Seminar Nanoparti-kel, Liposomen, Pharmakosomen, Mikrokapseln, Pellets. HannoverGoogle Scholar
  841. 2.
    Knop K, Lippold BC (1989) Pharm Ind 51:302–309Google Scholar
  842. 3.
    Thoma K, Zimmer T (1989) Pharm Ind 51:98–101Google Scholar
  843. 4.
    Briquet F, Brossard C, Ser J, Duchene D (1986) S T P Pharma 2:986–994Google Scholar
  844. 5.
    Akbuga J (1989) Int J Pharm 53:99–105Google Scholar
  845. 6.
    Bothmann V, Mehnert W, Frömming KH (1988) Acta Pharm Technol 34:17 SGoogle Scholar
  846. 7.
    Reynolds AD (1970) Manuf Chem Aerosol News 41:40–43Google Scholar
  847. 8.
    Malinowski HJ, Smith WE (1975) J Pharm Sei 64:1688–1692Google Scholar
  848. 9.
    Rowe RC (1985) Pharm Int 6:119–123Google Scholar
  849. 10.
    Appelgren C (1986) Proceedings of the 25th International Colloquium on Industrial Pharmacy, GentGoogle Scholar
  850. 11.
    Köhler H (1969) Dissertation, Eidgenössische Technische Hochschule, Zürich, SchweizGoogle Scholar
  851. 12.
    Wan LSC, Jeyabalan T (1985) Chem Pharm Bull 33:5449–5457PubMedGoogle Scholar
  852. 13.
    Stock KW, Meiners A (1973) Silesia Confiserie Manual No. 2, Silesia-Essenzenfabrik, NorfGoogle Scholar
  853. 14.
    Jones DM (1989) Solution and suspension layering. In: Ghebre-Sellassie I (Hrsg.) Pharmaceutical Pelletization Technology. Marcel Dekker, New York Basel, S. 145Google Scholar
  854. 15.
    Goodhart FW, Jan S (1989) Dry powder layering. In: Ghebre-Sellassie I (Hrsg.) Pharmaceutical Pelletziation Technology. Marcel Dekker, New York Basel, S. 165Google Scholar
  855. 16.
    Gajdos B (1983) Pharm Ind 45:722–728Google Scholar
  856. 17.
    Jäger KF (1983) Dissertation, Albert-Ludwigs-Universi-tät, FreiburgGoogle Scholar
  857. 18.
    Fries W, Jekle K (1986) Pharm Ind 48:187–192Google Scholar
  858. 19.
    Ritschel WA (1971) Pharm Ind 33:685–689Google Scholar
  859. 20.
    Erni W, Zeller M, Piot N (1980) Acta Pharm Technol 26:165–171Google Scholar
  860. 21.
    Wehner E, Voegele D (1983) Acta Pharm Technol 29:113–120Google Scholar
  861. 22.
    Nürnberg E, Hopp A (1983) Pharm Ind 45:1296–1300Google Scholar
  862. 23.
    Pich CH, Moest T (1984) Sphärische Einkristalle für pharmazeutische Zwecke. Offenlegungsschrift DE 3306250 AIGoogle Scholar
  863. 24.
    Ridgway K, Rupp R (1969) J Pharm Pharmacol 21: 30S–39SPubMedGoogle Scholar
  864. 25.
    Nakagawa M, Furuuchi M, Yamahata M, Gotoh K (1985) Powder Technol 44:195–202Google Scholar
  865. 26.
    Wan LSC, Jeyabalan T (1986) Acta Pharm Technol 32:197–199Google Scholar
  866. 27.
    Stanislaus F, Huber HJ (1987) Different drug delivery systems in bioavailability studies. In: Müller BW (Hrsg.) Controlled Drug Delivery. Wissenschaftliche Verlags-gesellschaft, Stuttgart, S. 56Google Scholar
  867. 1.
    Lippold BC (1984) Biopharmazie, 2. Aufl., Wissenschaft-liche Verlagsgesellschaft, StuttgartGoogle Scholar
  868. 2.
    Lippold BC (1988) Dtsch Apoth Ztg 133:9–15Google Scholar
  869. 3.
    Gundert-Remy U (1989) Controlled Release Products - Therapeutic Aspects. In: Gundert-Remy U, Möller H (Eds.) Oral Controlled Release Products, Wissenschaftli-che Verlagsgesellschaft, Stuttgart, pp 13fGoogle Scholar
  870. 4.
    Staudinger H (1989) Chronopharmacology as a Rationale for the Development of Controlled Release Products. In: Gundert-Remy U, Möller H (Eds.) Oral Controlled Re-lease Products, Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 83fGoogle Scholar
  871. 5.
    Lippold BC (1990) Pharm Unserer Zeit 19:13–21PubMedGoogle Scholar
  872. 6.
    Sandberg A, Ragnarsson G, Jonsson UE, Sjögren J (1988) Eur J Clin Pharmacol 33:S3–S7PubMedGoogle Scholar
  873. 7.
    Porter SC (1989) The Use of Opadry, Coateric, and Sure-lease in the Aqueous Film Coating of Pharmaceutical Oral Dosage Forms. In: McGinity JW (Ed.) Aqueous Polyme-rie Coatings for Pharmaceutical Dosage Forms, Dekker, New York, pp317fGoogle Scholar
  874. 8.
    Petereit H-U (1989) Verpressen von überzogenen Parti-keln zu zerfallenden Tabletten mit kontrollierter Wirk-stoffabgabe, APV-Kurs Tablettieren, HannoverGoogle Scholar
  875. 9.
    Bauer KH, Lehmann K, Osterwald H, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsge-sellschaft, StuttgartGoogle Scholar
  876. 10.
    Lippold BH, Sutter BK, Lippold BC (1989) Int J Pharm 54:15–25Google Scholar
  877. 11.
    Sutter B, Lippold BH, Lippold BC (1988) Acta Pharm Technol 34:179–188Google Scholar
  878. 12.
    Lippold BC (1989) Controlled Release Products-Ap-proaches of Pharmaceutical Technology. In: Gundert-Re-my U, Möller H (Eds.) Oral Controlled Release Products, Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 39 fGoogle Scholar
  879. 13.
    Banker GS, Sharma VE (1981) Advances in Controlled Gastrointestinal Absorption. In: Prescott LF, Nimmo WS (Eds.) Drug Absorption, MTP Press, Lancaster, pp 194fGoogle Scholar
  880. 14.
    Speiser P (1969) Sei Pharm 37:14–29Google Scholar
  881. 15.
    Hüttenrauch R (1974) Pharmazie 29:297–302PubMedGoogle Scholar
  882. 16.
    Baker RW (1987) Controlled Release of biologically Ac-tive Agents, Wiley, New YorkGoogle Scholar
  883. 17.
    Carstensen JT (1987) Theoretical Aspects of Polymer Ma-trix Systems. In: Müller BW (Ed.) Controlled Drug Deli-very, Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 132 fGoogle Scholar
  884. 18.
    Higuchi T (1962) J Pharm Sei 53:1145–1149Google Scholar
  885. 19.
    Schwartz JB, Simonelli AP, Higuchi WI (1968) J Pharm Sei 57:274–282Google Scholar
  886. 20.
    Huber HE, Dali LB (1966) J Pharm Sei 55:974–976Google Scholar
  887. 21.
    Lapidus H, Lordi NG (1966) J Pharm Sei 55:840–843Google Scholar
  888. 22.
    Lippold BC (1990) Quellende Polymere für Hydrogel-und Hydrokolloid-Matrixtabletten, APV-Kurs Polymere zur Beeinflussung der Wirkstoff-Freigabe aus festen ora-len Arzneiformen, DarmstadtGoogle Scholar
  889. 23.
    Higuchi WI (1962) J Pharm Sei 51:802–804Google Scholar
  890. 24.
    Higuchi T (1961) J Pharm Sei 50:874–875Google Scholar
  891. 25.
    Erni W, Zeller M, Piot N (1980) Acta Pharm Technol 26:165–171Google Scholar
  892. 26.
    Voegele D, Brockmeier D, von Hattingberg HM, Lippold BC (1983) Acta Pharm Technol 26:167–174Google Scholar
  893. 27.
    Boyd GE, Adamson AW, Myers LS (1947) J Am Chem Soc 69:2836–2848PubMedGoogle Scholar
  894. 28.
    Reichenberg D (1953) J Am Chem Soc 75:589–597Google Scholar
  895. 29.
    Theeuwes F (1975) J Pharm Sei 64:1987–1991Google Scholar
  896. 30.
    Heilmann K (1982) Therapeutische Systeme, Enke, Stutt-gartGoogle Scholar
  897. 31.
    Günther J (1988) Entwicklung und vergleichende In-vivo- Prüfung einer multipartikulären Retardschwimmarznei-form, Dissertation, DüsseldorfGoogle Scholar
  898. 32.
    Verhoeven J, de Boer AG, Junginger HE (1987) The use of Microporous Polymerie Powders for Controlled Re-lease Drug Delivery. In: Müller W(Ed.) Controlled Drug Delivery, Wissenschaftliche Verlagsgesellschaft, Stutt-gart, pp 226 fGoogle Scholar
  899. 33.
    Wirley L, Karim A, Pagone F, Streicher J, Wickman A (1988) Drug Develop Ind Pharm 14:13–28Google Scholar
  900. 34.
    Blume H, Siewert M, Steinijans V, Stricker H (1989) Pharm Ind 51:1025–33Google Scholar
  901. 1.
    Bauer KH, Frömming KH, Führer C (1989) Pharmazeuti-sche Technologie, 2. Aufl., Thieme, Stuttgart New YorkGoogle Scholar
  902. 2.
    Nürnberg E (1987) Wirkstofffreisetzung aus festen oralen Arzneiformen. In: Hartke K, Mutschier E (Hrsg.). DAB 9 Kommentar, Wissenschaftliche Verlagsgesellschaft Stutt-gart, Govi, Frankfurt, S. 202Google Scholar
  903. 3.
    Fürst DE (1988) Bailliere’s Clin Rheumatol 2:395–424Google Scholar
  904. 4.
    List PH (1985) Arzneiformenlehre, 4. Aufl. Wissenschaft-liche Verlagsgesellschaft, Stuttgart, S. 529Google Scholar
  905. 5.
    Shaw TRD, Carless JE (1974) Eur J Clin Pharmacol 7:269PubMedGoogle Scholar
  906. 6.
    Derendorf H, Garrett ER (1987) Pharmakokinetik Einfüh-rung in die Theorie und Relevanz der Arzneimittelthera-pie, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 81Google Scholar
  907. 7.
    Nürnberg E (1980) Acta Pharm Technol 26:39–67Google Scholar
  908. 8.
    Leonards JR (1962) Clin Pharmacol Ther 4:476–479Google Scholar
  909. 9.
    Dotevall G, Ekenved G (1976) Scand J Gastroenterol 801–805Google Scholar
  910. 10.
    Amson WD, Winer N (1981) J Pharm Sei 70:626–265Google Scholar
  911. 11.
    Gatti G, Barzaghi N, Attardo Parrinello G, Vitiello B, Perrucca E (1989) Int J Clin Pharm Res 385–389Google Scholar
  912. 12.
    Geisslinger G, Dietzel K, Bezler H, Nürnberg B, Brune K (1989) Int J Clin Pharmacol Ther Tox 27:324–328Google Scholar
  913. 13.
    Sevelius H, Runkel R, Segre E, Bloomfield SS (1980) Br J Clin Pharmac 10:259–263Google Scholar
  914. 14.
    Nürnberg E, Oechslein W (1990) Acta Pharm Technol 36:161–165Google Scholar
  915. 15.
    Nürnberg B, Peris-Antoli B, Brune K (1990) Acta Pharm Technol 36:166–170Google Scholar
  916. 16.
    European Patent Application AGIC, Application number 87305528.9, vom 22.06.87. Anmelder Merck & Co. IneGoogle Scholar
  917. 17.
    Jallad NS, Casg DC, Mastinez JJ, Mroszczak J, Weidler DJ (1990) J Clin Pharmacol 30:76–81PubMedGoogle Scholar
  918. 18.
    Graf E, Beyer C, Abdallah O (1982) Acta Pharm Technol 28:131–1335Google Scholar
  919. 19.
    Ramadan EM, el-Gawad H, Nonh AT (1987) Pharm Ind 49:508–513Google Scholar
  920. 20.
    Mortada LM, Mortada SAM (1982) Acta Pharm Technol 28:297–301Google Scholar
  921. 21.
    Nürnberg E, Fritsch C (1987) Dtsch Apoth Ztg 127:843–849Google Scholar
  922. 22.
    Kutz G (1988) Dissertation, Universität Erlangen-Nürn-bergGoogle Scholar
  923. 23.
    Bloch DW, El Egakey MA, Speiser PP (1982) Acta Pharm Technol 28:177–183Google Scholar
  924. 24.
    Mohamed MS, Ghazy FS, Mahdy MA (1985) Pharm Ind 47:1293–1295Google Scholar
  925. 25.
    Heyer K (1980) Dissertation, Freie Universität BerlinGoogle Scholar
  926. 26.
    Brauns U (1986) Dissertation, Universität KielGoogle Scholar
  927. 27.
    Kata M, Kedvessy G (1987) Pharm Ind 49:98–100Google Scholar
  928. 28.
    Lippold BC, Ohm AM (1986) Acta Pharm Technol 32:20–25Google Scholar
  929. 29.
    Deurloo MJM, Hermens AJJ, Romeyn SG, Verhoef JC, Merkus FWHM (1989) Pharm Res 6:853–856PubMedGoogle Scholar
  930. 30.
    O’Hagan DT, Critchley H, Farraj NF, Fisher AN, Johansen BR, Davis SS, Ilium L (1990) Pharm Res 7:772–776PubMedGoogle Scholar
  931. 31.
    Mentrup E, Wowra B, Zeller WJ, Sturm V, Stricker H (1989) Arzneim Forsch Drug Res 39:421–423Google Scholar
  932. 32.
    Siest G, Young D (1980) Drug Masurement and Drug Effects in Laboratory Health Science, Karger, BaselGoogle Scholar
  933. 33.
    Soehngen EC, Godin-Ostro E, Fielder FG, Ginsberg RS, Slusher MA, Weiner AL (1988) Arthritis Rheum 31:414–422PubMedGoogle Scholar
  934. 34.
    Schmitt M, Guentet TW (1990) J Pharm Sei 79:614–616Google Scholar
  935. 35.
    Ishizaki T, Sasaki T, Suganuma T, Horai Y, Chiba K, Watanabe M, Asuke W, Hoshi H (1980) Eur J Clin Phar-macol 18:407–414Google Scholar
  936. 36.
    Channer KS, Virjee JP (1986) J Clin Pharmacol 26:141–146PubMedGoogle Scholar
  937. 37.
    Davis SS, Norring-Christensen F, Krosla R, Feely LC (1988) J Pharm Pharmacol 40:205–207PubMedGoogle Scholar
  938. 38.
    Nürnberg E (1989) Schriftenreihe der Bayerischen Lan-desärztekammer 77:40Google Scholar
  939. 39.
    Donovan MD, Flynn GL, Amidon GL (1990) Pharm Res 7:808–815PubMedGoogle Scholar
  940. 40.
    Ziegler A (1986), Enterale Absorption In: Müller BW (Hrsg.) Suppositorien, Pharmakologie, Biopharmazie und Galenik rektal und vaginal anzuwendender Arznei-formen. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 54Google Scholar
  941. 41.
    Spahn H, Altmayer P, Cattarius-Korb S, Krüger B, Lang E, Mutschier E, Sörgel F (1985) Arzneim Forsch Drug Res 35:973–976Google Scholar
  942. 42.
    Nürnberg B, Schneider HT, Brune K Eur J Clin Pharma-col, eingereichtGoogle Scholar
  943. 43.
    Nürnberg B, Koehler G, Brune K (1991) Clin Pharmaco-kinet 20:81–89Google Scholar
  944. 44.
    Nürnberg B, Szeleny I, Schneider HT, Brune K (1990) Drug Metab Dispos 18:937–942Google Scholar
  945. 45.
    Nürnberg B, Brune K (1989) Biopharm Drug Disp 10:377–387Google Scholar
  946. 46.
    Verbeeck RK (1990) Clin Pharmacokinet 19:44–66PubMedGoogle Scholar
  947. 47.
    Geisslinger G, Schuster O, Stock KP, Loew D, Bach GL, Brune K (1990) Eur JClin Pharmacol 38:493–497Google Scholar
  948. 48.
    Nimmo J, Heading RC, Thothill P, Prescott LF (1973) Br Med J 587–589Google Scholar
  949. 49.
    Minami H, McCallum RW (1984) Gastroenterology 86:1592–1610PubMedGoogle Scholar
  950. 50.
    Jonderko G, Golab T, Jonderko K (1987) Br J Clin Phar-mac 24:103–105Google Scholar
  951. 51.
    Renondin JC, Sutton JA, Fräser M (1988) Br J Clin Phar-mac 25:702P–703PGoogle Scholar
  952. 52.
    Day RO, Williams KM, Graham GG, Lee E, Knihinicki RD, Champion GD (1988) Clin Pharmacol Ther 43:480–487PubMedGoogle Scholar
  953. 53.
    Milligan PA, Kelman AW, Whiting B (1990) Eur J Drug Metab Pharmacokinet 15 (Suppl):16Google Scholar
  954. 54.
    Winstanley PA, Orme MLE (1989) Br J Clin Pharmac 28:621–628Google Scholar
  955. 55.
    Mclean A, McNamara PJ, duSouich P, Gibaldi M, Lalka D (1978) Clin Pharmacol Ther 24:5–10PubMedGoogle Scholar
  956. 56.
    Walson PD, Mortensen ME (1989) Clin Pharmacokinet 17:116–137PubMedGoogle Scholar
  957. 57.
    Montamat SC, Cusack BJ, Vestal RE (1989) N Engl J Med 321:303–309PubMedGoogle Scholar
  958. 58.
    Daneshmend TK (1990) Brit J Clin Pharmac 29:783Google Scholar
  959. 59.
    Boyle R, Behan PO, Sutton JA (1990) Br J Clin Pharmac 30:405–409Google Scholar
  960. 60.
    van Baak MA (1990) Clin Pharmacokinet 19:23–43Google Scholar
  961. 61.
    Somani SU, Gupta SK, Frank S, Corder CN (1990) Drug Develop Res 20:251–275Google Scholar
  962. 62.
    Ho PC, Triggs EJ, Bourne DWA, Heazlewood VJ (1985) Br J Clin Pharmac 19:6775–684Google Scholar
  963. 63.
    Montgomery PR, Berger LG, Mitenko PA, Sitar DS (1986) Clin Pharmacol Ther 39:571–576PubMedGoogle Scholar
  964. 64.
    Macdonald JI, Herman RJ, Verbeeck RK (1990) Eur J Clin Pharmacol 38:175–179PubMedGoogle Scholar
  965. 65.
    Notarianni LJ (1990) Clin Pharmacokinet 18:20–36PubMedGoogle Scholar
  966. 66.
    Gilman JT (1990) Clin Pharmacokinet 19:1–10PubMedGoogle Scholar
  967. 1.
    Neumann BS (1967) The Flow Properties of Powders. In: Bean HS, Becket AH, Carless JE (Hrsg.) Advances in Phar-maceutical Sciences. Vol. 2, Academic Press, London New York, S. 181Google Scholar
  968. 2.
    Voigt R (1987) Lehrbuch der Pharmazeutischen Technolo-gie, 6. Auflage, Verlag Chemie, Weinheim, S. 145Google Scholar
  969. 1.
    Andrews J, Kniseley RM, Wagner HN (1966) Radioactive Pharmaceuticals, Oak-Ridge, US Atomic Energy Com-missionGoogle Scholar
  970. 2.
    Benes IF (1985) Radiopharmazie. In: Dolder R (Hrsg.) Praxis der Krankenhauspharmazie, Thieme, Stuttgart New York, S. 128–212Google Scholar
  971. 3.
    Conti L, Hegesippe M, De Saint Sauveur S, Tempe J (1972): Biosynthèase de sélénométhionine- Se pour usage scintigraphique, Int J Appl Radiat Isot 23:415–421Google Scholar
  972. 4.
    McAfee J (1975) Radioactive diagnostic agents. In: Subramanian C et al. (Eds.) Radiopharmaceuticals. The So-ciety of Nuclear Medicine, New YorkGoogle Scholar
  973. 5.
    Lamprecht RM, Wolf A (1975) Cyclotron Production of Radiohalogens and Their Use in Excitation Labeling. In: Subramanian et al. (Eds.) Radiopharmaceuticals. The So-ciety of Nuclear Medicine, New YorkGoogle Scholar
  974. 6.
    Ell PJ et al. (1985) Lancet 6:50–51Google Scholar
  975. 7.
    Sharpp F et al. (1986) J Nucl Med 27:171–177Google Scholar
  976. 8.
    Freeman LM et al. (1984, 1986). In: Freeman LM (Ed.) Freeman and Johnson’s Clinical Radionuclide Imaging, 3rd ed., Grune and Stratton, Orlando, FLGoogle Scholar
  977. 9.
    Tubis M. Wolf W et al. (Eds.) (1976) Radiopharmacy, „A Wiley-Interscience Publication“, New York London Syd-ney TorontoGoogle Scholar
  978. 10.
    Bernhard H, Lieser KH (1974) Euro Spectra 9:20–24Google Scholar
  979. 11.
    Cohen Y, Besnard M (1980) A. Radionuklides. Pharma-cokinetics. In: Hundeshagen H (Red.) Nuklearmedizin, Teil 1A, Bd. 15, Springer, Berlin Heidelberg New YorkGoogle Scholar
  980. 1.
    Provost C (1986) Int J Cosmet Sei 8:233–247Google Scholar
  981. 2.
    Münzel K (1953) Pharm Acta Helv 28:320–336PubMedGoogle Scholar
  982. 3.
    Münzel K (1968) J Soc Cosmet Chem 19:289–347Google Scholar
  983. 4.
    Bauer KH, Frömming KH, Führer C (1986) Pharmazeuti-sche Technologie, 1. Aufl., Thieme, Stuttgart New York, S. 314Google Scholar
  984. 5.
    Häusler FX (1989) Dissertation, Technische Universität, BraunschweigGoogle Scholar
  985. 6.
    Kung HC, Goddard ED (1964) J Phys Chem 68:3465–3469Google Scholar
  986. 7.
    Führer C (1969) APV-Informationsdienst 2/3:87–97Google Scholar
  987. 8.
    Führer C (1971) Pharmazie 26:43–45PubMedGoogle Scholar
  988. 9.
    Führer C, Friberg S, Fischer G (1976) Röntgenstrukturun-tersuchungen der Hydrophilen Salbe, 22. Jahreskongreß der APV, BerlinGoogle Scholar
  989. 10.
    Junginger H, Führer C, Beer A, Ziegenmeyer J (1979) Pharm Ind 41:380–385Google Scholar
  990. 11.
    Führer C, Junginger H, Friberg S (1978) J Soc Cosmet Chem 29:703–716Google Scholar
  991. 12.
    Junginger H, Führer C, Ziegenmeyer J, Friberg S (1979) J Soc Cosmet Chem 30:9–23Google Scholar
  992. 13.
    Junginger HE, Heering W (1990) Dtsch Apoth Ztg 130:684–685Google Scholar
  993. 14.
    Junginger H, Heering W (1983) Acta Pharm Technol 29:85–96Google Scholar
  994. 15.
    Müller-Goymann CC (1981) Dissertation, Technische Universität, BraunschweigGoogle Scholar
  995. 16.
    Müller-Goymann C, Schütze W (1990) Dtsch Apoth Ztg 130:561–562Google Scholar
  996. 17.
    Müller-Goymann C (1984) Seifen, Öle, Fette, Wachse 110:395–400Google Scholar
  997. 18.
    Nürnberg E (1969) Fette, Seifen, Anstrichm 71:386–394Google Scholar
  998. 19.
    Nürnberg E (1971) Pharmaz Ztg 116:1466–1472Google Scholar
  999. 20.
    Nürnberg E (1975) Pharmaz Ztg 120:1509–1519Google Scholar
  1000. 21.
    Nürnberg E, Kohl P (1980) Dtsch Apoth Ztg 120:1649–1657Google Scholar
  1001. 22.
    Nürnberg E, Muckenschnabel R (1982) Dtsch Apoth Ztg 122:2093–2106Google Scholar
  1002. 23.
    Kohl P (1979) Dissertation, Universität, ErlangenGoogle Scholar
  1003. 24.
    Muckenschnabel R (1983) Dissertation, Universität, Er-langenGoogle Scholar
  1004. 25.
    De Vringer T, Joosten JGH, Junginger HE (1986) Coli Polym Sei 264:691–700Google Scholar
  1005. 26.
    De Vringer T, Joosten JGH, Junginger HE (1987) Coli Polym Sei 265:167–179Google Scholar
  1006. 27.
    De Vringer T, Joosten JGH, Junginger HE (1987) Coli Polym Sei 265:448–457Google Scholar
  1007. 28.
    De Vringer T (1987) Dissertation, Universität, LeidenGoogle Scholar
  1008. 29.
    Lutton ES (1965) J Am Oil Chem Soc 42:1068–1070PubMedGoogle Scholar
  1009. 30.
    Klokkers K (1985) Dissertation, Technische Universität, BraunschweigGoogle Scholar
  1010. 31.
    Klokkers K, Führer C (1985) Acta Pharm Technol 31:151–159Google Scholar
  1011. 32.
    Barry BW, Saunders GM (1970) J Coli Int Sei 34:300–315Google Scholar
  1012. 33.
    Barry BW, Eccleston GM (1973) J Texture Stud 4:53–81Google Scholar
  1013. 34.
    Eccleston GM (1976) J Coli Int Sei 57:66–74Google Scholar
  1014. 35.
    Rowe RC, Patel HK (1985) J Pharm Pharmacol 37:222–225PubMedGoogle Scholar
  1015. 36.
    Rowe RC, Patel HK (1985) J Pharm Pharmacol 37:564–567PubMedGoogle Scholar
  1016. 37.
    Louden JD, Patel HK, Rowe RC (1985) Int J Pharm 25:179–190Google Scholar
  1017. 38.
    Patel HK, Rowe RC, Mc Mahon J, Stewart RF (1985) Int J Pharm 25:13–25Google Scholar
  1018. 39.
    Patel HK, Rowe RC, Mc Mahon J, Stewart RF (1985) Int J Pharm 25:237–242Google Scholar
  1019. 40.
    Patel HK, Rowe RC, Mc Mahon J, Stewart RF (1985), J Pharm Pharmacol 37:899–902PubMedGoogle Scholar
  1020. 41.
    Eccleston GM (1986) Pharm Int 7:63–70Google Scholar
  1021. 42.
    Junginger H (1984) Pharmazie 39:610–614PubMedGoogle Scholar
  1022. 43.
    Fischer G (1977) Dissertation, Technische Universität, BraunschweigGoogle Scholar
  1023. 44.
    Goede J (1983) Dissertation, Technische Universität, BraunschweigGoogle Scholar
  1024. 45.
    Orecchioni AM (1983) Dissertation, Université Paris-Sud, Chatenay-MalabryGoogle Scholar
  1025. 46.
    Hoffmann HN, Paulus EF (1969) Fette, Seifen, Anstrichm 71:399–403Google Scholar
  1026. 47.
    Provost C (1985) Dissertation, Katholieke Universiteit, LeuvenGoogle Scholar
  1027. 48.
    Nürnberg E, Pohler W (1983) Dtsch Apoth Ztg 123:1993–1998Google Scholar
  1028. 49.
    Nürnberg E, Pohler W (1986) Pharm Ind 48:1191–1196Google Scholar
  1029. 50.
    Pohler W (1983) Dissertation, Universität, ErlangenGoogle Scholar
  1030. 51.
    Nürnberg E, Pöllinger N (1986) Tenside Deterg 23:25–32Google Scholar
  1031. 52.
    Pöllinger N (1986) Dissertation, Universität, ErlangenGoogle Scholar
  1032. 53.
    Feger M (1978) Dissertation, Technische Universität, BraunschweigGoogle Scholar
  1033. 54.
    Müller-Goymann C (1984) Pharm Res 1:154–158Google Scholar
  1034. 55.
    Usselmann B, Müller-Goymann C (1984) Progr Coli Po-lym Sei 69:56–63Google Scholar
  1035. 56.
    Mueller T, Hakert H, Eckert T (1989) Coli Polym Sei 267:230–236Google Scholar
  1036. 57.
    Müller-Goymann C, Schütze W (1990) Dtsch Apoth Ztg 130:561–562Google Scholar
  1037. 58.
    Luszcak E (1990) Österr Apoth Ztg 44:741–742Google Scholar
  1038. 59.
    Fiedler HP (1989) Lexikon der Hilfsstoffe für Pharmazie, Kosmetik und angrenzende Gebiete, 3. Aufl., Band I und II, Editio Cantor, AulendorfGoogle Scholar
  1039. 60.
    Gebler H (1982) Tabellen für die Pharmazeutische Praxis, 2. Aufl., 1. Erg. 1987, Govi, FrankfurtGoogle Scholar
  1040. 61.
    Koglin B (1984) Kontinuierliche Herstellung von Salben, Cremes und Emulsionen. In: Asche H, Essig D, Schmidt PC (Hrsg.) Technologie von Salben, Suspensionen und Emulsionen, Wissenschaftliche Verlagsgesellschaft, Stutt-gart, S. 139Google Scholar
  1041. 62.
    Rogasch R, List PH, Bremecker KD (1990) Acta Pharm Technol 36:17SGoogle Scholar
  1042. 63.
    List PH (1985) Arzneiformenlehre: Ein Lehrbuch für Pharmazeuten, 4. Aufl., Wissenschaftliche Verlagsgesell-schaft StuttgartGoogle Scholar
  1043. 64.
    Lippold BC (1981) Acta Pharm Technol 27:1–9Google Scholar
  1044. 65.
    Feldmann RJ, Maibach HI (1967) J Invest Dermatol 48:181–183PubMedGoogle Scholar
  1045. 66.
    Dolder R (1980) Pharm Verfahrenstechnik heute 1:9–14, als Beilage der Dtsch Apoth Ztg 120Google Scholar
  1046. 67.
    Guttmann D, Higuchi T (1955) J Am Pharm Assoc, Sei Edit 44:668–678Google Scholar
  1047. 68.
    Török J, Mayer A (1976) Pharmazie 31:121–124PubMedGoogle Scholar
  1048. 69.
    Török J, Sallay J, Mayer A (1976) Pharmazie 31:174–175PubMedGoogle Scholar
  1049. 70.
    Mayer A, Török J, Stajer G (1977) Pharmazie 32:507–508PubMedGoogle Scholar
  1050. 71.
    El-Nimr AEM (1977) Pharmazie 32:509–510PubMedGoogle Scholar
  1051. 72.
    Di Colo G, Carelli V, Lofiego G, Nannipieri E (1983) II Farmaco, Ed Pr 38:323–333Google Scholar
  1052. 73.
    Benninger A (1977) Dissertation Universität, SaarbrückenGoogle Scholar
  1053. 74.
    Loth H, Holla-Benninger A, Hailer M (1979) Pharm Ind 41:789–796Google Scholar
  1054. 75.
    Lippold BC, Kurka P (1983) Pharmazie 38:347–348PubMedGoogle Scholar
  1055. 76.
    Hüttenrauch R, Süss W, Schmeiss U (1972) Pharmazie 27:169–175PubMedGoogle Scholar
  1056. 77.
    Hüttenrauch R, Fricke S (1979) Pharmazie 34:437–438Google Scholar
  1057. 78.
    Hüttenrauch R, Fricke S (1976) Pharmazie 31:408–409PubMedGoogle Scholar
  1058. 79.
    Hüttenrauch R, Fricke S, Baumann U (1982) Pharmazie 37:25–28PubMedGoogle Scholar
  1059. 80.
    Kneczke M, Landersjo L, Lundgren P, Führer C (1986) Acta Pharm Suec 8:105–113Google Scholar
  1060. 81.
    Nannipieri E, Di Colo G, Saettone MF, Serafini MF, Vitale D (1981) II Farmaco, Ed Pr 36:235–248Google Scholar
  1061. 82.
    Bodde HE, Junginger HE, De Vringer T (1986) ProgrColl Polym Sei 72:37–42Google Scholar
  1062. 83.
    Wahlgren S, Lindstrom AL, Friberg SE (1984) J Pharm Sei 73:1484–1486Google Scholar
  1063. 84.
    Müller-Goymann CC, Frank SG (1986) Int J Pharm 29:147–159Google Scholar
  1064. 85.
    Müller-Goymann CC (1987) Acta Pharm Technol 33:126–130Google Scholar
  1065. 86.
    Engström S, Landh T, Ljunger G (1989) Proc 5th Int Conf Pharm Technol 3:432–438Google Scholar
  1066. 87.
    Kindl G (1987) Pharm Ztg 132:1263–1268Google Scholar
  1067. 88.
    Kindl G (1987) Pharm Ztg 132:1385–1389Google Scholar
  1068. 89.
    Gurny R, Junginger HE (Hrsg.) (1990) Bioadhesion-Pos-sibilities and Future Trends, Wissenschaftliche Verlagsge-sellschaft, StuttgartGoogle Scholar
  1069. 1.
    Bundesgesetzblatt (1972) 1:1163–1166Google Scholar
  1070. 2.
    Bundesgesetzblatt für die Republik Österreich (1983) 77:927–949Google Scholar
  1071. 3.
    Der Schweizerische Bundesrat: AS 1989, 3405Google Scholar
  1072. 4.
    WHO (1983) Technical Report Series 687Google Scholar
  1073. 5.
    Behringwerke AG, Marburg, Herstellungs-und Prüfungs-vorschriftenGoogle Scholar
  1074. 6.
    Mayr A, Münz E (1965) Das Vaccinevirus. In: Herrlich A (Hrsg.) Handbuch der Schutzimpfungen, Springer, Berlin Heidelberg New York, S. 66Google Scholar
  1075. 7.
    Regamey RH (1965) Die Tetanusschutzimpfung. In: Herrlich A (Hrsg.) Handbuch der Schutzimpfungen, Springer, Berlin Heidelberg New York, S. 425Google Scholar
  1076. 8.
    Weber G (1965) Die Poliomyelitis-Schutzimpfung. In: Herrlich A (Hrsg.) Handbuch der Schutzimpfungen, Springer, Berlin Heidelberg New York, S. 482Google Scholar
  1077. 9.
    Guerin C (1980) The History of BCG. In: Sol Roy Rosenthal (Ed.) BCG-Vaccine: Tuberculosis-Cancer, PSG Publishing Company, Inc., Littleton, MA, p 35Google Scholar
  1078. 10.
    Germanier R (1982) Die Gelben Hefte XXII.69–74Google Scholar
  1079. 11.
    Reber G, Ungeheuer H (1982) Heterologe Sera ad us. hum. In: Ullmanns Encyklopädie der technischen Chemie 4., neuüberarbeitete und erweiterte Auflage, Bd. 21, Verlag Chemie, Weinheim, S. 285Google Scholar
  1080. 12.
    International Symposium on Adjuvants of Immunity Symposia Series in Immunobiological Standardization, Vol. 6,1967, Karger, Basel New YorkGoogle Scholar
  1081. 13.
    Mitchell GF (1988) The way ahead for vaccines and vac-cination: Symposium Summary, Vaccine, Vol. 6: pp 200–205PubMedGoogle Scholar
  1082. 14.
    International Symposium on Preservatives in Biological Products, Developments in Biological Standardization, Vol. 24,1974, Karger, Basel München Paris London New York SydneyGoogle Scholar
  1083. 15.
    Sokhey J (1988) Stability of oral polio vaccine at different temperatures, Vaccine, Vol. 6, pp 12–19PubMedGoogle Scholar
  1084. 1.
    Neumüller OA (1983) Römpps Chemie Lexikon, 8. Aufl., Franckh’sche Verlagsbuchhandlung, StuttgartGoogle Scholar
  1085. 2.
    Ostwald W (1926) Kleines Praktikum der Kolloidchemie, 6. Aufl., Steinkopff, Dresden LeipzigGoogle Scholar
  1086. 3.
    Ostwald W (1922) Die Welt der vernachlässigten Dimen-sionen, 8. Aufl., Steinkopff, Dresden LeipzigGoogle Scholar
  1087. 4.
    Manegold E (1959) Grundriß der Kolloidkunde, 2. erw. Aufl., Steinkopff, Dresden LeipzigGoogle Scholar
  1088. 5.
    Alexander KS, Azizi J, Dollimore D, Uppala V (1990) J Pharm Sei 79(5):401–406Google Scholar
  1089. 6.
    Schneider W, Starchansky S, Martin AN (1978) Am J Pharm Ed 42:280–289Google Scholar
  1090. 7.
    Carpenter CR (1983) Chem Eng 11:14Google Scholar
  1091. 8.
    Steiger-Trippi K (1961) Pharm Acta Helv 36:549Google Scholar
  1092. 9.
    Hiestand EN (1972) J Pharm Sei 61:268–272Google Scholar
  1093. 10.
    Ecanow B, Grundman R, Wilson R. G (1963) J Pharm Sei 52:757–762,1031–1038Google Scholar
  1094. 11.
    Ecanow B, Takruri H (1970) J Pharm Sei 59:1848–1849Google Scholar
  1095. 12.
    Ecanow B, Webster J, Blake MI (1982) J Pharm Sei 71:456–457Google Scholar
  1096. 13.
    Su KS, Quay JF, Campanale KM, Stucky JF (1984) J Pharm Sei 73(11):1602–1606Google Scholar
  1097. 13a.
    Zatz JL, Lue RY (1987) J Pharm Sei 76 (2):157–160Google Scholar
  1098. 14.
    Rambhau D, Gudsoorkar VR, Rao YM (1983) Indian J Physiol Pharmacol 27(3):217–220PubMedGoogle Scholar
  1099. 15.
    Hamaker HC (1937) Physica 4:1058Google Scholar
  1100. 16.
    Kayes JB (1977) J Pharm Pharmacol 29:163–168PubMedGoogle Scholar
  1101. 17.
    Schott H, Young CY (1973) J Pharm Sei 62:1797Google Scholar
  1102. 18.
    Whately TL, Steele G, Urwin I, Smail GA (1984) J Clin Hosp Pharm 9:113Google Scholar
  1103. 19.
    Gallardo V, Delgado A, Parera A, Salcado J (1990) J Pharm Pharmacol 42(4):225–229PubMedGoogle Scholar
  1104. 20.
    Fricke S, Hüttenrauch R (1991) Acta Pharm Technol 37(l):55–59Google Scholar
  1105. 21.
    Falkiewicz MJ (1988) Theory of Suspensions. In: Lieberman HA, Rieger MM, Banker GS (eds.) Pharmaceutical Dosage Forms: Disperse Systems Vol. 1, Dekker, New York Basel, p. 36Google Scholar
  1106. 22.
    Mathai KG, Ottewill RH (1970) Kolloid Z Z Polym 236:147–151Google Scholar
  1107. 23.
    Sato T, Ruch R (1980) Stabilization of colloidal disper-sions by polymer adsorption. In: Schick M, Fowkes F, Surfactant Science Series Vol. 9, Dekker, New YorkGoogle Scholar
  1108. 24.
    Fritz A, Riehl J (1989) J Pharm Ind 51:1150–1156Google Scholar
  1109. 25.
    Rawlings DA, Keyes JB (1980) Drug Dev Ind Pharm 6:427–440Google Scholar
  1110. 26.
    Carstensen JT, Su K (1984) Physikalische und chemische Faktoren bei der Entwicklung von dispersen Systemen. In: Asche H, Essig D, Schmidt PC (Hrsg.) Technologie von Salben, Suspensionen und Emulsionen, Paperback APV Band 10, Wissenschaftliche Verlagsbuchhandlung, Stuttgart, S. 15–25Google Scholar
  1111. 27.
    Leschonsky K (1984) Partikelgrößenbestimmungen in Su-spensionen. In: Asche H, Essig D, Schmidt PC (Hrsg.) Technologie von Salben, Suspensionen und Emulsionen, Paperback APV Band 10, Wissenschaftliche Verlags-gesellschaft, Stuttgart, S. 176–187Google Scholar
  1112. 28.
    Carless JE (1968) J Pharm Pharmacol 10:630–639Google Scholar
  1113. 29.
    Buckwalter FH, Dickison HL (1958) J Am Pharm Assoc Sei Ed 47:661–665Google Scholar
  1114. 30.
    Atkinson RM (1962) Nature 193:588–589PubMedGoogle Scholar
  1115. 31.
    Lees KA (1963) J Pharm Pharmacol 15:43t-55tGoogle Scholar
  1116. 32.
    Ziller KH, Rupprecht H (1988) Drug Dev Ind Pharm 14:2341–2370Google Scholar
  1117. 33.
    Haleblian JK (1975) J Pharm Sei 64:1269–1288Google Scholar
  1118. 34.
    Fox HW, Zisman WA (1952) J Colloid Sei 7:428Google Scholar
  1119. 35.
    Whorlow RW (1980) Rheological Techniques, Halsted Press, New YorkGoogle Scholar
  1120. 36.
    Schmidt PC, Benke K (1988) Pharm Acta Helv 63(4–5):117–127PubMedGoogle Scholar
  1121. 37.
    Schmidt PC, Benke K (1988) Pharm Acta Helv 63(7):188–196PubMedGoogle Scholar
  1122. 38.
    Rumpf H (1965) Chem Ing Tech 37:187Google Scholar
  1123. 39.
    Krapf AJ (1976) Pigment Resin Technol 5:7Google Scholar
  1124. 40.
    John W (1973) Farbe Lacke 79:537Google Scholar
  1125. 41.
    Bühler G (1982) Chem Ing Tech 54:371Google Scholar
  1126. 42.
    Pressemitteilung PM-270 A, Fryma Maschinen AG, CH- RheinfeldenGoogle Scholar
  1127. 43.
    Kuchta K (1978) Maschinenmarkt 84:310Google Scholar
  1128. 44.
    Pawlowski J (1971) Die Ähnlichkeitstheorie in der physi-kalisch-technischen Forschung, Springer, Berlin Heidel-berg New YorkGoogle Scholar
  1129. 45.
    Scheer AJ (1981) Drug Cosmet Ind 129: April-JuneGoogle Scholar
  1130. 46.
    Schumacher EM (1972) Perspect Clin Pharm 368–389Google Scholar
  1131. 47.
    Morefield EM, Feldkamp JR, Peck GE, White JL, Hem SL (1987) Int J Pharm 34:263–265Google Scholar
  1132. 48.
    Abshire R, Cash P (1986) J Parenter Sei Technol 40 (3):97–99Google Scholar
  1133. 49.
    Akers MJ, Fitesa AL, Robison RL (1987) J Parenter Sei Technol 41(3):88–96Google Scholar
  1134. 50.
    Witte C (1977) Pharm Ztg 122:1227–1232Google Scholar
  1135. 51.
    Waltersson JO (1986) Acta Pharm Suec 23 (3):129–138PubMedGoogle Scholar
  1136. 52.
    Evans DF, Pye G, Bramley R, Clark AG, Tyson TJ, Hardcastle JD (1988) Gut 29:1035–1041PubMedGoogle Scholar
  1137. 53.
    Rettig H (1978) Acta Pharm Technol 24:143–155Google Scholar
  1138. 54.
    Mauger JW, Howard SA, Amin K (1983) J Pharm Sei 72:190–193Google Scholar
  1139. 55.
    List PH (1985) Arzneiformenlehre, Wissenschaftliche Ver-lagsgesellschaft, StuttgartGoogle Scholar
  1140. 56.
    Ottewill RH, Walker T (1968) Kolloid Z Z Polym 227:108–116Google Scholar
  1141. 57.
    Lagaly G (1984) Energetische Wechselwirkungen in Dis-persionen und Emulsionen. In: Asche H, Essig D, Schmidt PC (Hrsg.) Technologie von Salben, Suspensio-nen und Emulsionen, Paperback APV Band 10, Wissen-schaftliche Verlagsbuchhandlung, StuttgartGoogle Scholar
  1142. 58.
    Lieberman HA, Rieger MM, Banker GS (eds.) (1988) Pharmaceutical Dosage Forms: Disperse Systems, Vol. 2, Dekker, New York BaselGoogle Scholar
  1143. 59.
    Koglin B (1984) Kontinuierliche Herstellung von Salben, Cremes und Emulsionen. In: Asche H, Essig D, Schmidt PC (Hrsg.) Technologie von Salben, Suspensionen und Emulsionen, Paperback APV Band 10, Wissenschaftliche Verlagsbuchhandlung, StuttgartGoogle Scholar
  1144. 1.
    DAB 9, S. 1347Google Scholar
  1145. 2.
    DAB 9, S. 1349Google Scholar
  1146. 3.
    Catellani P, Vaona G, Plazzi P, Colombo P (1988) Acta Pharm Technol 34/1:38–41Google Scholar
  1147. 4.
    Lehmann K, Petereit HU (1988) Acta Pharm Technol 34/4:189–190Google Scholar
  1148. 5.
    DAB 9, S. 1348Google Scholar
  1149. 6.
    Schmidt PC, Christin I (1990) Pharmazie 45/2:89–101PubMedGoogle Scholar
  1150. 7.
    Lachman L, Lieberman HA, Kanig IL (1986) The Theory and Practice of Industrial Pharmacy, 3rd. ed., Lea & Fe-biger, Philadelphia, p. 328–329,333,343Google Scholar
  1151. 8.
    AB-DDR, Arzneizubereitungen 5.0.1./XIVGoogle Scholar
  1152. 9.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 367–417Google Scholar
  1153. 10.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 419–582Google Scholar
  1154. 11.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 354–359Google Scholar
  1155. 12.
    Jonsson UE (1987) Drugs Suppl. 4:26–31Google Scholar
  1156. 13.
    Parrot EL (1988) Drug Dev Ind Pharm 14/8:1013–1021Google Scholar
  1157. 14.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 359–360Google Scholar
  1158. 15.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 247–284Google Scholar
  1159. 16.
    Moldenhauer H, Kala H, Zessin G, Dittgen M (1980) Pharmazie 35/11:714–726PubMedGoogle Scholar
  1160. 17.
    Watt PR (1988) Tablet Machine Instrumentation in Phar-maceutics. Principle and Practice, Horwood, New York Chichester Brisbane TorontoGoogle Scholar
  1161. 18.
    Hoblitzell JR, Rhodes CT (1985) Pharm Int 2:45–50Google Scholar
  1162. 19.
    Parrot EL (1990) Compression. In .Lieberman HA, Lachman L, Schwartz JB (eds.) Pharmaceutical Dosage Forms: Tablets, Vol. 2, Dekker, New York Basel, p. 201–243Google Scholar
  1163. 20.
    Dürr M, Hanssen D, Harwalik H (1972) Pharm Ind 34/11 a:905Google Scholar
  1164. 21.
    Nelson E, Naqui SM, Busse LW, Higuchi T (1954) J Am Pharm Ass Sei Ed 43/10:596–602Google Scholar
  1165. 22.
    Müller BW, Steffens KJ, List PH (1981) Pharm Ind 43/7:665–671Google Scholar
  1166. 23.
    Steffens KJ (1978) Dissertation, Universität MarburgGoogle Scholar
  1167. 24.
    Walz M (1988) Dissertation, Universität HeidelbergGoogle Scholar
  1168. 25.
    Miller TA, York P(1988) Int J Pharm 41:1–19Google Scholar
  1169. 26.
    Mitrevej A, Augsburger LL (1980) Drug Dev Ind Pharm 6/4:331–377Google Scholar
  1170. 27.
    Fischer W (1989) Dissertation, Universität BonnGoogle Scholar
  1171. 28.
    Neuhaus J (1985) Dissertation, Universität BonnGoogle Scholar
  1172. 29.
    Caspar U (1983) Dissertation, Universität BonnGoogle Scholar
  1173. 30.
    Hiestand EN, Well JE, Plot CB, Ochs JF (1977) J Pharm Sei 66:510–519Google Scholar
  1174. 31.
    Caramella C, Colombo P, Conte U, La Manna A (1987) Drug Dev Ind Pharm 13/12:2111–2145Google Scholar
  1175. 32.
    Kanig JL, Rudnic EM (1984) Pharm Technol 4:52–63Google Scholar
  1176. 33.
    Hüttenrauch R (1983) Pharmazie 38:198–199PubMedGoogle Scholar
  1177. 34.
    Kala H, Moldenhauer H, Giese R, Kedvessy G, Selmeczi B, Pintye, HK (1981) Pharmazie 36/12:833–838Google Scholar
  1178. 35.
    Kopp S (1986) Dissertation, Universität TübingenGoogle Scholar
  1179. 36.
    Hanssen D, Führer C, Schäfer B (1970) Pharm Ind 32/2:97–101Google Scholar
  1180. 37.
    Müller BW (1965) Pharm Ind 34/12:972–976Google Scholar
  1181. 38.
    Junginger H (1976) Pharm Ind 38/8:724–728Google Scholar
  1182. 39.
    Armstrong NA, Cham TM (1987) Changes in the particle size and size distribution of two pharmaceutical powders with dissimilar compation mechanisms under compac-tion. In: Rubinstein MH (ed.) Pharmaceutical Technolo-gy, Tabletting Technology, Vol. 1, Horwood, Chichester, p. 145–156Google Scholar
  1183. 40.
    Hüttenrauch R (1978) Acta Pharm Technol Suppl 6: 55–127Google Scholar
  1184. 41.
    Hüttenrauch R (1988) Acta Pharm Technol 34/1:1–10Google Scholar
  1185. 42.
    Hüttenrauch R (1983) Pharm Ind 45/4:435–440Google Scholar
  1186. 43.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 195–246Google Scholar
  1187. 44.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol. 1, Dekker, New York Basel, p. 203–214Google Scholar
  1188. 45.
    Armstrong NA (1986) Manufact Chem 12:29–31Google Scholar
  1189. 46.
    Sheffield Products (1988) Manufact Chem 12:57Google Scholar
  1190. 47.
    Fiedler HP (1989) Lexikon der Hilfsstoffe für Pharmazie, Kosmetik und angrenzende Gebiete, Bd. 1 und 2, Editio Cantor, AulendorfGoogle Scholar
  1191. 48.
    The Pharmaceutical Society of Great Britain (1986) Handbook of Pharmaceutical Excipients, 1 Lambeth High Street, LondonGoogle Scholar
  1192. 49.
    Ciba-Geigy, Hoffmann-La Roche, Sandoz (1974) Kata-log pharmazeutischer Hilfsstoffe, Deutscher Apotheker- Verlag, StuttgartGoogle Scholar
  1193. 50.
    Vromans H, De Boer AH, Bolhuis GK, Lerk CF (1985) Acta Pharm Suec 22:163–172; (1986) 23:217–230,231–240Google Scholar
  1194. 51.
    Whiteman M, Yarwood RJ (1988) Drug Dev Ind Pharm 14/8:1023–1040Google Scholar
  1195. 52.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 205–207Google Scholar
  1196. 53.
    Alderborn G (1985) Acta Pharm Suec 22/4:177–184, I-XIVGoogle Scholar
  1197. 54.
    Schmidt PC, Vortisch W (1987) Pharm Ind 49/5:495–503Google Scholar
  1198. 55.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 208–209Google Scholar
  1199. 56.
    Debord B, Lefebre C, Guyot-Hermann AM, Hubert J, Bouché R, Guyot JC (1987) Drug Dev Ind Pharm 13/9–11:1533–1546Google Scholar
  1200. 57.
    Schepky G, DOS 16 67 921, Anmeldungstag 12.01.1968Google Scholar
  1201. 58.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol. 1, Dekker, New York Basel, p. 207–208Google Scholar
  1202. 59.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol. 1, Dekker, New York Basel, p. 208Google Scholar
  1203. 60.
    Parrot EL (1989) Drug Dev Ind Pharm 15/4:651–583Google Scholar
  1204. 61.
    Reier GE, Shangraw RF (1966) J Pharm Sei 55/5:510–514Google Scholar
  1205. 62.
    Doelker E, Mordier D, Iten H, Humbert-Droz P (1987) Drug Dev Ind Pharm 13/9–11:1847–1875Google Scholar
  1206. 63.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 210–213Google Scholar
  1207. 64.
    Pesonen T, Paronen P (1987) Evaluation of a new cellu-lose material as a binding agent for the direct compres-sion of tablets. In: Rubinstein MH (ed.) Pharmaceutical Technology, Tabletting Technology, Vol. 1, Horwood, Chichester, p. 99–112Google Scholar
  1208. 65.
    Doelker E, Gurny G, Mordier D, Hart JP, Rees JE, Aulton ME (1987) Acta Pharm Suec 24/2:68–69Google Scholar
  1209. 66.
    Rabach H (1980) Dissertation, Universität HamburgGoogle Scholar
  1210. 67.
    Paronen P (1987) Heckel plots as indicators of elastic pro-perties of pharmaceuticals. In: Rubinstein MH (ed.) Pharmaceutical Technology, Tabletting Technology, Vol. 1, Horwood, Chichester, p. 139–144Google Scholar
  1211. 68.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 243–246Google Scholar
  1212. 69.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol. 1, Dekker, New York Basel, p. 209–210Google Scholar
  1213. 70.
    Gordon MS, Chowhan ZT (1987) J Pharm Sci 76/12:907–909PubMedGoogle Scholar
  1214. 71.
    Sekulovic D, Zajic L, Nikitovic L, Radovanovic N, Vaskovic M (1988) Pharmazie 43/2:139PubMedGoogle Scholar
  1215. 72.
    Ponchel G, Duchene D (1990) Drug Dev Ind Pharm 16/4:613–628Google Scholar
  1216. 73.
    Chang Sheen P, II Kim S (1989) Drug Dev Ind Pharm 15/3:401–414Google Scholar
  1217. 74.
    Gould PL, Tan SB (1985) Drug Dev Ind Pharm 11/9,10:1819–1836; (1986) 12/11–13:1929–1945Google Scholar
  1218. 75.
    Gissinger D, Stamm A (1980) Pharm Ind 42/2:189–192Google Scholar
  1219. 76.
    Dawoodbhai SS, Chueh HR, Rodes CT (1987) Drug Dev Ind Pharm 13/13:2441–2467Google Scholar
  1220. 77.
    Williams RO, McGinity IW (1987) A study of the influ-ence of magnesium stearate or talc on the compaction properties of direct compression excipients using tablet-ing indices. In: Rubinstein MH (ed.) Pharmaceutical Technology, Tabletting Technology, Vol. 1, Horwood, Chichester, p. 157–165Google Scholar
  1221. 78.
    Reisen P (1987) Dissertation, Universität KielGoogle Scholar
  1222. 79.
    Bauer KH, Frömming KH, Führer C (1986) Pharmazeu-tische Technologie, Thieme, Stuttgart New York, S. 382Google Scholar
  1223. 80.
    List PH (1985) Arzneiformenlehre, 4. Aufl., Wissen-schaftliche Verlagsgesellschaft, Stuttgart, S. 75Google Scholar
  1224. 81.
    Gruber P, Gläsel VI, Klingelhöller W, Liske T (1988) Pharm Ind 50/7:839–845Google Scholar
  1225. 82.
    Staniforth IN, Cryer S. Ahmed HA, Davies SP (1989) Drug Dev Ind Pharm 15/14–16:2276–2294Google Scholar
  1226. 83.
    Drescher W (1988) Dissertation, Universität FreiburgGoogle Scholar
  1227. 84.
    Masilungan FC, Kraus KF (1989) Drug Dev Ind Pharm 15/11:1771–1778Google Scholar
  1228. 85.
    Bateman SD, Rubinstein MH, Thacker HS (1989) J Pharm Pharmacol Suppl 12:32 PGoogle Scholar
  1229. 86.
    Hinsch J, Mielck JB (1978) Pharm Ind 40:971–973Google Scholar
  1230. 87.
    Schmidt PC, Tenter U, Hocke J (1986) Pharm Ind 48/2:1552–1553Google Scholar
  1231. 88.
    Wiederkehr-von Vincenz C, Soliva M, Speiser P (1977) Pharm Ind 39/7:722–726Google Scholar
  1232. 89.
    Lachman L, Lieberman HA, Kanig IL (1986) The Theory and Practice of Industrial Pharmacy, 3rd. ed., Lea & Fe-biger, Philadelphia, p. 89–95Google Scholar
  1233. 90.
    Korsch W (1980) Swiss Pharma 24:28–33Google Scholar
  1234. 91.
    Hager M (1989) Pharmaceutical Manufacturing Interna-tional, Sterling, London, p. 165–166Google Scholar
  1235. 92.
    Poska RP, Glasscock JF, Badalamenti AI, Magerlein DB, Magerlein IM (1989) Pharm Technol Int 11/12:33–34,39–44Google Scholar
  1236. 93.
    Seibt Pharma Technik 90 (1989) Seibt, MünchenGoogle Scholar
  1237. 94.
    Lieberman HA, Lachman L, Schwartz JB (1990) Pharma-ceutical Dosage Forms: Tablets, Vol.2, Dekker, New York Basel, p. 571–608Google Scholar
  1238. 95.
    Lieberman HA, Lachman L, Schwartz JB (1990) Pharma-ceutical Dosage Forms: Tablets, Vol.2, Dekker, New York Basel, p. 317–348Google Scholar
  1239. 96.
    Feltkamp H, Fuchs P, Sucker H (1983) Pharmazeutische Qualitätskontrolle, Thieme, Stuttgart New York, S. 685–715Google Scholar
  1240. 97.
    Müller A, Moll F (1983) Acta Pharm Technol 29/3:195–203, (1985)31/4:224–229Google Scholar
  1241. 98.
    DAB 9, S. 104–105Google Scholar
  1242. 99.
    BP 88, Vol. II, p. 893Google Scholar
  1243. 100.
  1244. 101.
    AB-DDR, Arzneizubereitungen, 21.02./XIVGoogle Scholar
  1245. 102.
    USPXXII,p. 1617–1618Google Scholar
  1246. 103.
    Wollish EG, Mlodozeniee AR (1982) Pharm Teehnol 6:49Google Scholar
  1247. 104.
    DAB9,S. 101–102Google Scholar
  1248. 105.
    BP 88, A141Google Scholar
  1249. 106.
    Helv VII, V.5.1.1Google Scholar
  1250. 107.
    Sehepky G (1986) Stabilisierung von physikalischen Ei-genschaften fester Arzneiformen. In: Essig D, Hofer J, Schmidt PC, Stumpf H (Hrsg.) Stabilisierungstechnolo-gie - Wege zur haltbaren Arzneiform, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 45Google Scholar
  1251. 108.
    DAB 9, S. 105,1347Google Scholar
  1252. 109.
    BP88,p. 892Google Scholar
  1253. 110.
    Lord AG (1987) Pharm Teehnol 9:64–70Google Scholar
  1254. 111.
    AB-DDR, Arzneizubereitungen, 21.0.4./XIVGoogle Scholar
  1255. 112.
    AB-DDR, Arzneizubereitungen, 21.0.3./XIVGoogle Scholar
  1256. 113.
    DAB 9, S. 107–109Google Scholar
  1257. 114.
    Helv VII, V.5.4Google Scholar
  1258. 115.
    Herzfeldt CD (1981) 126:1494–1500; (1982) 127:1393–1397; (1983) 128:581–591; (1984) 129:736–746, 2966–2971Google Scholar
  1259. 116.
    Koch HP (1984) Pharm Acta Helv 59:98–105,130–139,178–190Google Scholar
  1260. 117.
    DAB 9, S. 1348Google Scholar
  1261. 118.
    BP 88, p. 893Google Scholar
  1262. 119.
    Sam AP, Middelbeek E, Baaijens L (1987) Acta Pharm Suec 24/2:83Google Scholar
  1263. 120.
    AB-DDR, Arzneizubereitungen, 28.0.1./XIVGoogle Scholar
  1264. 121.
    Bauer KH, Frömming KH, Führer C (1986) Pharmazeu-tische Technologie, Thieme, Stuttgart New York, S. 392Google Scholar
  1265. 122.
    Hermann E, Lundgaard H (1959) Farmaceutisk Tidende 69/47:755Google Scholar
  1266. 123.
    Bauer KH, Frömming KH, Führer C (1986) Pharma-zeutische Technologie, Thieme, Stuttgart New York, S. 386Google Scholar
  1267. 124.
    USP XXII, p. 1696Google Scholar
  1268. 125.
    USP XXII, p. 1858Google Scholar
  1269. 126.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 108–110Google Scholar
  1270. 127.
    Lieberman HA, Lachman L, Schwartz JB (1989) Pharma-ceutical Dosage Forms: Tablets, Vol.1, Dekker, New York Basel, p. 110–116Google Scholar
  1271. 128.
    DAB 9, S. 1348Google Scholar
  1272. 129.
    Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 35Google Scholar
  1273. 130.
    DAB 9, S. 1349Google Scholar
  1274. 131.
    Koch, Ritschel (1986) Synopsis der Biopharmazie und Pharmakokinetik, ecomed, Landsberg München, S. 40Google Scholar
  1275. 132.
    Pfeifer, Pflegel, Borchert (1984) Grundlagen der Bio-pharmazie, Verlag Chemie, WeinheimGoogle Scholar
  1276. 133.
    Healey JNC (1989) Enteric Coatings and Delayed Re-lease. In: Drug Delivery to the Gastrointestinal Tract, Horwood, Chichester, p. 86Google Scholar
  1277. 134.
    Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 35ff.Google Scholar
  1278. 135.
    Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 71 ff.Google Scholar
  1279. 136.
    Healey JNC (1989) Enteric Coatings and Delayed Re-lease. In: Drug Delivery to the Gastrointestinal Tract, Horwood, Chichester, p. 83–96Google Scholar
  1280. 137.
    Sehepky G (1986) Stabilisierung von physikalischen Ei-genschaften fester Arzneiformen. In: Essig D, Hofer J, Schmidt PC, Stumpf H (Hrsg.) Stabilisierungstechnolo-gie, Paperback APV, Bd. 15, Wissenschaftliche Verlags-gesellschaft, Stuttgart, S. 60Google Scholar
  1281. 138.
    Sehepky G (1986) Stabilisierung von physikalischen Ei-genschaften fester Arzneiformen. In: Essig D, Hofer J, Schmidt PC, Stumpf H (Hrsg.) Stabilisierungstechnolo-gie, Paperback APV, Bd. 15, Wissenschaftliche Verlags-gesellschaft, Stuttgart, S. 45Google Scholar
  1282. 139.
    Flaig E (1983) Acta Pharm Teehnol 29/1:51–61Google Scholar
  1283. 140.
    Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 170–173Google Scholar
  1284. 141.
    Schneider H, Speiser P (1968) Acta Pharm Helv 43:399ff.Google Scholar
  1285. 142.
    Bauer KH (1977) Pharm Ind 39/2:149–156,3:268–270Google Scholar
  1286. 143.
    Rothe W, Groppenbächer G (1973) Pharm Ind 35/11:723–726Google Scholar
  1287. 144.
    Matter UE, Hüttlin H, Lenkeit D, Pickard JF, Contini S (1973) Pharm Ind 35/lla:815–816Google Scholar
  1288. 145.
    Preis W, Demmer F, Groppenbächer G, Heinemann H (1985) Pharm Ind 47/1:73–76Google Scholar
  1289. 146.
    Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 160–162Google Scholar
  1290. 147.
    Moldenhauer H, Hünerbein B, Kala H (1971) Pharmazie 11:675–681Google Scholar
  1291. 148.
    Heyd A (1974–1975) Drug Dev Comm 1 (2): 133–142Google Scholar
  1292. 149.
    Seibt Pharma Technik 90 (1989) Seibt, MünchenGoogle Scholar
  1293. 150.
    Sehepky G, EPO105 394 A2Google Scholar
  1294. 151.
    Sehepky G, Hirsch R, DP 1667924 C3, Anmeldung 05.03.1968Google Scholar
  1295. 152.
    Banker GS, Pech GE (1981) Pharm Teehnol 4:55–61Google Scholar
  1296. 153.
    Osterwald H, Bauer KH (1981) Acta Pharm Teehnol 27/2:99–107Google Scholar
  1297. 154.
    Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 1–300Google Scholar
  1298. 155.
    Porter SC, Hogan IE (1984) Pharm Int 5:122–127Google Scholar
  1299. 156.
    McGinity IW (1989) Aqueous polymeric coatings for pharmaceutical dosage forms, Dekker, New York BaselGoogle Scholar
  1300. 157.
    Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 37Google Scholar
  1301. 158.
    Fiedler HP (1989) Lexikon der Hilfsstoffe für Pharmazie, Kosmetik und angrenzende Gebiete, Bd. 1 und 2, Editio Cantor, AulendorfGoogle Scholar
  1302. 159.
    Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 161Google Scholar
  1303. 160.
    Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 231–277Google Scholar
  1304. 161.
    Lachman L, Lieberman HA, Kanig IL (1986) The Theory and Practice of Industrial Pharmacy, Lea& Febiger, Phi-ladelphia, p. 364–373Google Scholar
  1305. 162.
    Osterwald H, Bauer KH (1980) Acta Pharm Teehnol 26/3:201–209Google Scholar
  1306. 163.
    The Pharmaceutical Society of Great Britain (1986) Handbook of Pharmaceutical Excipients, 1 Lambeth High Street, LondonGoogle Scholar
  1307. 164.
    Ciba-Geigy, Hoffmann-La Roche, Sandoz (1974) Kata-log pharmazeutischer Hilfsstoffe, Deutscher Apotheker- Verlag, StuttgartGoogle Scholar
  1308. 165.
    Röhm Pharma, DarmstadtGoogle Scholar
  1309. 166.
    McGinity IW (1989) Aqueous polymeric coatings for pharmaceutical dosage forms, Dekker, New York Basel, p. 63–79Google Scholar
  1310. 167.
    Hannula AM, Speiser P (1988) Acta Pharm Teehnol 34/4:234–236Google Scholar
  1311. 168.
    Benedikt G, Steinijans VW, Dietrich R (1988) Arzneim Forsch Drug Res 38(11) 8a:1203–1209Google Scholar
  1312. 169.
    Dietrich R, Brausse R (1988) Arzneim Forsch Drug Res 38(II) 8a:1210–1219Google Scholar
  1313. 170.
    Thoma K, Zimmer T (1986) Acta Pharm Technol 32/4:193–196Google Scholar
  1314. 171.
    Bauer KH, Fömming KH, Führer C (1989) Pharma-zeutische Technologie, Thieme, Stuttgart New York, S. 105Google Scholar
  1315. 172.
    Bauer KH, Fömming KH, Führer C (1989) Pharmazeuti-sche Technologie, Thieme, Stuttgart New York, S. 409Google Scholar
  1316. 173.
    Lachman L, Lieberman HA, Kanig IL (1986) The Theory and Practice of Industrial Pharmacy, Lea & Febiger, Phi-ladelphia, p. 351Google Scholar
  1317. 174.
    McGinity IW (ed.) (1989) Aqueous polymeric coatings for pharmaceutical dosage forms, Dekker, New York Basel, p. 273–275Google Scholar
  1318. 175.
    Lachman L, Lieberman HA, Kanig IL(1986) The Theory and Practice of Industrial Pharmacy, Lea & Febiger, Phi-ladelphia, p. 348–351Google Scholar
  1319. 176.
    Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 182–184Google Scholar
  1320. 177.
    Hüttlin H (1985) Pharm Ind 47/5:512–514Google Scholar
  1321. 178.
    Bryuninckx B (1983) Acta Pharm Technol 29/3:241–244Google Scholar
  1322. 179.
    Rothgang G (1980) Acta Pharm Technol 26/4:276–278Google Scholar
  1323. 180.
    Rölz W (1980) Acta Pharm Technol 26/4:287–289Google Scholar
  1324. 181.
    KöblitzT, Patt L, DertingerG (1988) Pharm Ind 50/1:81–91Google Scholar
  1325. 182.
    Bauer KH, Lehmann K, Osterwald HP, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 167–195Google Scholar
  1326. 183.
    Rowe RC (1985) Pharm Int 9:225–230Google Scholar
  1327. 184.
    Nürnberg E (1986). In: Kommentar zum Deutschen Arz-neibuch 9. Ausgabe, Bd. 1, Wissenschaftliche Verlagsge-sellschaft, Stuttgart, S. 192Google Scholar
  1328. 185.
    Butterfly, für Dragierung und Filmcoating, Fa. Hüttlin, SteinenGoogle Scholar
  1329. 186.
    Wadke DA, Serajuddin AT, Jacobson H (1989). In: Lieberman HA, Lachman L, Schwartz IB (eds.) Pharmaceu-tical Dosage Forms: Tablets, Vol. 1, Dekker, New York Basel, p. 1–73Google Scholar
  1330. 187.
    Fiese EF, Hägen TA (1986). In: Lachman L, Lieberman HA, Kanig IL (eds.) The Theory and Practice of Industri-cal Pharmacy, Lea & Febiger, Philadelphia, p. 171–196Google Scholar
  1331. 188.
    Stahl PH (1989) Pharm Ind 51/4:425–439Google Scholar
  1332. 189.
    Nyqvist H (1986) Drug Dev Ind Pharm 12(7):953–968Google Scholar
  1333. 190.
    Schepky G (1989) Drug Dev Ind Pharm 15/10:1715–1741Google Scholar
  1334. 191.
    Grimm W, Schepky G (1980) Stabilitätsprüfung in der Pharmazie, Editio Cantor, Aulendorf, S. 186–290Google Scholar
  1335. 192.
    Chrzanowski FA, Ulissi LA, Fegely BI, Newman AC (1986) Drug Dev Ind Pharm 12/6:783–800Google Scholar
  1336. 193.
    Ahlneck C, Waltersson IO (1986) Acta Pharm Suec 23:139–150PubMedGoogle Scholar
  1337. 194.
    Monkhouse DC (1984) Drug Dev Ind Pharm 10/8,9:1372–1412Google Scholar
  1338. 195.
    Essig D, Hofer J, Schmidt PC, Stumpf H (1986) Stabilisie-rungstechnologie, Wissenschaftliche Verlagsgesell-schaft, StuttgartGoogle Scholar
  1339. 196.
    Alderborn G (1988) Acta Pharm Suec 25:232–238Google Scholar
  1340. 197.
    Voigt R, Richter M (1988) Pharmazie 43/3:191–194PubMedGoogle Scholar
  1341. 198.
    Voigt R, Richter M, Rahn HW, Polte KH (1988) Pharma-zie 43/4:251–254Google Scholar
  1342. 199.
    El-Gindy NA, Samaha MW, El-Maradny HA (1988) Drug Dev Ind Pharm 14(7):977–1005Google Scholar
  1343. 200.
    Massoud A, Bauer KH (1986) Pharm Ind 48/4:399–403Google Scholar
  1344. 201.
    Shangraw RF (1989). In: Lieberman HA, Lachman L, Schwartz IB (eds.) Pharmaceutical Dosage Forms: Ta-blets, Vol. 1, Dekker, New York Basel, p. 195–246Google Scholar
  1345. 202.
    Bavitz IF, Shiromani PK (1986) Drug Dev Ind Pharm 12(14):2481–2492Google Scholar
  1346. 203.
    Shah NH, Stiel D, Weiss M, Infeld MH, Malick AW (1986) Drug Dev Ind Pharm 12(8,9):1329–1346Google Scholar
  1347. 204.
    Doelker E (1983). In: Breimer DD, Speiser P (eds.) Topics in Pharmaceutical Sciences, Elsevier, Amster-dam, p. 371–386Google Scholar
  1348. 205.
    Schwartz IB (1981) Pharm Technol 9:102ff.Google Scholar
  1349. 206.
    Schepky G (1986) Stabilisierung von physikalischen Ei-genschaften fester Arzneiformen. In: Essig D, Hofer J, Schmidt PC, Stumpf H (1986) Stabilisierungstechnolo-gie, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 48ff.Google Scholar
  1350. 207.
    Okhamafe AO, York P (1989) J Pharm Pharmacol 41:1–6PubMedGoogle Scholar
  1351. 208.
    Rowe RC (1983) Acta Pharm Technol 29/3:205–207Google Scholar
  1352. 209.
    Film Applicators, Fa. Sheen Instruments, Sheendale Road, Richmond, Surrey, England TW 9 2JLGoogle Scholar
  1353. 210.
    Massoud A, Bauer KH (1989) Pharm Ind 51/2:203–209Google Scholar
  1354. 211.
    Meyer A (1985) Dissertation, Universität FreiburgGoogle Scholar
  1355. 212.
    Bühler V (1989) Flüssige Arzneiformen schwerlöslicher Arzneistoffe zur oralen und parenteralen Anwendung, APV-Kurs 460, Januar 1989, FuldaGoogle Scholar
  1356. 213.
    Bauer KH, Lehmann K, Osterwald H, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 59Google Scholar
  1357. 214.
    Bauer KH, Lehmann K, Osterwald H, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 60Google Scholar
  1358. 215.
    Bauer KH, Lehmann K, Osterwald H, Rothgang G (1988) Überzogene Arzneiformen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 61Google Scholar
  1359. 216.
    Shin-Etsu Chemical, Tokyo, Pharmacoat, Technical In-formation No. P-18, October 1977, p. 1–2Google Scholar
  1360. 217.
    Röhm Pharma, Weiterstadt (Info LD-11) Eudragit L, an-wendungstechnisches MerkblattGoogle Scholar
  1361. 218.
    Lippold BH, Sutter BK, Lippold BC (1989) Int J Pharm 54:15–25Google Scholar
  1362. 1.
    Higuchi T (1977) Oesterr Apoth Ztg 31:931–934Google Scholar
  1363. 2.
    Nagai T (1966) Yakugaku Zasshi 106:99–104Google Scholar
  1364. 3.
    Heilmann K (1977) Therapeutische Systeme, Enke, Stutt-gartGoogle Scholar
  1365. 4.
    Zaffaroni A (1980) Pharm Int 1:1–3Google Scholar
  1366. 5.
    Anderson JM, Kim SW(1986) Advances in Drug Delivery Systems, Elsevier Science Publishers B.V., Amsterdam Oxford New York TokyoGoogle Scholar
  1367. 6.
    Müller BW (1987) Controlled Drug Delivery, APV-Paper-back, Band 17, Wissenschaftliche Verlagsgesellschaft StuttgartGoogle Scholar
  1368. 7.
    Robinson JR, Lee VH (1987) Controlled Drug Delivery, Fundamentals and Applications, 2nd ed., Marcel Dekker Inc., New York BaselGoogle Scholar
  1369. 8.
    Kydonieus AF, Berner B (1987) Transdermal Delivery of Drugs, Vol. 1–3, CRC Press, Boca RatonGoogle Scholar
  1370. 9.
    Heller J (1988) Biomaterials 1:51–58Google Scholar
  1371. 10.
    Heller J (1988) J Contr Release 8:111–125Google Scholar
  1372. 11.
    Monkhouse DC, Huq AS (1988) Drug Dev Ind Pharm 14:83–209Google Scholar
  1373. 12.
    Shaw JE (1982) Transdermal Therapeutic Systems. In Brandau R, Lippold BH (Hrsg.) Dermal and Transdermal Absorption, APV-Paperback, Band 4, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 171–209Google Scholar
  1374. 13.
    Pflegel P, Dittgen M (1987) Pharmazie 42:799–809PubMedGoogle Scholar
  1375. 14.
    Chien YW (1983) Drug Dev Ind Pharm 9:497–520Google Scholar
  1376. 15.
    Knoch A, Merkle HP (1985) Acta Pharm Teehnol 31:197–209Google Scholar
  1377. 16.
    Chien YW, Keshary PR, Huang YC, Sarpotdar PP (1983) J Pharm Sci 72:968–970PubMedGoogle Scholar
  1378. 17.
    Marty JP, Wepierre J (1983) Acta Pharm Suec 20:55–56Google Scholar
  1379. 18.
    Zaffaroni A (1981) Med Res Rev 1:373–386PubMedGoogle Scholar
  1380. 19.
    Franetzki M (1984) Pharm Res No.6:237–282Google Scholar
  1381. 20.
    Theeuwes F (1981) Ther 13:149–191Google Scholar
  1382. 21.
    Sefton MV, Lusher HM, Firth SR, Waher MU (1979) Ann Biomed Eng 7:329–343PubMedGoogle Scholar
  1383. 22.
    Horbett TA, Kost T, Ratner BD (1983) Am Chem Soc Div Polym Chem Prep 24:34–35Google Scholar
  1384. 23.
    Sun AM, Shea GM (1986) Microencapsulation of living cells- A longterm delivery system. In: Anderson JM, Kim SW (Eds.) Advances in Drug Delivery Systems, Elsevier Science Publishers B.V.,Amsterdam Oxford New York Tokyo, pp 137–142Google Scholar
  1385. 24.
    Jeong SY, Kim SW, Holmberg DL, McRea JC (1986) Glucose sensitive membranes for controlled delivery of Insulin: Insulin Transport studies. In: Anderson JM, Kim SW (Eds.) Advances in Drug Delivery Systems, Elsivier Science Publishers B.V., Amsterdam Oxford New York Tokyo, pp 153–164Google Scholar
  1386. 25.
    Michaels AS (1986) Controlled release, Challenges and opportunities for the next decade. In: Anderson JM, Kim SW (Eds.) Advances in Drug Delivery Systems, Elsevier Science Publishers B.V., Amsterdam Oxford New York Tokyo, pp 405–410Google Scholar
  1387. 26.
    Davis SS, Ilium L (1985) Proc Int Symp Contr Rei Bioact Mat 12:326–338Google Scholar
  1388. 27.
    Riedel E, Triebsch W (1988) Verbandstoff-Fibel, Wiss. Verlagsgesellschaft Stuttgart, S. 60–147Google Scholar
  1389. 28.
    Stowasser H, Wetting R (1984) Wunden und Hauterkran-kungen und ihre Behandlung mit Metalline, Lohmann GmbH, NeuwiedGoogle Scholar
  1390. 1.
    ISO 9000 (1987) (E) Int Org for Standization, GenfGoogle Scholar
  1391. 2.
    Heidi W, Breunig A (1987) Pharm Ind 49:964–967Google Scholar
  1392. 3.
    Meccarelli E, Scaglioni O (1968) Pharm Acta Helv 43:635–643PubMedGoogle Scholar
  1393. 4.
    Speed W (1985) EOQC Meeting BruxellesGoogle Scholar
  1394. 5.
    Bacon FR, Raggon FC (1959) J Am Cosm Soc 42:199–205Google Scholar
  1395. 6..
    Becker K (1979) Verp Rundschau 30:425–28Google Scholar
  1396. 7.
    Lebovits A (1966) Mod Plastics 139–210Google Scholar
  1397. 8.
    Cairns JA (1974) Packaging for Climatic Protection, Newnes-Butterworths, LondonGoogle Scholar
  1398. 9.
    Koszinowski J (1990) Verp Rundschau 41:3 15–17Google Scholar
  1399. 10.
    Jarsen D (1984) Qualitätssicherung von pharmazeutischen Packmitteln, Edition Cantor, AulendorfGoogle Scholar
  1400. 11.
    Algner S, Helbig J, Spingier E (1984) Primär-Packmittel. Herstellung -I- Optimierung + Kontrolle = Sicherheit, APV Paperback, Band 9Google Scholar
  1401. 12.
    Helbig J, Spingier E (1985) Kunftstoffe für die Pharma-zeutische Verpackung, APV Paperback, Band 13Google Scholar
  1402. 13.
    Hauschild G, Spingier E (1988) Migration bei Kunststoff-verpackungen, APV Paperback, Band 19Google Scholar
  1403. 14.
    Feltkamp H, Fuchs P, Sucker H (1983) Pharmazeutische Qualitätskontrolle, Thieme, Stuttgart New YorkGoogle Scholar
  1404. 15.
    Ross CF (1975) Packaging of pharmaceuticals, The Insti-tute of Packaging, Newnes-Butterworths, LondonGoogle Scholar
  1405. 16.
    Klingelhöller W, Schönduve E (1976) Pharm Ind 38, lla: 1025–1034Google Scholar
  1406. 17.
    Besch R, Kimpel B, Landwehr F (1980) Pharm Ind 42, lla:1164–1176Google Scholar
  1407. 18.
    N.N. (1988) Neue Verp 12/88:84–92Google Scholar
  1408. 19.
    Rettig HL (1988) Neue Verp 12/88:26–41Google Scholar
  1409. 1.
    Thoma K, Serno P, Precht D (1983) Pharm Ind 45:420–425Google Scholar
  1410. 2.
    Brower JF, Juenge EC, Page DP, Dow ML (1980) J Pharm Sei 69:942–945Google Scholar
  1411. 3.
    Pawelczyk E, Zajac M (1970) Acta Polon Pharm 27: 113–117Google Scholar
  1412. 4.
    Boer Y, Cox HLM, Pijnenburg JMA (1981) Pharm Weekbl 116:1090–1098Google Scholar
  1413. 5.
    Karolyi I, Kedvessy G, Regdon G, Regdon E (1976) Phar-mazie 31:179–180Google Scholar
  1414. 6.
    Voigt R, Bornschein M, Grohmann A (1982) Pharmazie 37:529–536PubMedGoogle Scholar
  1415. 7.
    Thoma K (1980) Arzneiformen zur rektalen und vaginalen Applikation, Werbe-und Vertriebsgesellschaft Dtsch. Apoth., FrankfurtGoogle Scholar
  1416. 8.
    de Buman A, Riva A, Sucker H (1979) Acta Pharm Teehnol. Suppl 7:77–79Google Scholar
  1417. 9.
    Gebler H (1982) Tabellen für die pharmazeutische Praxis, 2. Aufl., Govi, FrankfurtGoogle Scholar
  1418. 10.
    Herrmann D (1984) Primärpackmittel im Streßtest mit Arzneimitteln. In: Algner S, Heibig J, Spingier E (Hrsg.) Primärpackmittel. Wiss. Verlagsges., Stuttgart, S. 124Google Scholar
  1419. 11.
    Thoma K (1986) Neuere Arzneiformen in der Apotheken-rezeptur, Deutscher Apotheker-Verlag, StuttgartGoogle Scholar
  1420. 12.
    Thoma K, Serno P (1982) Pharm Ztg 127:980–986Google Scholar
  1421. 13.
    Fischer FX, Ackermann P (1983) Acta Pharm Technol 29:13–17Google Scholar
  1422. 14.
    Krówczynski L, Knapczyk J (1979) Pharm Ztg 124:1553–1556Google Scholar
  1423. 15.
    Firmenschrift Suppositorienmassen der Dynamit Nobel AG (1976) Troisdorf-OberlarGoogle Scholar
  1424. 16.
    Setnikar I, Fantelli S (1962) J Pharm Sei 51:566–571Google Scholar
  1425. 17.
    Müller BW (1982) Suppositorien und rektale Absorption. In: Gelbe Reihe. Govi, Frankfurt, S. 121Google Scholar
  1426. 18.
    Mühlemann H, Neuenschwander RH (1956) Pharm Acta Helv 31:305PubMedGoogle Scholar
  1427. 19.
    de Leede LGJ, de Boer AG, van Velzen SL, Breimer DD (1981) Proc first Europ Congress Biopharm Pharmacokin, part 1:239–243Google Scholar
  1428. 20.
    de Boer AG, de Leede LGH, Breimer DD (1982) Pharma-cy Internat:267–269Google Scholar
  1429. 21.
    Knudsen FU (1977) Acta Paediatr Scand 66:563–567PubMedGoogle Scholar
  1430. 22.
    de Boer AG, Molenaar F, de Leede LGJ (1982) Clin Pharmacokin 7:285–311Google Scholar
  1431. 23.
    Fischer FX (1986) Literaturübersicht über die rektale Ab-sorption von Wirkstoffen. In: Müller BW (Hrsg.) Suppo-sitorien. Wiss. Verlagsges., Stuttgart, S. 208Google Scholar
  1432. 24.
    Molenaar F (1980) Pharm Weekbl 115:477–487Google Scholar
  1433. 25.
    Molenaar F, Oldenhof NJJ, Groenewoud W, Huizinga T (1979) Pharm Weekbl Sci Ed 1:25–30Google Scholar
  1434. 26.
    Djimbo M, Moés AJ, (1986) J Pharm Belg 41:393–401PubMedGoogle Scholar
  1435. 27.
    Ichikawa K, Ohata I, Mitomi M, Kawamura S, Maeno H, Kawata H (1980) J Pharm Pharmacol 32:314–318PubMedGoogle Scholar
  1436. 28.
    Kim S, Kamada A, Higuchi T, Nishihata T (1983) J Pharm Pharmacol 35:100–103PubMedGoogle Scholar
  1437. 29.
    Dolder R (1978) Vaginalpräparate. In: Sucker H, Fuchs P, Speiser P (Hrsg.) Pharmazeutische Technologie, Thieme, Stuttgart, S. 509Google Scholar
  1438. 30.
    Simunek F (1986) Vaginale Arzneiformen. In: Müller BW (Hrsg.) Suppositorien. Wiss. Verlagsges., Stuttgart, S. 26Google Scholar
  1439. 1.
    Hänsel R, Trunzler G (1989) Wissenswertes über Phyto-pharmaka, Braun, KarlsruheGoogle Scholar
  1440. 2.
    Steinegger E, Hänsel R (1988) Lehrbuch der Pharmakog-nosie und Phytopharmazie, Springer, Berlin HeidelbergGoogle Scholar
  1441. 3.
    Hanke G (1984) Qualität pflanzlicher Arzneimittel, Wissen-schaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  1442. 4.
    List P, Schmidt PC (1984) Technologie pflanzlicher Arznei-zubereitungen, Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  1443. 5.
    Tech D, Rumpf H, Schönert K (1972) Zerkleinern. In: Bartholome E, Biekert E, Hollmann H, Ley H (Hrsg.) Ullmanns Enzyklopädie der technischen Chemie, 4. Aufl., Verlag Chemie, WeinheimGoogle Scholar
  1444. 6.
    Bauer KH, Frömming KH, Führer C (1986) Pflanzliche Arzneizubereitungen. In: Pharmazeutische Technologie, Thieme, StuttgartGoogle Scholar
  1445. 7.
    Wichtl M (1984) Teedrogen, Wissenschaftliche Verlagsge-sellschaft, StuttgartGoogle Scholar
  1446. 8.
    Braun R (1987) Standardzulassungen für Fertigarzneimit-tel, Deutscher Apotheker Verlag, Stuttgart, Govi, Frank-furt/MainGoogle Scholar
  1447. 9.
    List PH (1970) Allgemeine pharmazeutisch-technologische Arbeitsverfahren, Bd. VII, A. In: List PH, Hörhammer L (Hrsg.) Hagers Handbuch der pharmazeutischen Praxis, 4. Ausg. Springer, Berlin HeidelbergGoogle Scholar
  1448. 1.
    Komitee für Laboratorien und offizielle Medikamenten-kontrolle und Sektion Industrie-Apotheker der FIP (1980) Pharm Ind 42:982–984Google Scholar
  1449. 2.
    Feiden K (1987) Pharm Technol J 8:5–7Google Scholar
  1450. 3.
    Commission of the European Communities (1989) „No-tice to Applicants“ for marketing authorizations for pro-prietory medicinal products in the member states of the European Community, 1049 BrüsselsGoogle Scholar
  1451. 4.
    Bundesgesundheitsamt (1988) Erläuterungen des BGA zum Antrag auf Zulassung eines Arzneimittels, 2. Aufl.Google Scholar
  1452. 5.
    Betriebsverordnung für pharmazeutische Unternehmer (PharmBetrV) (1985) Pharm Ind 47:251–257Google Scholar
  1453. 6.
    Pharmazeutische Inspektions Convention (PIC) (1983) Grundregeln für die sachgemäße Herstellung pharmazeu-tischer Produkte („Basic Standards“) Dokument PH 3/83Google Scholar
  1454. 7.
    Food and Drug Administration (1987) Guideline on gen-eral principles of process validation, FDA Center for Drugs and Biologies, Rockville, MD 20857Google Scholar
  1455. 8.
    PMA’s validation advisory committee (1985) Pharm Tech-nol 9:78–82Google Scholar
  1456. 9.
    EG-Leitfaden einer guten Herstellungspraxis für Arznei-mittel (1990) Pharm Ind 52:853–874Google Scholar
  1457. 10.
    Frey EM (1984) Pharm Ind 46:601–609Google Scholar
  1458. 11.
    Franklin NC (1983) Validierungstransfer. In: Sucker H (1983) Praxis der Validierung, Wissenschaftliche Verlags-gesellschaft, StuttgartGoogle Scholar
  1459. 12.
    Naumann T (1987) Pharm Technol J 8:61–64Google Scholar
  1460. 13.
    Chapman KG (1983) Pharm Technol 7:51–57Google Scholar
  1461. 14.
    Lingnau J (1987) Pharm Technol J 8:65–69Google Scholar
  1462. 15.
    Sirch E (1990) Die Bedeutung von technischer Abnahme, Kalibrierung und Qualifizierung bei pharmazeutischen Produktionsanlagen, Concept-Seminar „Validierung im Rahmen europäischer Richtlinien“, Frankfurt/MainGoogle Scholar
  1463. 16.
    Sucker H, Fuchs P, Speiser P (1978) Pharmazeutische Technologie, Thieme, StuttgartGoogle Scholar
  1464. 17.
    Lingnau J (1989) Drug Dev Ind Pharm 15:1029–1046Google Scholar
  1465. 18.
    Food and Drug Administration (1988) Draft Guideline on the preparation of investigational new drug products, Di-vision of Manufacturing and Product Quality (HFN 320) Rockville, MD 20857Google Scholar
  1466. 19.
    Avallone HL (1990) Pharm Technol Intern 2(8):66–68Google Scholar
  1467. 20.
    Wallhäußer KH (1982) Pharm Ind 44:401–404Google Scholar
  1468. 21.
    Wallhäußer KH (1985) Pharm Ind 47:314–319Google Scholar
  1469. 22.
    Parenteral Drug Association (1980) Validation of aseptic fillingforsolutiondrugproducts,TechnicalMonograph2Google Scholar
  1470. 23.
    Seyfarth H (1987) Pharm Ind 49:1176–1183Google Scholar
  1471. 24.
    FIP-Bericht (1990) Pharm Ind 52:1001–1005Google Scholar
  1472. 25.
    DIN 58950/Teil 3 (1988) Abnahmeprüfungen an pharma-zeutischen DampfsterilisatorenGoogle Scholar
  1473. 26.
    Agalloco JP (1986) Validation of aseptic filling operations. In: Carleton FJ, Agalloco JP, Validation of aseptic phar-maceutical processes, Marcel Dekker, New York BaselGoogle Scholar
  1474. 27.
    Frieben WR, Folck RJ, Devisser A (1982) J Parenter Sei Technol 36:112–116Google Scholar
  1475. 28.
    FIP-Bericht (1988) Pharm Ind 50:731–734Google Scholar
  1476. 29.
    Dietz GR (1986) Validation of Co 60 radiation steriliza-tion. In: Carleton FJ, Agalloco JP, Validation of aseptic pharmaceutical processes, Marcel Dekker, New York Ba-selGoogle Scholar
  1477. 30.
    Wallhäußer KH (1988) Praxis der Sterilisation-Desinfek-tion-Konservierung, 4.Aufl., Thieme, StuttgartGoogle Scholar
  1478. 31.
    AM Rad V (1987) Bundesgesetzblatt 1987 Teil 1:502Google Scholar
  1479. 32.
    Bekanntmachung des BGA (1987) über Zulassung und Registrierung von Arzneimitteln/Erläuterungen zum An-trag auf Zulassung von Arzneimitteln, die mit ionisieren-den Strahlen behandelt worden sindGoogle Scholar
  1480. 33.
    Brandau R (1983) Validierung halbfester Formen in der Entwicklung. In: Sucker H (1983) Praxis der Validierung, Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  1481. 34.
    Lingnau J (1983) Validierung halbfester Formen in der Produktion. In: Sucker H (1983) Praxis der Validierung, Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  1482. 35.
    Lingnau J (1977) Acta Pharm Technol 23(l):39–52Google Scholar
  1483. 36.
    FIP-Bericht (1980) Pharm Acta Helv 55:29–39Google Scholar
  1484. 37.
    Seyfarth H, Lechner U (1990) Pharm Ind 52:1129–1142Google Scholar
  1485. 38.
    Riniker HP (1987) Pharm Technol J 8:57–60Google Scholar
  1486. 39.
    Rudolph JS (1984) Validation of solid dosage forms. In: Loftus BT, Nash RA, Pharmaceutical process validation, Marcel Dekker, New York BaselGoogle Scholar
  1487. 40.
    Thieme H (1982) Pharm Ind 44:919–924Google Scholar
  1488. 41.
    Rahm H (1983) Validierung fester Formen in der Produk-tion. In: Sucker H (1983) Praxis der Validierung, Wissen-schaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  1489. 42.
    Algner S, Lietz H (1983) Validierung in der Packungsent-wicklung und Verpackung. In: Sucker H (1983) Praxis der Validierung, Wissenschaftliche Verlagsgesellschaft, Stutt-gartGoogle Scholar
  1490. 43.
    Algner S (1983) Pharm Ind 45:1171–1175Google Scholar
  1491. 44.
    Ventura DA, Goodsir SW (1986) Component preparation processes. In: (s. 26)Google Scholar
  1492. 45.
    Avallone HL (1989) Pharm Eng 9:37–40,57Google Scholar
  1493. 46.
    Zimmermann G (1989) Pharm Technol J 10(4):45–51Google Scholar
  1494. 47.
    Faubel G, Schott W, van der Stouwe C (1989) Pharm Ind 51:310–320Google Scholar
  1495. 48.
    PMA’s Computer systems validation committee (1986) Pharm Technol 10:24–34Google Scholar
  1496. 49.
    Dertinger G (1987) Pharm technol J 8:43–47Google Scholar
  1497. 50.
    Bosshardt H, Schorderet F (1983) Validierung analyti-scher Methoden. In: Feltkamp H, Fuchs P, Sucker H, Pharmazeutische Qualitätskontrolle, Thieme, Stuttgart New YorkGoogle Scholar
  1498. 51.
    Grimm W (1983) Validierung der Haltbarkeitsaussage. In: Sucker H (1983) Praxis der Validierung, Wissenschaft-liche Verlagsgesellschaft, StuttgartGoogle Scholar
  1499. 52.
    Schwemmer WL (1990) Pharm Eng 10(3):44–46Google Scholar
  1500. 53.
    Trubinski CJ, Majeed M (1984) Retrospective Process Validation. In: Loftus BT, Nash RA(1984) Pharmaceuti-cal Process Validation, Marcel Dekker, New York BaselGoogle Scholar
  1501. 54.
    Geschwandtner H, Hambloch H, Hempel HE, Lanz W, Stupp HJ, Weirich W, Wiesenthal K (1989) Pharm Ind 51:911–913Google Scholar
  1502. 55.
    Mclean A, McNamara PJ, duSouich P, Gibaldi M, Lalka D (1978) Clin Pharmacol Ther 24:5–10PubMedGoogle Scholar
  1503. 56.
    Walson PD, Mortensen ME (1989) Clin Pharmacokinet 17:116–137PubMedGoogle Scholar
  1504. 57.
    Montamat SC, Cusack BJ, Vestal RE (1989) N Engl J Med 321:303–309PubMedGoogle Scholar
  1505. 58.
    Daneshmend TK (1990) Brit J Clin Pharmac 29:783Google Scholar
  1506. 59.
    Boyle R, Behan PO, Sutton JA (1990) Br J Clin Pharmac 30:405–409Google Scholar
  1507. 60.
    van Baak MA (1990) Clin Pharmacokinet 19:23–43Google Scholar
  1508. 61.
    Somani SU, Gupta SK, Frank S, Corder CN (1990) Drug Develop Res 20:251–275Google Scholar
  1509. 62.
    Ho PC, Triggs EJ, Bourne DWA, Heazlewood VJ (1985) Br J Clin Pharmac 19:6775–684Google Scholar
  1510. 63.
    Montgomery PR, Berger LG, Mitenko PA, Sitar DS (1986) Clin Pharmacol Ther 39:571–576PubMedGoogle Scholar
  1511. 64.
    Macdonald JI, Herman RJ, Verbeeck RK (1990) Eur J Clin Pharmacol 38:175–179PubMedGoogle Scholar
  1512. 65.
    Notarianni LJ (1990) Clin Pharmacokinet 18:20–36PubMedGoogle Scholar
  1513. 66.
    Gilman JT (1990) Clin Pharmacokinet 19:1–10PubMedGoogle Scholar
  1514. 1.
    Neumann BS (1967) The Flow Properties of Powders. In: Bean HS, Becket AH, Carless JE (Hrsg.) Advances in Phar-maceutical Sciences. Vol. 2, Academic Press, London New York, S. 181Google Scholar
  1515. 2.
    Voigt R (1987) Lehrbuch der Pharmazeutischen Technolo-gie, 6. Auflage, Verlag Chemie, Weinheim, S. 145Google Scholar
  1516. 1.
    Andrews J, Kniseley RM, Wagner HN (1966) Radioactive Pharmaceuticals, Oak-Ridge, US Atomic Energy Com-missionGoogle Scholar
  1517. 2.
    Benes IF (1985) Radiopharmazie. In: Dolder R (Hrsg.) Praxis der Krankenhauspharmazie, Thieme, Stuttgart New York, S. 128–212Google Scholar
  1518. 3.
    Conti L, Hegesippe M, De Saint Sauveur S, Tempe J (1972): Biosynthèase de sélénométhionine- Se pour usage scintigraphique, Int J Appl Radiat Isot 23:415–421Google Scholar
  1519. 4.
    McAfee J (1975) Radioactive diagnostic agents. In: Sub-ramanian C et al. (Eds.) Radiopharmaceuticals. The So-ciety of Nuclear Medicine, New YorkGoogle Scholar
  1520. 5.
    Lamprecht RM, Wolf A (1975) Cyclotron Production of Radiohalogens and Their Use in Excitation Labeling. In: Subramanian et al. (Eds.) Radiopharmaceuticals. The So-ciety of Nuclear Medicine, New YorkGoogle Scholar
  1521. 6.
    Ell PJ et al. (1985) Lancet 6:50–51Google Scholar
  1522. 7.
    Sharpp F et al. (1986) J Nucl Med 27:171–177Google Scholar
  1523. 8.
    Freeman LM et al. (1984, 1986). In: Freeman LM (Ed.) Freeman and Johnson’s Clinical Radionuclide Imaging, 3rd ed., Grune and Stratton, Orlando, FLGoogle Scholar
  1524. 9.
    Tubis M. Wolf W et al. (Eds.) (1976) Radiopharmacy, „A Wiley-Interscience Publication“, New York London Syd-ney TorontoGoogle Scholar
  1525. 10.
    Bernhard H, Lieser KH (1974) Euro Spectra 9:20–24Google Scholar
  1526. 11.
    Cohen Y, Besnard M (1980) A. Radionuklides. Pharma-cokinetics. In: Hundeshagen H (Red.) Nuklearmedizin, Teil 1A, Bd. 15, Springer, Berlin Heidelberg New YorkGoogle Scholar
  1527. 1.
    Provost C (1986) Int J Cosmet Sei 8:233–247Google Scholar
  1528. 2.
    Münzel K (1953) Pharm Acta Helv 28:320–336PubMedGoogle Scholar
  1529. 3.
    Münzel K (1968) J Soc Cosmet Chem 19:289–347Google Scholar
  1530. 4.
    Bauer KH, Frömming KH, Führer C (1986) Pharmazeuti-sche Technologie, 1. Aufl., Thieme, Stuttgart New York, S. 314Google Scholar
  1531. 5.
    Häusler FX (1989) Dissertation, Technische Universität, BraunschweigGoogle Scholar
  1532. 6.
    Kung HC, Goddard ED (1964) J Phys Chem 68:3465–3469Google Scholar
  1533. 7.
    Führer C (1969) APV-Informationsdienst 2/3:87–97Google Scholar
  1534. 8.
    Führer C (1971) Pharmazie 26:43–45PubMedGoogle Scholar
  1535. 9.
    Führer C, Friberg S, Fischer G (1976) Röntgenstrukturun-tersuchungen der Hydrophilen Salbe, 22. Jahreskongreß der APV, BerlinGoogle Scholar
  1536. 10.
    Junginger H, Führer C, Beer A, Ziegenmeyer J (1979) Pharm Ind 41:380–385Google Scholar
  1537. 11.
    Führer C, Junginger H, Friberg S (1978) J Soc Cosmet Chem 29:703–716Google Scholar
  1538. 12.
    Junginger H, Führer C, Ziegenmeyer J, Friberg S (1979) J Soc Cosmet Chem 30:9–23Google Scholar
  1539. 13.
    Junginger HE, Heering W (1990) Dtsch Apoth Ztg 130:684–685Google Scholar
  1540. 14.
    Junginger H, Heering W (1983) Acta Pharm Technol 29:85–96Google Scholar
  1541. 15.
    Müller-Goymann CC (1981) Dissertation, Technische Universität, BraunschweigGoogle Scholar
  1542. 16.
    Müller-Goymann C, Schütze W (1990) Dtsch Apoth Ztg 130:561–562Google Scholar
  1543. 17.
    Müller-Goymann C (1984) Seifen, Öle, Fette, Wachse 110:395–400Google Scholar
  1544. 18.
    Nürnberg E (1969) Fette, Seifen, Anstrichm 71:386–394Google Scholar
  1545. 19.
    Nürnberg E (1971) Pharmaz Ztg 116:1466–1472Google Scholar
  1546. 20.
    Nürnberg E (1975) Pharmaz Ztg 120:1509–1519Google Scholar
  1547. 21.
    Nürnberg E, Kohl P (1980) Dtsch Apoth Ztg 120:1649–1657Google Scholar
  1548. 22.
    Nürnberg E, Muckenschnabel R (1982) Dtsch Apoth Ztg 122:2093–2106Google Scholar
  1549. 23.
    Kohl P (1979) Dissertation, Universität, ErlangenGoogle Scholar
  1550. 24.
    Muckenschnabel R (1983) Dissertation, Universität, Er-langenGoogle Scholar
  1551. 25.
    De Vringer T, Joosten JGH, Junginger HE (1986) Coli Polym Sei 264:691–700Google Scholar
  1552. 26.
    De Vringer T, Joosten JGH, Junginger HE (1987) Coli Polym Sei 265:167–179Google Scholar
  1553. 27.</